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Abstract 
Human embryonic stem cells display several features of heterogeneity in culture. This 
heterogeneity is poorly understood and may impair differentiation protocol efficiency. There is 
increasing evidence that stem cell heterogeneity is dynamic and affects lineage fate decisions 
whilst cells are still pluripotent. The aim of this project was to develop new approaches for 
understanding the heterogeneity of cells within the pluripotent stem cell compartment that 
influences stem cell fate decisions. Understanding the rules governing stem cell heterogeneity 
would open up opportunities to manipulate these features for the improved application of 
differentiation protocols or within regular cell culture maintenance. 
 
Two novel methods for the interrogation of pluripotent stem cell heterogeneity have been 
developed in this thesis. The first approach examines pluripotent stem cell dynamics by 
modelling the population fluctuations of the sensitive pluripotency marker SSEA3 of a 
pluripotent Embryonal Carcinoma (EC) cell line, NTera2. The model generated explained the 
heterogeneity dynamics of SSEA3 within NTera2 and in a predictive manner that also revealed 
candidate substate populations.  
 
The second approach developed was the application of Raman spectroscopy for the non-
invasive assessment of heterogeneity within and between stem cell populations according to 
biochemical signatures. These studies showed that a hyperspectral, grid based, approach proved 
sensitive for examination of cell biochemistry and furthermore, this approach was used to 
address biological questions. Raman Spectroscopy proved sensitive enough to notice differences 
between cell lines, between differentiated and undifferentiated cells, between intracellular 
compartments, and could discriminate between different pluripotent cells associated with 
differing lineage biases. 
 
This work therefore represents a development in both our understanding of pluripotent stem 
cell dynamics and the potential for using both modelling and Raman spectroscopy to analyse 
this phenomenon.  
 2 
 
 
 
Chapter 1 
 
 
Introduction 
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1.1 Introduction 
Multicellular animals demonstrate remarkable cellular specialisation, upon which their survival 
is dependent. However, despite the diverse array of cell types present within the body, in each 
case they are all the direct progeny of one cell: the zygote. All the cellular diversification in 
phenotype resulting in the complex organismal systems, organs and tissues of that animal are 
traced back to that initial, singular, cell. The feat of animal development is remarkably intricate 
and yet for all its complexities, it is completed with astonishing precision and accuracy. 
Necessarily then, the zygote represents the cell within the organism that is most plastic in terms 
of the range of potential cell types its progeny could become and is often therefore referred to 
as totipotent. 
 
Later in development, cells of the inner cell mass of the blastocyst are restricted to progeny that 
can contribute to all the cells of the adult organism but not extra embryonic tissue and are thus 
termed pluripotent. Pluripotent cells represent a great resource for the field of regenerative 
medicine, where it is, in principle, possible to direct these cells in vitro into the formation of any 
cell type required for therapeutic application, including even organ formation.  The 
understanding of how to derive cells of interest from these pluripotent cells via differentiation 
assays has grown immensely yet remains grossly incomplete and the processes by which 
pluripotent cells make cell fate decisions are not well delineated. Given the range of cell fates 
that a pluripotent cell may adopt, it is perhaps not surprising that not all cells in a pluripotent 
cell culture behave uniformly. Cryptic heterogeneity in decision making of pluripotent cells 
represents a problem to differentiation protocols in that the starting population of cells are 
liable to respond with different efficacies to the applied stimulus. Methods by which this 
heterogeneity can be studied and interrogated are lacking. This thesis presents two novel 
approaches for exploring cryptic pluripotent stem cell heterogeneity. It is anticipated that if this 
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heterogeneity is understood, it may be manipulated in order to improve the efficiencies of 
directed differentiation protocols of pluripotent stem cells. 
 
Following a brief history of research in the pluripotent stem cell field, an introduction to current 
examination of stem cell identity and heterogeneity is provided. Two novel approaches to 
understand underlying stem cell heterogeneity are introduced via: a mathematical modelling 
application to the study of stem cell population dynamics is and an introduction to Raman 
spectroscopy.  
  
History of Stem Cell Research 
1.2 Pluripotency 
The zygote would be the first specific cell ever to be termed a stem cell as coined by eminent 
German biologist (Haeckel, 1868). Although he originally applied the term “Stammzelle” 
(German for stem cell) to describe what he believed to be the first common unicellular ancestor 
of all multicellular organisms, Haeckel was also the first to propose applying the term to the 
fertilised egg (Haeckel, 1877). This term was indeed applied to early investigations into 
embryology, including investigations into Weissman’s germ-plasm hypothesis (Weissman, 1885) 
where it was proposed that there were, for all intents and purposes, two types of tissue - germ 
cells and somatic. Under this paradigm, it was suggested that germ cells, which contained the 
germ-plasm that is transmitted from one generation to the next, give rise to the other cells of 
the body (somatic cells) and other germ cells. Somatic cells, on the other hand, are incapable of 
generating germ cells and therefore impotent at transferring germ-plasm from one generation 
to the next. In the absence of modern understanding of genetics, this idea captured the 
imaginations of several embryologists of the time, such as Boveri and Häcker, who sought to 
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isolate the earliest germ cells in developing embryos (Boveri, 1892; Häcker, 1892; Ramalho-
Santos and Willenbring, 2007). From both of their studies, the term stammzelle was 
consequently heavily associated with what we recognise today as the germline lineage, 
primordial germ cells and germline stem cells. In fact, it was not until Wilson reviewed their 
works in English four years later that the word stem cell was popularised in the English lexicon, 
and he is consequently sometimes misattributed as having coined the term (Maienschein, 2003; 
Shostak, 2006; Wilson, 1896). 
 
Concurrently, at around the turn of the 20 th century, biologists working on the development and 
regeneration of the hematopoietic system postulated that there was a common precursor cell 
to the various cell types found in blood (reviewed by (Ramalho-Santos and Willenbring, 2007)). 
This common precursor of the blood cell types was also designated the title of stem cell; and 
this designation was popularised by Maximow (Maximow, 1908) Neumann (Neumann, 1912) 
and others. However, the first time the word stem cell was used in reference to the 
hematopoietic system was by Pappenheim in 1896 to describe the precursor cell to red and 
white blood cells (Pappenheim, 1896). Although it was not until much later that a common 
precursor cell to the entire hematopoietic system was definitively identified (Becker et al., 1963; 
Till and Mc, 1961; Till and McCulloch, 1964). During this time, an important clarification to stem 
cell identity emerged, and one integral to stem cells’ relevance to regenerative medicine; a stem 
cell also required the capacity of self-renewal in addition to potency. 
 
As a result of two independent fields of research we now have our modern definition of a stem 
cell, that is, a cell that simultaneously possesses the properties of potency and self-renewal. 
Under this definition, stem cells have been identified in a variety of tissues throughout the 
human organism such as the central nervous system, skin, intestines and so on. Although these 
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cells all exhibit some degree of potency, not all stem cells are equally potent with stem cells 
identified in the adult being generally restricted to give rise to progeny within their relevant 
tissue (Reviewed by (Robey, 2000)). This is not terribly surprising since as a general rule, during 
the process of development as the organisms grows, cells divide and gradually become more 
specialised; progressively losing potency as a result. Consequently, stem cells acquired from the 
adult have a limited capacity for regenerative medicine, whereas the pluripotent stem cells of 
the early embryo, still capable of producing all the cells of the adult organism do not suffer such 
a restriction. It is this potential that embryonic stem cells capture the imagination of researchers 
in the application of regenerative medicine. 
 
1.3 Embryonal Carcinomas 
Curiously enough, the origins of embryonic stem cell research begin not with the embryo but 
can arguably be traced back to earlier studies on teratocarcinoma in the 1950s. 
Teratocarcinomas are generally highly malignant tumours that tend to occur in the testis (Dixon 
and Moore, 1952; Mostofi and Price, 1973) . These occur rarely in the human population, 
although their occurrence peaks in young post-pubescent males and there has been a dramatic 
rise in their incidence over the last 60 years (Andrews, 2002; Moller, 1993). The peculiar 
property of teratocarcinomas, compared to other carcinomas and which also brought them into 
prominence in pluripotent cell research, was their heterogeneous histology. Teratocarcinomas 
have been documented to contain all manner of cells, tissues and even partially formed organs 
derived from all three germ layers and all completely ectopic to the testes such as; teeth, pieces 
of bone, nerve, muscles, skin and hair. Some tumours even contained tissue arrangements and 
identities that closely resembles that of the early developing embryo.  This feature is in fact the 
root of teratocarcinoma’s etymology with “teratos” being the Greek for “monster.” Yet in 
addition to these differentiated cell types, these tumours also contained undifferentiated cell 
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types which were the key malignant and pluripotent stem cell of the tumour and termed 
embryonic carcinoma (EC) cells. 
 
Teratocarcinoma’s bizarre appearance and relative rarity meant that study of the condition was 
restricted to occasional spontaneous human gonadal tumours. The scarcity of sample material 
was compounded by the fact that teratocarcinoma is also extremely rare in mice and rats, the 
most common laboratory animals, and so was difficult to study experimentally. This all changed 
however when a particular strain of mouse, Strain 129, was reported to spontaneously develop 
testicular teratomas and teratocarcinomas within the seminiferous tubules of the developing 
gonad (Stevens and Little, 1954). Furthermore, a method by which these tumours could be 
induced by explanting the genital ridges of Strain 129 foetuses between 11 and 13.5 days of 
development indicating primordial germ cells as the source of the tumour (Stevens, 1964, 1967, 
1970; Stevens and Hummel, 1957). Primordial germ cells migrate into the genital ridge at 11 
days, but there is an implied change in primordial germ cell behaviour by 13.5days that precludes 
tumour formation, presumably attributed to these cells entering mitotic arrest (Bendel-Stenzel 
et al., 1998) In addition, single cells derived from a teratocarcinoma and injected 
intraperitoneally in mouse were shown to be capable of producing all cells within a 
teratocarcinoma (Kleinsmith and Pierce, 1964). This finding demonstrated that 
teratocarcinomas possess a unique type of cell, that has the capacity to grow indefinitely 
(ensuring malignancy) and whose progeny have great potency, able to differentiate into multiple 
adult cell types. Further experimentation on teratocarcinomas and early embryos determined 
great similarity in their differentiation potential by grafting early embryos onto extra-uterine 
sites that generated re-transplantable teratocarcinomas; suggesting that the pluripotency of 
cells from the early embryo and from teratocarcinomas were similar if not identical (Brinster, 
1974). 
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Meanwhile, experiments on human teratocarcinoma were limited but there were attempts to 
study them via xenotransplantation into hamster cheek pouch (Pierce and Verney, 1961). The 
next major chapter in pluripotent cell study began with the successful in vitro culture of mouse 
embryonic carcinoma cell lines. Originally, the potency of these tumours made culturing the 
undifferentiated EC cells difficult and cultures typically proliferated poorly, exhibiting haphazard 
and unpredictable differentiation (Evans, 1972; Jakob et al., 1973; Kahan and Ephrussi, 1970; 
Nicolas et al., 1975; Pierce and Verney, 1961; Rosenthal et al., 1970) . Eventually, culturing 
techniques were refined sufficiently to permit indefinite culture of mouse EC cells from 
teratocarcinomas that were demonstrably pluripotent as determined by teratocarcinoma 
formation following subcutaneous injection of these cells (Martin, 1975; Martin and Evans, 
1974, 1975). Furthermore, the culture of these mouse EC on non-adherent plates resulted in the 
formation of cell clumps, eponymously called embryoid bodies due to their morphological 
similarity to the early mouse embryo (Martin, 1975; Martin and Evans, 1974, 1975).  
 
The in vitro derivation of human EC cell lines followed suit with their murine counterparts; 
explanting teratocarcinoma tissue samples in order to permit the culture of the malignant, 
pluripotent, EC stem cell of the tumour. The earliest derived human cell lines established in vitro  
were TERA1, TERA2 and SuSa (Fogh J, 1975; Hogan et al., 1977) although these appeared to have 
compromised differentiation potential and it was not until about a decade later that human EC 
lines capable of differentiation were obtained, which remarkably included subclones from the 
TERA2 cell line (Andrews et al., 1984b). The cell line NTera2.D1, subcloned from a xenograft 
tumour of the cell line TERA2, demonstrably had the capacity to differentiate in vitro into several 
cell types, including neurons, when exposed to retinoic acid (Andrews, 1984; Andrews et al., 
1984b). 
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1.4 Embryonic Stem Cells 
Given the pluripotent properties of EC cells, and that it is possible to indirectly acquire EC cells 
from embryos grafted to extra-uterine sites that go on to form teratocarcinomas, the next 
question was whether similar cells could be derived from the embryo that had not already 
undergone malignant transformation. Although many attempts to culture cells from early 
mammalian embryos were performed prior to 1950 for the purposes of mammalian sample 
tissue generation none of the cultured cell lines fulfilled the modern criteria by which an 
embryonic stem (ES) cell is defined (Cole, 1965; Edwards, 2004). An embryonic stem cell should 
be capable of giving rise to all tissues in the adult organism ( i.e. pluripotent) and this criterion 
may be assessed by differentiation in vitro and by differentiation in vivo within tumours caused 
by ES cell injection or by participation in chimeric organisms. The most stringent definition 
maintains that a chimeric organism, where ES cells injected into the inner cell mass of the early 
embryo contribute to the tissues of the adult, should develop normally and that these ES cells 
contribute to germ cells in the chimaera that are then able to facilitate the development of a 
normal, fertile adult in the next generation. 
 
The derivation of a cell line capable of fulfilling these criteria was first  performed in mouse. 
Since then, several attempts of deriving ES cells from other animals (including human) have been 
performed (reviewed in (Gardner, 2004)) and so far ES cells derived from rat are the only other 
capable to successfully form a germline chimaera (Buehr et al., 2008; Li et al., 2008) . It goes 
without saying that such experiments are not permissible in humans and so only the 
differentiation potential criterion is applied to human ES cells. In fact, derivation of mouse ES 
lines occurred independently, both employing methods to acquire cells from the inner cell mass 
of the embryo by explanting blastocysts on a feeder layer of mitotically inactivated mouse 
fibroblasts (Evans and Kaufman, 1981; Martin, 1981). The implementation of this feeder layer 
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was a necessary innovation for making ES line derivation permissible. Despite this success, 
mouse ES cell lines are prone to spontaneous differentiation in culture unless supplemented 
with leukaemia inhibitory factor (LIF); a discovery that was made later (Smith et al., 1988; 
Williams et al., 1988) but LIF now remains a standard ingredient in mouse ES cell culture. 
 
Derivation of human ES cell lines took well over another decade to perform, despite the fact that 
the isolation techniques required were comparable. There are numerous reasons as to why 
there was such a lag behind mouse experiments, not least of which include the dissuasive legal 
and political dilemmas, coupled with the difficulties available with obtaining human embryonic 
material. The co-incidence of several factors enabled the early successful derivation of human 
ES cell lines including the successful technology of in-vitro fertilisation (IVF) which meant 
established IVF clinics could provide a reliable source of high-quality embryos whilst 
simultaneously acquiring permission from donors to utilise embryos that were superfluous to 
requirement for the treatment for research purposes. Furthermore, researchers had experience 
working with the derivation of other primate ES cell lines (Thomson et al., 1995) and private 
companies were willing to fund the research; circumventing the government funding in 
countries where public funds were prohibited for use in stem cell research, such as the USA. 
Once the first human ES cell lines were derived (Thomson et al., 1998) their perceived medical 
value quickly superseded the hesitance attributed to human ES cell research in the minds of 
scientists and the general public resulting with remarkable progress in human ES cell research.  
 
Given that the assessment of pluripotency via chimaera assay is not permissible in humans, this 
remains unexplored. However, human ES cells display the property of pluripotency both in the 
contexts of both in vitro differentiation and in vivo teratocarcinoma formation when injected 
into immunocompromised mice; forming distinct and diverse tissues of the adult. The 
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teratocarcinoma assay still remains the most definitive test of human ES cell pluripotency, 
however improvements in in vitro differentiation-potential assays are providing evidence for 
pluripotency that is becoming more readily accepted than previously. 
 
The derivation of human ES cells with their associated potential in regenerative medicine 
reignited the interest in mouse ES cells in terms of how to culture them and control of their 
differentiation in vitro. It was even considered that differentiation protocols developed in the 
mouse could be applied to the human. Today, derivation of mouse ES cells now no longer 
requires the feeder layer of mitotically inactivated fibroblasts, but can be successfully performed 
in the presence of LIF and bone morphogenetic proteins (Ying et al., 2003). Furthermore, in part 
by applying information learnt from mouse EC cell differentiation, knowledge of the 
differentiation of mouse ES cells down predetermined pathways by the complementary 
application of various chemicals, growth factors and matrices is becoming increasingly 
comprehensive (for example, (Kim et al., 2002; Li et al., 2003; Smith, 2001; Wichterle et al., 
2002). Understanding of molecular mechanisms underlying pluripotency and differentiation has 
also dramatically increased in the mouse context; with Pou5f1, Nanog, Sox2, Esrrb, Klf2, Klf4, 
and Tbx3 being recognised as being key pluripotency factors. 
 
Despite the advances made in the understanding and manipulation of mouse ES cells, human ES 
cells do not behave in the same way as mouse and so a direct transfer of the techniques crafted 
in the mouse ES cell context are not applicable. One of the first and most noticeable differences 
is the respect to LIF in culture. When exposed to LIF, mouse ES cells tend to become more 
homogeneous with much reduced spontaneous differentiation mediated by activation of signal 
transducer and activator of transcription (STAT3) via LIF receptor (Smith et al., 1988; Williams et 
al., 1988). Despite the conserved STAT3 signalling pathway, and functional LIF mediated 
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activation of STAT3, human ES cells do not remain in an undifferentiated state in the presence 
of LIF (Daheron et al., 2004). Indeed, even now, despite the plethora of work gone into the 
development of defined culture conditions and growth matrices, there is great debate over what 
conditions are the best for the maintenance of human ES cells in an undifferentiated state 
resulting in different laboratories using their own preferred techniques. 
 
One of the core similarities between mouse ES cells and human ES cells are those of the shared 
pluripotency transcription factors. In particular, the forced expression of the transcription 
factors Pou5f1 (also commonly referred to as OCT4), Klf4, c-MYC and Sox2 is capable of inducing 
both mouse and human terminally differentiated fibroblasts to adopt a pluripotent state 
resembling their respective ES cell counterpart (Takahashi and Yamanaka, 2006; Takehara et al., 
2008). This breakthrough discovery, earning the Nobel Prize in Physiology and Medicine in 2012, 
has created a new type of pluripotent stem cell termed induced pluripotent stem (IPS) cells that 
can be generated from somatic cells (Nobel foundation; (Yamanaka, 2007)). The potential 
medical applications using patient-specific IPS cell technology are manifold and elaborated upon 
elsewhere (Yamanaka, 2007). Despite the febrile reception of IPS cells, it is important to recall 
that there are marked, albeit subtle, differences between IPS cells and their ES cell counterparts. 
Most notably, IPS cells often do not exhibit the same epigenetic markers as ES cells and tend to 
resemble, in varying degrees, the epigenetic markers of the adult somatic cell from which it was 
induced (Chin et al., 2009; Deng et al., 2009; Doi et al., 2009; Hawkins et al., 2010) . Furthermore, 
with methods for generating IPS cells becoming more efficient and more accessible, there is a 
growing library of cell lines termed IPS cells that have not necessarily had their pluripotency 
tested with the same rigour expected of human or mouse ES cells. 
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1.5 Antigen markers for pluripotent cells: 
Keeping track of the behaviours of pluripotent stem cells remains a challenge, for instance the 
ability to characterise whether any one particular cell in population is differentiated, 
differentiating or still pluripotent is crucial to understanding fate decisions a cell may make in 
this regard. It is clear that suitable markers are required for this purpose. Crude measures such 
as cell morphology are subjective and not guaranteed to be accurate in all cases. With the now 
developed field of immunohistochemistry, it is now possible to identify, isolate and produce 
antibodies to antigens specific to different cells types of interest.  
 
The association of antigens unique to particular cell types is a phenomenon readily exploited by 
biologists in numerous contexts; and the field of stem cell biology is no exception. antibodies 
that recognise these antigens are often utilised in order to help identify cells of interest within 
a mixed population. Originally employed by developmental biologists, “differentiation antigens” 
are useful tools for examining developmental progression and multifaceted cellular systems. 
Examination of the development and function of the lymphoid system using antibodies to 
discover how different subsets of lymphocyte cells functioned and related to one another 
marked one particular success of these tools’ application (Boyse and Old, 1978). 
 
As early as 1969, Boyse and Old suggested that some such differentiation antigens could be 
recognised with regard stem cell differentiation and morphogenesis. Indeed, when the idea that 
teratocarcinomas provided models for early embryonic differentiation gained prominence in the 
1970s, these immunological principles were applied to this new paradigm. By immunising the 
syngeneic mouse line ‘strain 129’ with the murine embryonic carcinoma line F9, polyclonal 
antisera were produced that defined the “F9 antigen” which became one of the most well-
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known marker at that time (Artzt et al., 1973; Fenderson and Andrews, 1992). Although these 
sera recognised antigen(s), the F9 antigen, shared by EC cells, late morulae and inner cell mass 
cell types, they proved difficult to analyse due to their polyclonal nature. The development of 
well-defined monoclonal antibodies later in the 1970s soon replaced the use of polyclonal 
antisera (Kohler and Milstein, 1975) 
 
Stage Specific Embryonic Antigen 1 (SSEA1) was one of the first embryonic antigens defined by 
monoclonal antibodies. SSEA1 shared similar expression patterns to the F9 antigen during 
development being present during late cleavage stage embryos, on ICM cells, primitive 
ectoderm, visceral endoderm and primordial germ cells (Fox et al., 1981; Solter and Knowles, 
1978). In culture SSEA1 expression is present on mouse EC cells and absent following 
differentiation to parietal endoderm (Solter and Damjanov, 1979). A peculiar feature of SSEA1 
and many other early embryonic antigens identified subsequently is that they possess 
carbohydrate structures; for example, the SSEA1 epitope is an oligosaccharide associated with 
lactoseries type 2 chains linked to glycosphingolipids (Gooi et al., 1981) though the epitope is 
also associated with high molecular weight glycoproteins (Andrews et al., 1981; Childs et al., 
1983). 
 
In contrast to mouse, studies on human EC cell lines reveal that typically SSEA1 is not expressed 
until the cells are induced to differentiate. Instead, in the undifferentiated state, two other 
globo-series glycosphingolipid antigens are expressed; SSEA3 and SSEA4 (Kannagi et al., 1983b; 
Shevinsky et al., 1982). Two other prominent carbohydrate antigens that have been identified 
on human EC cells are TRA-1-60 and TRA-1-81 (Andrews et al., 1984a). These antigens, and 
SSEA3 in particular, are rapidly downregulated in response to differentiation; not only in human 
EC cells, but also in human embryonic stem cells (Draper et al., 2002; Fenderson et al., 1987), 
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which in turn has led to the proposition that SSEA3 represents a sensitive marker of the human 
pluripotent state (Enver et al., 2005b). During human development, SSEA3 and SSEA4, but not 
SSEA1, are detected in the inner cell mass (ICM) with SSEA1 expression seen in the morula 
(Fenderson and Andrews, 1992). 
 
Glycolipids are common cell membrane components associated primarily with the outer leaflet 
of the plasma membrane, all of which consist of an oligosaccharide chain linked via glucose to 
Ceramide. The production of glycolipids, including SSEA3 and SSEA4, occurs within the Golgi 
apparatus of the cell and is based upon the sequential additions of nucleotide activated sugar 
moieties to a ceramide backbone that are performed by several glycosyltransferases (Chen et 
al., 1989). Each glycosyltransferase catalyses the addition of a monosaccharide to an acceptor 
with precise specificity, although there are examples of glycosyltransferases that enable the 
transfer of multiple donors (Blixt et al., 1999; Zhou et al., 2000). There are over one hundred 
known glycolipid structures and this diversity is a result of the cell’s use of multiple 
monosaccharaides (glucose, N-acetylglucosamine, galactose, N-acetyl-galactosamine, fucose, 
N-acetylneuraminic acid), α and β linkage arrangements as well as multiple linkage 
arrangements on each monosaccharide which results in a staggering number of combinatorial 
possibilities. The formation of globoseries glycosphingolipid antigens (such as SSEA3 and SSEA4) 
is dependent on the formation of lactosylceramide upon which a nucleated galactose 
monosaccharide is added by α14 galactosyltransferase (Figure 1.1).  From this backbone, 
SSEA3 is produced by the addition of N-acetylgalactosamine followed then by galactose. The 
SSEA4 antigen is built upon the SSEA3 antigen by the terminal addition of N-acetylneuraminic 
acid by sialyl transferase (Chen et al., 1989). The precise mechanism; including the production 
of the relevant glycosyltransferases and the maintenance of the nucleotide activated 
monosaccharide pools required to generate the SSEA3 and SSEA4 moieties are not yet entirely 
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delineated but it remains clear that its generation is not based on a simple gene expression 
profile. 
 
Despite the close association of SSEA3 and SSEA4 to pluripotency in human ES cells, it has also 
been demonstrated that these antigens are not necessary for pluripotency (Brimble et al., 2007). 
This has been demonstrated both within normal hESCs by deliberate inhibition of SSEA3 
biosynthesis (Brimble et al., 2007) and within cultures of hESCs that have become adapted via 
selective advantage to cell culture; where the loss of SSEA3 has not necessitated differentiation 
(Enver et al., 2005a). The expression of SSEA3 is not limited to that of early embryonic stem cells 
and is also present on red blood cells, where they are part of the P blood group system (Andrews, 
2011). However, a small proportion of the human population are incapable of synthesising 
globo-series antigens, and as a consequence have red blood cells that are SSEA3 negative, 
suggesting that SSEA3 expression is unnecessary for human development (Race and Sanger, 
1975; Tippett et al., 1986). Indeed, individuals with the pp and pk phenotypes are incapable of 
synthesising either SSEA3 or SSEA4 but appear healthy despite their lack of these strongly 
developmentally regulated antigens (Figure 1.1) (Tippet et al., 1986). That said, pp and pk 
phenotype women have high rates of spontaneous abortion, indicating that SSEA3 and SSEA4 
may be involved in immune recognition (Andrews, 2011; Tippett et al., 1986) 
 
One feature of SSEA3 an SSEA4 expression is that the SSEA3 antibody (MC631) recognises and 
reacts to both glycolipids since the epitope recognised by MC631 is present in both glyoclipids  
(Figure 1.1) (Kannagi et al., 1983a). The SSEA4 antibody (MC813-70) recognises the terminal 
three sugars of the SSEA4 antigen and thus does not react with the SSEA3 antigen. During the 
process of differentiation, human pluripotent ES and EC cells lose the expression of both SSEA3 
and SSEA4. However, paradoxically, SSEA3 expression is lost more rapidly (Fenderson et al., 
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1987). Despite the fact SSEA4 expression remains detectable and high by use of the SSEA4 
antibody (MC813-70), the binding of the SSEA3 antibody (MC631) remains unaccountably low 
despite the expected cross-reactivity to the internal trisaccharide epitope of the SSEA4 reactive 
glycolipid (Draper et al., 2002; Fenderson et al., 1987). This is a counter-intuitive observation 
since the presence of the SSEA4 antigen should permit the binding of the SSEA3 antibody. A 
possible explanation is that the detection of these antigens is dependent upon the manner in 
which they are displayed on the cell surface in addition to whether they are merely synthesised 
(Wright and Andrews, 2009). The mechanism governing the presentation of these antigens 
remains unknown and has led to the postulation that the expression of SSEA3 may integrate 
different information about a cell’s state rather than the expression pattern of any particular 
gene (Wright and Andrews, 2009). 
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The production of SSEA3 is not directly regulated by any one particular gene but, like with all 
glycosphingolipids, its manufacture is contingent on multiple factors including sufficient 
metabolite pools, synthesis of the relevant glycosyltransferases and the presentation of the 
antigen on the cell surface. As a result, SSEA3 expression is manifest by circumstantial 
intracellular dynamics that integrate to yield its production. The presence of SSEA3 therefore is 
reflective of a particular state of that cell’s metabolism rather than a direct determinant of gene 
expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 – The Carbohydrate Structures of SSEA3 and SSEA4. The globoseries structure requires 
the production of lactosylceramide (red), to which further sugar moieties are sequentially added. The 
first nucleated sugar added to lactosylceramide is Galactose and this reaction is mediated by α14 
galactosyltransferase (†). The addition of further sugars is dependent on the action of further specific 
glycosyltransferases. The SSEA3 and SSEA4 moiety differ by the final addition of N-acetylneuramin ic 
acid by sialyl-transferase (‡) to the SSEA3 moiety. These antigens are also found on red blood cells as 
part of the P blood group system; the P Pk and pp antigens are marked (blue dashed boxes). The epitopes 
recognised by the antibodies MC631 and MC813-70 are also marked.  
3Galβ1  3GalNAcβ1  3Galα1  3Galβ1  4Glcβ1  ceramide 
NeuNAcα2 3Galβ1  3GalNAcβ1  3Galα1  3Galβ1  4Glcβ1  ceramide 
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1.6 Pluripotent cell heterogeneity 
A pluripotent cell has fundamentally three choices; the capacity to differentiate into any of the 
three germ layers, continue replication whilst remaining pluripotent or die, although it may exist 
in a state of quiescence prior to fulfilling any of those fates. While antibodies have now been 
generated for the identification of pluripotent stem cells, no cell surface antigens have been 
recognised that enable the prospective identification of cell fate choice. For instance, no cell 
surface antigen has been discovered that recognises pluripotent stem cells that have a bias 
towards endoderm differentiation. Despite the fact that pluripotent stem cell populations are 
clonal and that all these sister cells share the properties of self-renewal and pluripotency, it 
quickly becomes clear when working with these systems that not all cells in a culture behave 
identically. Perhaps the most obvious examples of this disparity in behaviour are the poor 
efficiencies of directed differentiation experiments and the phenomenon of spontaneous 
differentiation in culture. These alone demonstrate that not all cells within a culture behave 
uniformly. 
 
There are two main, non-mutually exclusive, sources of variation that could explain such a 
difference. The first is that slight differences in microenvironment are responsible which 
ultimately manifest themselves by altering cell behaviour. For instance, cells in different 
locations even within the same culture vessel happen to be exposed to alternative levels of 
growth factors, metabolites and neighbouring cell contacts. In this case, even cells that could be 
considered identical in every other respect, may exhibit varied behaviours.  
 
The second broad possibility is that the cells themselves are not identical, and this too could be 
the attributed to a number of factors. Examples include position in the cell cycle, transcription 
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factor production, alternative gene regulatory networks or stochastic alterations to any of the 
above. These subtle differences could easily alter a cell’s propensity to react to differentiation 
cues, causing spontaneous or non-uniform directed differentiation. A proportion of these 
differences could be ascribed to cells whose fate is already determined and have committed to 
differentiation; thus disqualifying themselves from the pluripotent stem cell population. 
However, it is also conceivable that in fact these cells retain pluripotency but that their 
propensity to follow any particular differentiation lineage varies over time as well as in response 
to culture conditions, including feedback signals from cells already differentiating. In this sense, 
it can be argued that the outcome of a differentiation protocol is not only contingent on that 
protocol’s conditions but also on the underlying phenotype of the starting cells. 
 
The possibility that pluripotent stem cells could simultaneously possess the properties of self-
renewal, pluripotency and lineage bias appears oxymoronic at first. If daughter cells have an 
alternative differentiation propensity to the mother, then arguably the property of self-renewal 
has been violated and the daughters exist in a different state to the mother. Actually, this 
interpretation is not necessitated. Whilst it may be true that at any given time a cell may be 
more likely to differentiate down one path than another, if this bias naturally fluxed and were 
different in a future state, then it does not exist in any one incontrovertible state. Here, that cell 
would be described as present within the hypothetical “stem cell compartment” (possessing the 
capacities of pluripotency and self-renewal) like the mother cell, but occupying a different “sub-
state” within that stem cell compartment (described in Figure 1.2). Cells occupying different 
substates may at that point in time have differing lineage biases; being more or less probable of 
differentiating into Ectoderm for example. A key distinction to be drawn here is that sub-states 
require the property of interconversion; for if a cell entered a state where it’s differentiation 
potential were unalterable, then it would represent a state different to that of the parental 
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population and at least the property of self-renewal will have been contravened. The disparity 
in behaviour between cells in pluripotent stem cell culture may therefore have two, non-
mutually exclusive, explanations. The first is that the cause for differing behaviour between cells 
is that there are de facto multiple, distinct, cell populations that happen to cohabit the same 
culture. The second is that these cells exist within the same cell population but are occupying 
different, but interconvertible, substates and that these substates are responsible for the 
difference in behaviour. 
 
 
 
 
 
 
Commitment 
Differentiation 
(Endoderm) 
Differentiation 
(Ectoderm) 
Figure 1.2 - The Stem Cell compartment hypothesis. Stem cells within the stem cell compartment  
retain the properties of pluripotency and self renewal, however their propensity to differentiate into a 
particular lineage may be encouraged or hampered depending on where within the hypothetical stem 
cell compartment the cell occupies at any particular time. In this illustration, the bowl represents the 
stem cell compartment, and the green ball represents a pluripotent stem cell. Depending upon the ball’s 
position in the bowl alters the likelihood of which side it may leave the bowl. Currently for example, 
the ball is closer to committed differentiation along the Ectoderm route, however given its dynamics, 
it may soon occupy a pro-endoderm fate instead. In this way, it is possible for cells to express lineage 
bias at any particular time, yet retain the same propensity to differentiate down any other lineage 
pathway if considered over time. 
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Indeed, within mouse embryonic stem cells, it has been demonstrated that such subtle forms of 
heterogeneity exist. For instance, mouse ES cell cultures are heterogeneous with respect to 
Nanog and Stella expression. Nanog positive and negative cells are both interconvertible, 
however Nanog negative cells also exhibit an increased propensity to differentiate (Chambers 
et al., 2007). Stella, on the other hand, fluctuates within mouse ES cell cultures in a manner 
resembling a dynamic equilibrium where on average 20-30% of cells in a culture are positive for 
Stella expression despite the transitions of individual cells between Stella positive and negative 
states (Hayashi et al., 2008). The populations of Stella positive and negative cells may 
interconvert however only Stella negative, but not Stella positive, cells were permissive for 
trophectoderm differentiation (Hayashi et al., 2008). 
 
In the human context, the early stages of human ES cell differentiation presents cells that co-
express lineage specific transcription factors in addition to the pluripotency associated genes 
(Laslett et al., 2007). Although this may be reflective of functionally distinct substates, any 
relationship between this co-expression of lineage specific transcription factors with 
pluripotency genes and functional differentiation bias was not determined in this case (Laslett 
et al., 2007). Indeed, the idea of lineage promiscuity where progenitor cell types may 
simultaneously express cell surface markers that are associated with distinct differentiated cell 
types has existed for some time and was the subject of examination in the hematopoietic system 
(Greaves et al., 1986). 
 
The paradigm that individual stem cells naturally vary in their gene expression patterns and 
identity in an interconvertible manner presents a challenge to stem cell biologists. Suddenly, 
population based transcriptome analyses represent a homogenous mixture of heterogeneous 
cell transcripts. The representation of distinct transcriptomes is obscured by that of the 
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amalgam; catapulting the importance of single cell studies to the forefront of stem cell research. 
Furthermore, a unique complication in the field of stem cell biology is that once a transcriptome 
has been identified, even peculiar to a particular cell/population, it is impossible to know what 
biases that cell would have in the context of differentiation lineage since determining the 
transcriptome necessitated that cell’s destruction. This problem is compounded even further by 
the fact that human ES cells require intercellular cues for survival and maintaining pluripotency; 
which hinders functional analysis of cells in culture on a single cell basis (Fox et al., 2008). 
 
This has led to the application of non-destructive techniques to examine the relationship 
between stem cell heterogeneity and cell fate such as cell surface antigen studies to determine 
potential substates. The cell surface antigen SSEA3 for instance has been studied closely in 
relation to pluripotency due to its close association to the undifferentiated state ( See antigen 
section). A comparative clonogenic analysis of early passage and late passage, culture adapted 
ES cells suggested that SSEA3-ve and SSEA3-ve populations represent two different, 
interconvertible substates, where in the early passage ES cells, SSEA3 -ve cells had an increased 
propensity to differentiate similar to NANOG-ve mouse ES cells. The effect of culture adaptation 
had selected for ES cell variants that were capable of being simultaneously SSEA3 -ve and 
undifferentiated; since ultimately normal ES cell differentiation eventually removes that cell’s 
progeny from the reproducing population (Enver et al., 2005b). Although undesirable for any 
medical application, this case demonstrated a hidden value for adapted ES variants as a useful 
tool for exploring normal ES cell behaviour. 
 
Indeed, study of SSEA3 in relation to pluripotency has also successfully revealed that even while 
in a pluripotent state, EC cells within the same population exhibit different biases with regard 
differentiation potential to neuronal or non-neuronal fates (Tonge et al., 2011) Furthermore, it 
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has been demonstrated that these biases changed over time rather than being the result of a 
particular EC cell that had an already determined fate (Tonge and Andrews, 2010). In this 
example, cultures of the EC line NTera2 were used in a differentiation assay utilising retinoic acid 
(Andrews, 1984) that was designed to examine cell fate decisions. Well documented, the 
exposure of whole NTera2 cultures to all-trans retinoic acid (10-5 M concentration) for 1-2 days 
is sufficient to irreversibly commit almost all cells to differentiation resulting in 1-5% of the 
population becoming neurons after around 12-14 days and the remainder of the population 
constituting a heterogeneous mix of other cell types (Andrews, 1984; Fenderson et al., 1987; 
Tonge and Andrews, 2010). However, when individual NTera2 cells (modified to constitutively 
express tdTomato for identification) were plated onto a bed of unlabelled NTera2 cells and 
immediately subject to the same retinoic acid differentiation protocol, resulting tomato-labelled 
NTera2 colonies did not all pertain to a single phenotype. The proportion of neurons within the 
colonies ranged from 0-100%; with colonies containing entirely neurons or no neurons indicating 
that the eventual phenotype of these differentiated cells was determined very early in response 
to retinoic acid exposure; denoting alternative lineage biases of the initial seeded cell. On its 
own, this result could just reflect two different populations with separate biases, of the labelled 
NTera2 cells that do not interconvert. By repeating this experiment, but waiting 24 hours or 48 
hours before exposing the seeded cells to retinoic acid, the proportion of neurons present within 
the differentiated colonies changed; the longer exposure to retinoic acid was postponed, the 
closer the proportion of neurons in the colonies was to the result of global cell retinoic acid 
exposure of 1-5%. By postponing retinoic acid exposure, seeded cells were presented the 
opportunity to divide and permit the interconversion between pro-neuronal and pro-non-
neuronal states. The fact that delayed exposure yielded a reduced proportion of differentiated 
colonies that were entirely neuronal or non-neuronal as the instant exposure treatment strongly 
suggests deviance from the lineage bias of the initial cell. 
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It has been suggested that the pluripotent stem cell represents a ‘ground state’, or stable 
attractor, and that maintenance of that ground state involves prevention of cells leaving that 
attractor (Ying et al., 2008). (Although mouse and human ES cell share a network of transcription 
factors, they respond to those factors in different ways. For instance, human ES cell pluripotency 
is not maintained with the introduction of LIF, whereas it is critical for the maintenance of naïve 
mouse ES cell pluripotency (Niwa et al., 1998). Furthermore, the action of activin/TGFβ and BMP 
signalling pathways act with opposite effect in the two species; with activin/TGFβ signalling 
maintaining human ES cell pluripotency whilst BMP signalling induces differentiation and vice 
versa in the mouse ES cell context. Incidentally, this evidence has been used, amongst others, 
to build the argument that mouse ES cells and human ES cells as maintained in vitro correspond 
to different stages of embryonic development (Brons et al., 2007; Peerani et al., 2007; Pera et 
al., 2004; Tesar et al., 2007). 
 
The issue of heterogeneity with respect to pluripotent cell identity has been examined in great 
detail in the mouse ES cell system. At least three different types of pluripotent stem cell have 
been defined within the mouse ES cell context, each purported to be counterpart to an in vivo 
pluripotent cell type at different stages of development (Figure 1.3). These cell types are 
referred to as naïve embryonic stem cells (also known as groundstate), formative pluripotent 
stem cells and primed stem cells that are deemed to correspond to pluripotent cells of the 
preimplantation epiblast (E4.5), the formative epiblast (E5.5) and postimplantation epiblast 
(EpiSC) (E6.5) respectively. 
 
Mouse ES cells were classically derived and maintained in serum-based media on a layer of 
mitotically inactivated mouse fibroblast “feeder” cells (Evans and Kaufman, 1981; Kalkan and 
Smith, 2014). Mouse ES cells cultured this way display a degree of morphological and 
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transcriptional heterogeneity (Tosolini and Jouneau, 2016). Progressively, the use of feeder 
layers was supplanted by the use of media supplemented with LIF as well as serum (Kalkan and 
Smith, 2014). Regardless, the individual cells within the population of mouse ES cells derived 
and maintained in either manner varied significantly in their expression of pluripotency genes  
(Chambers et al., 2007; Festuccia et al., 2012; Marks et al., 2012; Niwa et al., 2009; Toyooka et 
al., 2008). 
 
The heterogeneity displayed in culture by these mouse ES cells is ascribed to sub-optimal culture 
conditions and the development of defined culture conditions for the maintenance of 
pluripotent stem cells resulted in the generation of the 2i/LIF media system. This culture media 
makes use of two inhibitors (2i) that block mitogen activated protein kinase and glycogen 
synthase kinase 3 whilst LIF activates the Stat3 pathway (Blair et al., 2011; Niwa et al., 1998; 
Wray et al., 2010; Ying et al., 2008). This medium not only maintains the pluripotency of cultured 
ES cells, but it also acts to reduce the degree of variation in the expression of pluripotency factors 
and upon inspection cells appear to express pluripotency factors at similar levels to the cells of 
the early preimplantation epiblast. The combined description of homogeneous cells 
representative of an extremely early point of development earnt this cell type the description 
of naïve stem cell. The use of the 2i/LIF media can be applied to the culture of already derived 
mouse ES cell lines to reduce heterogeneity in culture; with cultures resembling the naïve state. 
Another breakthrough in the use of the 2i/LIF media is that it permits the derivation of ES cell 
lines from all mouse and rat strains tested, where before ES cell cultures could only be derived 
from the inbred 129 mouse strain (Buehr et al., 2008; Hayashi et al., 2008; Li et al., 2008; Nichols 
and Smith, 2009).  
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The description of the formative pluripotent mouse ES cell is more recent and refers in part to 
the transition from naïve ES cells to primed ES cells. In mouse this transition occurs 
spontaneously in response to withdrawal from 2i conditions. During this transition, naïve ES cells 
asynchronously downregulate Rex1 expression (Betschinger et al., 2013; Boroviak et al., 2014; 
Marks et al., 2012). The Rex1 negative cells, termed formative ES cells, remain pluripotent and 
are thought to represent cells of the early post-implantation embryo. After this formative ES cell 
stage, cells continue down their developmental lineage and begin to resemble the primed 
pluripotent cell identity in culture that corresponds to that of the primitive streak 
postimplantation epiblast proper.  
 
Primed pluripotent cells are termed such since they represent cells of the primitive streak that 
are ‘primed’ for lineage commitment (Nichols and Smith, 2009) . These primed pluripotent stem 
cells may be derived directly from the postimplantation epiblast and are thus referred to also as 
EpiSCs. EpiSCs may be derived from a range of postimplantation stages (E5.5 to E8) and express 
the pluripotency factors Oct4 and Sox2, but they do not express other factors considered 
necessary for naïve pluripotency except for Nanog (Kalkan and Smith, 2014). EpiSCs may be 
differentiated in vitro or in teratomas, but single cell differentiation assays have not been 
performed and it remains unclear whether EpiSC cultures represent mixtures of different lineage 
precursors with some pluripotent precursors (Tsakiridis et al., 2015). 
 
Parallels between the primed mouse EpiSCs and that of human ES cells have been drawn before, 
most notably because they both exhibit heterogeneity in terms of morphology and pluripotency 
factor expression, as well as exhibiting similarities in energy metabolism and DNA methylation 
(Weinberger et al., 2016). Additionally, mouse EpiSC and human ES cells behave similarly in 
response to TGFβ/activin signalling and neither respond to LIF in culture. However, the nature 
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of human and mouse ES cell correspondence is not clear-cut. Human ES cells and mouse primed 
ES cells are not identical, nor do human ES cells respond to 2i/LIF in the same manner as mouse 
primed ES cells. In the mouse, leaving the naïve state is in part marked by loss of the expression 
of Rex1, with EpiSCs being negative for Rex1 expression, however the pluripotency factor Rex1 
is expressed by human ES cells (Shi et al., 2006). Furthermore, one of the core pluripotency 
transcription factors for the maintenance of naïve mouse ES cells, Esrrb, does not possess a 
binding site for other key pluripotency factors in humans indicating that the pluripotency 
networks between these species has not been completely conserved (Takashima et al., 2014) . 
The question remains open as to whether the equivalent of a naïve state exists in the human in 
vitro ES cell context. 
 
Human ESCs are notorious for their heterogeneous nature, poor clonogenic potential and high 
rate of spontaneous differentiation in culture. Spontaneous differentiation of human ES cells in 
culture further complicates their maintenance since the differentiated progeny generate 
feedback signals that alter the growth of the parental population or even drive further 
differentiation of the parent population, for instance by endodermal BMP production (Enver et 
al., 2005a; Peerani et al., 2007).  Alternatively, other differentiated cells in culture may act as a 
stem cell niche and help maintain proliferation of the ES cells by the production of factors such 
as IGF1 from fibroblast-like cells (Bendall et al., 2007). 
 
The presence of differentiated cells in a culture of ES cells clearly presents that culture as 
heterogeneous, however a more cryptic form of heterogeneity may exist within the stem cell 
compartment itself, manifesting in different differentiation responses or protein expression. 
Developmentally important factors such as OCT4 and NANOG exhibit varied expression on stem 
cells, and may indicate the presence of interconvertible substates within that population. As 
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previously discussed, SSEA3 also presents itself as a cell surface marker that indicates the 
presence of interconvertible substates (Enver et al., 2005b). Indeed, interconvertible substates 
have also been demonstrated within several adult stem cell populations (Booth and Potten, 
2000; Hu et al., 1997; Jones et al., 2007) as well as well as early mouse embryos and ES cells 
(Chambers et al., 2007; Hayashi et al., 2008). 
With the growing evidence that ES cell heterogeneity impacts upon differentiation potential in 
culture, tools for the identification of substates within the stem cell compartment become 
crucial for the delineation of this effect. So far there remains no prospective marker for cells 
occupying different substates although there are numerous approaches that could be explored 
in order to uncover these cryptic behaviours including mathematical modelling of population 
dynamics or non-destructive methods of cell state identification.  
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Figure 1.3 – Progression from naïve to primed pluripotency in mouse with a comparison between the in vivo and in vitro counterparts. In vivo: Up to the eight
cell stage, blastomeres are totipotent. At embryonic day (E) 3.5, the inner cell mass (ICM) cells express both pluripotency and endoderm genes. At E4.5, the
epiblast and primitive endoderm lineages separate, and the epiblast represents the naïve state of pluripotency. The E4.5 epiblast is the cell of origin of mESC,
although it is possible to derive them from earlier stages, but these cells mature in vitro to resemble mESCs derived from the E4.5 epiblast. Naïve mESCs all
express Rex1 homogeneously. The embryo implants in the womb between E4.5 and E5.5. EpiSCs are most similar to the late E6.5 epiblast, although they may be
derived from E3.5 up to E6.5 and are described as being in a “primed” pluripotent state. As part of the transition from naïve to primed pluripotency upon the
removal of 2i media conditions in culture, mESCs asynchronously downregulate Rex1 and being to resemble cells of the early, “formative” epiblast.
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1.7 Heterogeneity and Cell Fates In vivo 
The paradigm of cellular substates and heterogeneity is generally applied to in vitro studies since 
these are much easier systems to interrogate than their in vivo counterparts. With regard to 
pluripotent stem cells, this is probably a result of the fact that these cells are immortal in vitro, 
whereas their in vivo counterparts exist transiently as part of development. This short window 
of opportunity can make substate heterogeneity difficult to examine in vitro, especially since 
there is a symphony of concurrent developmental activity acting to guide cellular proliferation 
and differentiation. There are, however, well documented systems describing the process of 
spontaneous tissue patterning decisions made by equipotent cells in response to stochastic 
fluctuations of endogenous factors. 
 
The Notch-Delta system, for example, comprises of the Notch family of type 1 transmembrane 
receptors and membrane bound ligands. This signalling pathway is activated by cell-cell 
interaction bringing the receptors and ligands into contact (Artavanis-Tsakonas et al., 1999). 
Upon ligand binding, the Notch receptors are cleaved and the intracellular domain is 
translocated to the nucleus, where it can influence the transcription of downstream genes, such 
as the Hes family (Selkoe and Kopan, 2003). The Notch-Delta system is subject to fluctuation in 
expression of both the receptor and ligand. Small changes in either can cause changes in either 
the expression or response to signalling, leading to amplified responses to signals (Artavanis-
Tsakonas et al., 1999). 
 
The Notch-Delta system is employed for specifying robust and separate cell identities in eye 
development in Drosophila. Neuroectodermal cells are initially equipotent and express Delta in 
a comparable manner. However, cells that recognise this ligand on a neighbouring cell will 
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downregulate its own ligand expression. Thus, small initial fluctuations in Notch/Delta 
expression can initiate cells to adopt a binary state. Ultimately, this leads to fate decisions, low 
Delta-expressing cells become epidermal, and high delta expressing cells become neural  
(Artavanis-Tsakonas et al., 1999; Heitzler and Simpson, 1991; Sestan et al., 1999). 
 
Another example of the Notch-Delta system used for cell fate determination is in the nematode 
C. elegans with regard to anchor cell/ventral uterine cell specification. In this system, two 
precursor cells can adopt either identity, and the Notch-homologue (Lin-12) and its ligand (Lag-
2) are expressed on both initially. The Lin-12 activation promotes its own expression and inhibits 
Lag-2, and thus stochastic fluctuations in signalling leads to the cells adopting a definite Lin-12 
or Lag-2 expressing status, and then differentiating into the ventral uterine cell or anchor cell 
respectively (Christensen et al., 1996; Wilkinson et al., 1994).  
 
An alternative paradigm whereby endogenous factor fluctuations results in distinct cell fates for 
participating cells is in somitogenesis where the basic helix-loop-helix (bHLH) factor Hes7, is 
expressed in an oscillatory manner in the presomitic mesoderm (Dequeant and Pourquie, 2008; 
Imayoshi et al., 2013; Kageyama et al., 2012; Oates et al., 2012) . Hes7 auto-supresses by 
interacting with its promotor, and its mRNA and protein have a circa 20 minute halflife (Bessho 
et al., 2003; Bessho et al., 2001). Together this leads to 2 hour cycles of Hes7 expression that are 
shown to be critical in generating somites from the presomitic mesoderm. The Hes7 oscillatory 
clock allows genes to be activated or repressed in a synchronous manner, allowing cells within 
a tissue to initiate developmental processes as a defined unit. In the case of the presomitic 
mesoderm, two independent somites of a regular size are generated simultaneously on either 
side of the neural tube at a precise time. Experimental disruption of the synchronised state leads 
to irregular or impaired somitogenisis (Hirata et al., 2004). Additionally, dissociated cells lose 
 33 
 
Hes7 periodicity, suggesting that cell-cell communication is important for oscillator 
maintenance, in this example Notch-Delta has once again been identified (Jiang et al., 2000; 
Maroto et al., 2005; Masamizu et al., 2006; Niwa et al., 2011; Riedel-Kruse et al., 2007). 
 
Hes1 is another bHLH factor that oscillates during somitogenesis, in addition to other tissues 
(Hirata et al., 2002). Notably, fluctuating Hes1 regulates proliferation and differentiation in 
neural progenitor cells (Imayoshi et al., 2013; Shimojo et al., 2008). Hes1 functions to slow 
differentiation and ensure progeny types are distributed appropriately. Loss of this factor leads 
to premature differentiation that depletes the progenitor pool and produces a small and 
deformed brains comprising of only certain types of neurons. Hes1 fluctuates initially, but 
becomes stabilised when neural progenitor cells differentiate into astrocytes, and is lost in 
differentiating neurons. Ascl1 expression is repressed by Hes1, and the release of repression 
allows Ascl1 expression to induce neuronal differentiation (Imayoshi et al., 2013).  
 
These examples above indicate that there are indeed mechanisms that occur during 
development that rely upon apparently stochastic processes to generate regular patterns. 
Therefore, it’s worth noting that the behaviour cells exhibit in culture may be able to inform of 
processes that occur in vivo. However, especially in the case of pluripotent stem cells, in vitro 
cell behaviour is likely adapted to culture conditions that are not the same as those experienced 
by their in vivo counterparts. This is in addition to the evidence that stem cell substate 
heterogeneities exist in vitro in their own right (see previous). With regard application to 
regenerative medicine, most approaches focus on the directed differentiation of pluripotent 
cells in vitro, are based upon processes understood in vivo. The paradigm of stem cell substate 
heterogeneity is capable of influencing those differentiation decisions and by extension 
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differentiation efficiencies, regardless of whether there is opportunity for such a process to 
occur to their in vivo counterparts of the inner cell mass. 
1.8 Modelling Heterogeneity 
In general, there are two methods for interrogating the mode of action of an unknown system; 
systems identification and analytical modelling. Systems identification treats a new system as a 
black box type problem and will examine the system in terms of inputs and outputs; i.e. how 
information is transformed by the system. Although systems identification approaches do not 
purport to elucidate on the internal mechanism of this black box they instead inform on how 
inputs are mapped to outputs and thus have a predictive capacity. Analytical modelling, on the 
other hand, attempts to understand the mechanism of the black box by comprehensively 
dissecting all of the individual interactions that may take place within that system then 
fastidiously integrating all these interactions in order to describe how an input would be 
processed to an output. 
 
These two methods may be investigated exclusively in their own right but a comprehensive and 
complete model of any particular system will include a cohesive integration of both approaches. 
It should be noted that an analytical modelling approach is a much more labour intensive 
method; and the capacity to map an input to an output using this method requires considerably 
more computational power than utilising a systems identification approach. Furthermore, 
analytical modelling can lead to a more accurate description of the relationships between 
mechanisms governing the system. Conversely, the model can only be as complete as the 
understanding of the processes that are entered into the model. 
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Multiple methods have been adopted in order to address features of cell heterogeneity and it is 
not a problem displayed only by pluripotent stem cells. Models constructed by collating existing 
experimental and bioinfomatic data, have been shown to have a predictive capacity: for 
example, the cross-antagonism of Fli-1 and EKLF at the erythroid megakaryocyte lineage branch 
point was predicted before it was demonstrated experimentally (Frontelo et al., 2007; Swiers et 
al., 2006). However, models of a network are generally a description of interrelationships of 
factors, rather than a true picture of the fluctuating components (i.e. proteins and mRNA levels, 
and the activities thereof) of that network, thus, the ability of these models to predict complex 
dynamics that permit a cell to enter particular differentiation lineages is limited.  
 
In the hematopoietic field, a well-described decision point in the myeloid progenitor cell is the 
cross-inhibitory interaction between the transcription factors GATA-1 and PU.1 that allows the 
decision between erythroid/megakaryocyte and myeloid-monocytic fates by promoting lineage-
specific transcription (Laiosa et al., 2006). In addition to mutual inhibition, GATA-1 and PU.1 also 
auto-stimulate, and modelling this simple circuit mathematically suggests three stable states 
(termed ‘attractors’): either of the differentiation lineages, or the bi-potent progenitor state in 
which both transcription factors are held in balance. This model provides an explanation as to 
why classical ‘differentiated’ markers are found in combination in undifferentiated cells 
(Chickarmane et al., 2009; Hu et al., 1997; Huang et al., 2007). Other examples of these switches 
have been described for the early lineage decisions of embryonic stem cells (Boyer et al., 2005; 
Chambers et al., 2003; Chickarmane and Peterson, 2008; Chickarmane et al., 2006) . 
 
This example of GATA-1 and PU.1 dynamics provides a neat explanation for a simple, binary 
decision based upon a relatively uncomplicated model for the decision path. However, reality 
rarely presents itself with such simplistic decision trees. Experimental evidence of the 
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transcriptional response of human leukaemia cells (HL-60) differentiating down a single cell fate 
in response to two different inductive signals shows that although both sets arrive at the 
myelomonocytic fate (the attractor), different molecular pathways are utilised to do so (Huang 
et al., 2005). 
 
As the stem cell state is considered an attractor, by definition a stable state, it has been 
suggested that the steering of a cell towards any specific differentiation state is a two-step 
process. The first step involves the destabilisation from the state of potency, and the second the 
impetus towards a secondary attractor state, or differentiated cell type (Huang et al., 2007). This 
model is evidenced by the multipotent cell line EML, which expresses the cell surface antigen 
Sca-1 at high or low levels, and experiments have shown that when sorted by expression level, 
either sorted population will reconstitute both high and low Sca-1 expressing cells, suggesting 
interconvertibility between these two states.  However, Sca-1 expression levels correlate with 
Pu.1 and inversely with GATA-1 expression and this appears to link to lineage bias.  Therefore, 
EML stem cells appears to exist in lineage biased, but interconvertible, substates (Chang et al., 
2008b). 
 
This is not the only evidence that cells stably within the stem cell attractor can exhibit different 
lineage biases. Blood stem/progenitor cells assayed by RT-PCR were found to express a mixture 
of lineage characteristic genes, although levels of each gene were heterogeneous within the 
population. Therefore, it was proposed that although each cell was multipotent, at any given 
point it was likely to favour one lineage over others, and that this bias was in flux (Delassus et 
al., 1999; Enver et al., 1998). The nature of lineage bias and lineage commitment remains unclear 
and it is not known whether lineage commitment is a gradual process or a discrete transition 
(Pina et al., 2012). Exploration of some multipotent systems has enabled the interrogation of 
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early stages associated with lineage affiliation that indicated an important role for 
transcriptional noise (Chang et al., 2008a).  
 
In this thesis, a systems identification approach was adopted to assess whether some aspects of 
cell heterogeneity in a population could be modelled in a predictive manner. In this case, the 
feature of SSEA3 heterogeneity in culture was interrogated to help identify how substates are 
manifest. In keeping with the black box metaphor above, here the cell population’s SSEA3 
intensity distribution is considered the black box input, the cells within the population as the 
black box and finally the subsequent population’s SSEA3 expression as the black box output. In 
other words, an examination of cell population SSEA3 distributions with regard their change 
from one day to the next. In particular, understanding how cells alter their SSEA3 expressions 
from one day to the next may uncover particular intensities of SSEA3 expressing cells that exhibit 
unique behaviours worthy of further interrogation. For instance, the identification of an 
attractor region where a cell’s SSEA3 intensity is unlikely to change over time could be indicative 
of a substate population. 
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1.9 Raman Spectroscopy 
Systems identification modelling of pluripotent stem cell dynamics is not the only method by 
which stem cell substates may be identified and subsequently explored. Methods that examine 
stem cell behaviour may also be employed in order to categorise pluripotent cell types. The most 
common methods by which pluripotency is interrogated in vitro generally fall into two main 
categories; destructive and non-destructive. As outlined above, almost all “omics” studies 
(transcriptomic, metabolomic) mandate the destruction and lysis of the cell of interest; making 
the future behaviour of that cell impossible to assess. The common non-destructive methods all 
require some degree of interference with the cell, be it by genetic alteration in the process of 
reporter line generation for proteins of interest or by cell surface antigen studies. Cell surface 
antigens are likely to have some function, and their interaction with antibodies may elicit some 
unknown response. In the context of substates within the stem cell compartment, where subtle 
behaviours are of great significance, any artefactual change to behaviour will be of consequence. 
 
If, then, any interaction with a cell is of detriment to the effective understanding of future 
behaviour, the problem of stem cell substates could be deemed intractable; the act of measuring 
the system changing the outcome of the behaviour sought to be understood. Methods that 
interact minimally with the cell would be preferable to those that do not. Raman spectroscopy 
may provide such a method since it is capable of interrogating the biochemical compliment of a 
cell in a non-invasive manner. 
 
Raman spectroscopy is a vibrational spectroscopy technique that exploits the Raman effect for 
the determination of chemical information. The Raman effect is the phenomenon whereby light 
is scattered in an inelastic manner as a direct consequence of a photon’s interaction with a 
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molecular bond. The interaction with the molecule results in a change of energy in that photon 
which, since a photon’s energy is a direct function of its inverse wavelength and the speed of 
light, corresponds directly to a change in that photon’s wavelength. The change of energy that 
the photon is subject to is directly related to the chemical species of molecular bond with which 
it interacted (Figure 1.4). Using a monochromatic light source, the Raman scattering that occurs 
from that sample may be examined in the form of any resulting light that is of a different 
wavelength to the initial source. The Raman effect is a rare phenomenon and affects only about 
1 in every 10 million scattered photons. 
 
 
 
 
 
The inelastic scattering of light was first theoretically predicted in 1923 by the Austrian quantum 
physicist A. Smekal (Smekal, 1923). Although previously scientists had been studying light 
scattering in various media, no change in wavelength had been observed and thus this scattering 
Figure 1.4 – The Raman Effect. The Raman effect is a rare phenomenon whereby photons interact 
with molecular bonds. Most light will transmit straight through the molecule or be reflected. Some 
light, however, will interact with the molecular bond and be scattered as a result. Most of this 
scattering will be elastic, with no transfer of energy between bond and photon; this interaction is 
called elastic scattering, or Rayleigh scattering. A small fraction of scattered photons (~1 in every 
10
7
 scattered photons) will interact with the molecular bond and an energy transfer event will occur, 
changing the photon’s wavelength; which is known as inelastic scattering or, the Raman effect. The 
energy transferred relates directly with the molecular bond species, thus inelastic scattering of these 
photons is informative of the molecule(s) that those photons interacted with. White light contains 
lights of many wavelengths and so photon wavelengths associated with Raman scatter are not 
detectable or interpretable. Using a monochromatic light source such as a laser, enables the 
difference in wavelength of inelastically scattered photons to be measured; providing an indirect 
measure of the chemical composition with which photons interacted. 
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was deemed energetically elastic (Einstein, 1910; Strutt) with the only exception being in specific 
cases in the X-Ray spectrum called Compton scattering (Compton, 1923). One of the chief issues 
of the time was the production of a monochromatic light source and effective filters that could 
exclude the effects of elastic light scattering and transmission of light from the original source. 
The inelastic scattering of light was first observed in 1928 by Sir C. V. Raman (together with 
Krishnan and almost simultaneously by competing group Landsberg and Mandelstam), after 
whom the effect is now named, by the application of a narrow band photographic filter to 
generate a monochromatic light source from the Sun. Coupling this monochromatic source with 
the use of a “crossed filter” to subsequently block light of that wavelength, but permit the 
transmission of other wavelengths, resulted in the observation of light that had indeed changed 
wavelength. The practical discovery of the Raman effect earned him the Nobel prize in physics 
in 1930. 
 
Following the discovery of the Raman effect, the systematic description of the effect and its 
relation to particular molecular vibrational frequencies was performed by G. Placzek between 
1930 and 1934 (Placzek, 1934). Indeed, due to the low sensitivity of the technique at the time, 
highly concentrated samples, in large volumes were required to characterise the molecular 
vibrations of that sample. The advent of the laser in the 1960s provided a means of generating 
vast quantities of monochromatic photons that in turn boosted the sensitivity of the Raman 
technique. 
 
Given the fact that the Raman effect is demonstrated by the interaction of molecular bonds with 
photons, which may be made interpretable by the use of a monochromatic light source, Raman 
spectroscopy offers a unique technique for the interrogation of chemical samples. Indeed, 
Raman spectroscopy has been implemented in a variety of fields, particularly in chemistry and 
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material sciences for the purposes of sample identification and for measures of sample purity 
(Eliasson and Matousek, 2007; Wolf, 1996). In a simplistic interpretation, cells exist as, albeit 
very complex, biochemical mixtures. The interaction of these chemicals ultimately culminates in 
the performance of a majority of cellular behaviours and conversely cells performing different 
behaviours do so as a result of differing chemical composition and interaction. Here, it is 
proposed that the differences in cellular behaviour may be explored in a non-destructive 
manner that requires little to no sample preparation. Indeed, Raman spectroscopy has gained 
traction in the biological sciences and has been used to discriminate between different cell types 
(Dochow et al., 2011; Ellis and Goodacre, 2006). Here it is proposed that Raman spectroscopy 
may be employed to distinguish between more cryptic cell types – possibly even different 
substates. 
Although this application of Raman spectroscopy to that of pluripotent stem cell substates is a 
novel, exploratory application, it is not beyond the realm of possibility that differences are to be 
expected between different substates. As mentioned above, cells that exhibit different 
behaviours do so primarily due their chemical compliment at the time that includes transcription 
factors and proteins. Furthermore, pluripotent cells and their differentiated derivatives can be 
distinguished based upon their Raman spectra, indicating that cellular behaviours can be 
delineated based upon their chemical composition. Finally, there are gross changes in cellular 
energy metabolism that correlate with the process of transitioning from a pluripotent to 
differentiated state, although the exact nature of this relationship is not fully resolved (Kondoh 
et al., 2007; Varum et al., 2011; Zhang et al., 2015). 
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1.10 Technical Contributions 
This thesis was built, in part, upon the work and help by others in collaboration. In terms of 
technical contribution for Chapter 3: Dr. Mark Jones operated the FACS machine to sort cells 
required for the modelling experiments; Dr. Xioakai Nie and Professor Daniel Coca for the 
mathematical development of the modelling process used; Dr. Xioakai Nie for modelling the 
experimental data. With reference to Raman spectroscopy in Chapters 4 and 5: Raman 
spectroscopy work outsourced to Renishaw was performed by Dr. Katherine Lau who acquired 
and analysed the Raman spectra (presented in Section 5.2; Figure 5.1); Professor Wei Huang 
provided the Raman microscope and equipment tuition used for the other Raman experiments; 
Dr. Veronica Biga for the development of the regional isolation tool in MATLAB (Mathworks inc.) 
that allowed the isolation of Raman spectra from regions of interest. 
 
1.11 Aims and Objectives 
This thesis describes the generation and optimisation of two methods for examining pluripotent 
stem cell heterogeneity in the stem cell compartment. The first method interrogates SSEA3 
dynamics within a pluripotent cell population that are subsequently modelled in order to 
uncover the underlying rules that govern ES cell SSEA3 expression levels. The underlying pattern 
of SSEA3 dynamics within the population could be employed to identify substates within the 
population, especially given the close relationship between SSEA3 and pluripotency. The second 
method aims to optimise the non-intrusive Raman spectroscopy technique with application to 
ES cell research in order to uncover biochemical signatures that may belie subtle differences in 
ES cell behaviour. The clear advantage of Raman spectroscopy is that in principal cells may be 
studied in real time and future behaviours examined.  
 43 
 
 
 
Chapter 2 
 
 
Materials and Methods 
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2.1 Cell lines 
A number of different cell lines were used and are outlined below: 
Human Embryonic Stem Cell lines 
Human embryonic stem cell lines used were derived previously, within ethical and legal 
guidelines from fully-informed, consenting patients. 
H14.S9 Cell Line 
The H14s9 cell line is a karyotypically normal cell sub-line of the H14 human embryonic stem cell 
line. 
 H14.BJ1 Cell Line 
The H14BJ1 cell line used is a karyotypically abnormal cell line previously described (Baker et al. 
2007). The H14BJ1 karyotype includes an extra copy of chromosome 17 containing an 
amplification of chromosomal region 17p11.2. 
H7.s6 Cell line 
The H7.s6 cell line is a karyotypically abnormal variant (46,XX, der(6)t(6;17)(q27;q1)) of the H7 
embryonic stem cell line derived by Dr. James Thomson (University of Wisconsin). The karyotypic 
abnormality is considered an adaptation caused by mutation and natural selection facilitated by 
long term cell line culture (Draper et al., 2004).  
Shef4 Gata6:GFP Reporter Cell line 
The Shef4 line was derived using a micro-drop culture system on mitotically inactivated mouse 
embryonic fibroblast cells (Aflatoonian et al., 2010). A sub clone of the Shef4 embryonic stem 
cell line was used here that had a GFP construct knocked into the ATG site of the second exon 
of one allele at the GATA6 locus. This modification was performed by Dr. Andrew Smith 
(University of Edinburgh) using zinc finger nucleases to cause a double stranded break at the 
integration site and the GFP cassette (Figure 2.1) electroporated into the Shef4 line. Cells that 
had undergone successful integration of the GFP cassette were clonally selected through 
neomycin selection and sub-clones subsequently created. The subclone Sheff4 Gata6:GFP 
(S4G6)/F-9 A3 was used and neomycin resistance was removed using TAT-FLP recombinase.  
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Hes3 Mixl1:GFP reporter cell line 
The Hes3 human embryonic stem cell line was derived from cells isolated from the inner cell 
mass of the embryo. The cell line was later modified by Dr. Elefanty et al (Monash University) to 
include a targeted insertion of GFP into exon1 of the MIXL1 locus via electroporation (Davis et 
al., 2008). Successfully transfected cells were selected for through neomycin resistance. 
Successfully integrated cells were expanded and transiently transfected with a vector expressing 
Cre-recombinase in order to remove neomycin resistance (Figure 2.2). 
Human Embryonic Carcinoma Cell lines 
Human embryonic carcinoma cell lines used are described below. 
N2102 Ep cell line 
The N2102EP embryonic carcinoma cell line was derived from a primary human testicular 
teratocarcinoma and later sub-cloned (Andrews et al., 1982). This cell line exhibits low rates of 
spontaneous differentiation in vitro. 
NTera2 Clone D1 cell line 
The NTera2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line sub-
cloned from parental NTera2 lines established in 1984 from nude mouse xenograft of the TERA2 
cell line (Andrews et al., 1984b). The TERA2 cell line was originally established from a lung 
metastasis of a testicular teratocarcinoma in 1975 (Fogh J, 1975). 
Mouse Cell lines 
Cell lines derived from mouse: 
Mouse Embryonic Fibroblast (MEF) Cells 
Mouse embryonic fibroblast cell lines were derived from embryonic day 13.5 embryos of the 
MF1 mouse strain grown in-house. Embryos were excised followed by thorough mechanical and 
enzymatic (trypsin) tissue/cell dissociation. Residual tissue chunks were filtered out by gravity 
and the remaining mixture was seeded into culture vessels and permitted to grow to 90% 
confluence before being harvested and cryopreserved for later use. 
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Figure 2.1- GFP transfection cassette electroporated into the Shef4 line to generate the Shef4 GATA6:GFP 
(S4G6) reporter cell line. The cassette contains the wild-type GFP gene bolted to puromycin resistance through 
an IRES. The GFP construct is knocked into the ATG site of the second exon of one allele for the GATA6 locus 
resulting in an heterozygous GATA6:GFP cell line. The ATG site is targeted using zinc finger nucleases, 
causing a double stranded break at the integration site. Constitutive neomycin expression (via the PGK 
promoter) allowed for the selection of successfully transfected cells. The S4G6 4/F-9 A3 subclone used had 
neomycin expression removed using TAT-FLP recombinase. 
Figure 2.2 – GFP targeting to the MIXL1 locus in the Hes3 cell line (Davis et al, 2008). Gene targeting vector structure 
used to insert sequences of GFP into exon one of the MIXL1 locus in order to generate the MIXL1:GFP reporter cell 
line in human Embryonic Stem cells.  
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2.2 Reagents 
Media & Matrices 
Human Embryonic Stem Cell Culture 
Human embryonic stem (hES) cells were either grown with or without mitotically inactivated 
mouse embryonic fibroblast (MEF) support. When grown using MEF support, culture vessels 
were first treated with 0.1% gelatin (Thomson and Marshall, 1998) and cell cultures were grown 
in hES cell media (Table 2.1). When grown in the absence of MEFs, embryonic stem cells were 
cultured on culture vessels treated with Vitronectin (LifeTech A14701SA) and maintained using 
E8 media (LifeTech A1517001). 
 
 
 
Table 2.1 - Media composition used for human embryonic stem cell cultures when grown on mouse 
embryonic fibroblasts  
Component Final 
Volume 
Knockout DMEM 800mL 
Knockout Serum Replacement 200mL 
1% Non-essential Amino Acids 10mL 
1mM L-Glutamine 10mL 
0.1mM β-mercaptoethanol 2mL 
4ng/mL human bFGF 1mL 
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Human Embryonic Carcinoma Media 
Cell culture for human embryonic carcinoma cell lines and mouse embryonic feeder cells were 
cultured in media containing 90% DMEM and 10% foetal calf serum (See table 2.3). 
Cell staining/ Antibodies used 
Cellular staining was performed using the reagents listed in Table 2.2. 
 
 
Table 2.2 - List of antibodies/ cell markers used and their supplier details  
Antibody Target Antigen  Antibody 
species/subtype 
Supplier Cat Number 
Primary Antibodies 
P3-X-63-AG8    In house  
MC631-2C2 SSEA3  Rat IgM In house  
MC480 SSEA1  Mouse IgM In house  
TRA-1-60s TRA-1-60  Mouse IgM In house  
Secondary Antibodies 
Alexa Fluor 488   Goatαmouse IgG Thermo-Fisher Z25002 
DyLight 647   Goatαmouse IgM Thermo-Fisher 62265 
Nucleus Staining 
Hoechst 33342  DNA   Sigma B2261 
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General Reagents 
A list of reagents used are listed in table 2.3 below. 
Table 2.3 - List of general reagents used during experiments 
Reagent Supplier Catalogue Number 
Dulbecco’s Phosphate Buffered Saline (w/o 
Mg++ or Ca++) 
Sigma-Aldrich D1408 
Paraformaldehyde Sigma-Aldrich 441244-1KG 
Gentamycin Sigma-Aldrich G1397-10ml 
Dulbecco’s Modified Eagle’s Medium Sigma-Aldrich D5796 
Dulbecco’s Modified Eagle’s Medium 
w/o Phenol Red 
Sigma Aldrich D1145 
Foetal Calf Serum (EU) HyClone SV30143.03 
Mitomycin C Sigma-Aldrich M-4287 
Y-27632 (ROCK Inhibitor) Sigma-Aldrich Y0503 
Sodium Hydroxide  Sigma-Aldrich S8045-1KG 
Propidium Iodide Sigma-Aldrich P4170-100mg 
Vitronectin Life Technologies A14701SA 
E8 Media Life Technologies A1517001 
TrypLE Life Technologies 12563-029 
Knockout DMEM Life Technologies 10829-018 
Knockout Serum Replacement Life Technologies 10828010 
1% Non-Essential Amino Acids Life Technologies 1140-035 
1mM L-Glutamine Life Technologies 25030-81 
0.1mM β-mercaptoethanol Life Technologies 31350-010 
4ng/mL human bFGF RnD Systems 233-FB-01M 
Bovine Serum Albumin (BSA) Sigma-Aldrich A-1470 
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Methods 
2.3 Cell culture 
Human Embryonic Stem Cell culture 
Human embryonic stem cells were cultured either with or without mouse embryonic fibroblast 
support as required by different experimental procedures described below. In all cases, hESCs 
were incubated in a humidified incubator at 37oC with 5% CO2. 
Mouse Embryonic Fibroblast dependent culture 
Human ES cells were cultured on mitomycin inactivated MEFs derived in-house from the MF1 
mouse strain. Stocks of these MEFs were defrosted at P0 and cultured to P4 with DMEM/10% 
FCS and incubated in 10% CO2 humidified incubator at 37oC prior to inactivation treatment with 
mitomycin C.  Mitomycin C was diluted in DMEM/FCS at 1ug/mL and added to MEFs for 2h. Cells 
were then washed in PBS and detached from culture vessels using trypsin:EDTA for 2minutes at 
37oC. Trypsin was neutralised by the addition of DMEM/10%FCS then cells were harvested, 
centrifuged, supernatant aspirated, resuspended in DMEM/10%FCS and counted. On average 
2x106 cells were resuspended in 0.5mL of freeze media (80% DMEM, 10% FCS & 10% DMSO) and 
stored at -80oC. 
 
The culture surface of T-25 Flasks was coated with 2mL of 0.1% Gelatin/PBS and incubated for 
30 minutes at room temperature. Following incubation, gelatin was aspirated from the T25 
flasks and MEFs were seeded at a density of 10,000 cells/cm2 in DMEM/10%FCS and incubated 
in 10% CO2 at 37oC overnight prior to use. Fresh MEFs were used for hESC culture whenever 
possible. In preparation for hESC culture, the media from MEF flasks was aspirated and replaced 
with 2mL of hESC media and incubated at 37oC with 10% CO2 for a minimum of 30 minutes to 
equilibrate. Media from hESC cultures to be passaged was aspirated and replaced with 1mL/T25 
of 1mg/mL collagenase IV to facilitate colony detachment. Cells were incubated for 7 minutes 
at 37oC after which collagenase was aspirated and removed with 3mL of fresh hESC media. Cells 
were gently scraped using a plastic Pasteur pipette or glass beads to detach cells from the flask 
surface and split into the equilibrated MEF flasks at a ratio of 1:3-1:4. 
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Mouse Embryonic Fibroblast independent culture 
When culture on mouse embryonic fibroblasts was not used, human embryonic stem cells were 
cultured on a matrix of Vitronectin and with E8 media. Vitronectin was thawed on ice and diluted 
1:100 with Dulbecco’s Phosphate Buffered Saline (PBS see table 2.3). Culture vessels were 
coated with 100µL/cm2 of diluted Vitronectin for 1 hour at room temperature, which could then 
be stored for up to 1 week at 4oC. 
 
Human Embryonic Carcinoma Cell culture 
Human embryonic carcinoma cell lines were cultured at 37oC in DMEM/10%FCS under a 
humidified atmosphere of 10% CO2 in air. Cultures were passaged by either enzymatic or 
mechanical detachment. For enzymatic detachment, media was aspirated from culture and 
replaced with 1mL 0.25% trypsin in EDTA and incubated at 37 oC for 2 minutes. Flasks were 
knocked to aid detachment prior to trypsin inactivation by the addition of 4mL DMEM/10% FCS 
and cells were rinsed with this media to aid detachment then transferred to a 15mL falcon tube 
and centrifuged at 1000rpm for 3 minutes. The supernatant was aspirated and the cell pellet  
resuspended and triturated in DMEM/10%FCS and split at a ratio of 1-3:1-4. For mechanical 
passage, media was aspirated from culture vessels and replaced with 1mL DMEM/10% FCS and 
mechanically detached using glass beads. DMEM/10% FCS was used to wash the cells off the 
beads and collected to be split at 1:3-1:4. 
 
Mouse Embryonic Fibroblast Cell culture 
Mouse embryonic fibroblast cells were not only used to facilitate human embryonic stem cell 
culture. For experiments requiring non-inactivated mouse embryonic fibroblasts, cultures were 
cultured at 37oC in DMEM/10%FCS under a humidified atmosphere of 10% CO2 in air. Cultures 
were passaged enzymatically using 0.25% trypsin:EDTA as described for human embryonic 
carcinoma cell culture. 
 
Cell Culture in preparation for Raman Spectroscopy 
Cells for examination with Raman spectroscopy were grown on Raman grade CaF2 (Crystran) 
discs within a petri-dish as the culture vessel. These CaF2 discs were utilised in the same manner 
as regular culture plastic. Human EC cells were seeded directly onto CaF2 slides and maintained 
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with 10% FCS/DMEM. Human ES cell lines were cultured in a MEF free format using 
vitronectin/E8 supplemented with Y-27632 as the matrix/media combination as described 
above (see above). In each case, cells were seeded and left to attach overnight prior to PFA 
fixation (See below). 
 
Thawing Cell lines for culture 
Cell vials were transported on ice when removed from liquid nitrogen facilitated 
cryopreservation. Cell were allowed to partially thaw in a 37oC water bath. To prevent DMSO 
mediated cell damage, cells were not left to thaw completely prior to further manipulation. Cells 
were quickly transferred into a 15ml falcon tube, diluted with 10ml of pre-warmed appropriate 
media; human ES cell media for human ES cell lines and DMEM/10%FCS for human EC and MEF 
cell lines. Cells were centrifuged at 1000rpm for 3 minutes. The supernatant was aspirated and 
cells were resuspended in fresh relevant media before being plated in prepared flasks. Note that 
human embryonic stem cell lines require inactivated mouse embryonic fibroblast culture vessels 
prepared in advance and when seeded, human embryonic stem cell culture media was 
supplemented with 10µM Y-27632 to improve cell survival. 
 
Single cell dissociation of Human Embryonic Stem Cells 
For experiments that required single cells, hESCs were dissociated using TrypLE. Media was 
aspirated from the cells and 100µL/cm2 of 1X TrypLE added to the vessel. After incubating for 2 
minutes at 37oC, the cells were dislodged by gently hitting the flask, and then returned for a 
further minute to 37oC. Two volumes of hESC media were added to neutralise the TrypLE, and 
the cells were transferred to a 15mL falcon tube and centrifuged at 1000rpm for 3 minutes.  The 
supernatant was aspirated and cells were re-suspended in hESC media for further downstream 
application. 
 
Single Cell Dissociation of Human Embryonic Carcinoma cells 
For experiments that required single cells, hEC were dissociated using trypsin. Media was 
aspirated from the cells and 40µL/cm2 of 0.25%trypsin, in 1 mM EDTA in calcium and 
magnesium free PBS were added to the vessel. Cells were incubated for 2 minutes at 37oC, 5% 
CO2, the trypsin removed and cells were dislodged by gently hitting the flask. DMEM/10%FCS 
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(160µL/cm2) was added to inactivate the trypsin. Cells were transferred to a 15mL tube and 
centrifuged at 1000rpm for 3 minutes after which the supernatant were removed and cells 
resuspended in DMEM/10%FCS. 
 
Cell Counting 
Cells to be counted were first dissociated to single cells (see above) and resuspended into an 
appropriate volume of media. 10µL of cell suspension was added to an improved nebauer 
haemocytometer and the four corner grids were counted. Consequently, the number of cells/mL 
of the 10µL sample is determined: 
 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 [𝑐𝑒𝑙𝑙 𝑚𝐿⁄ ] =  
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑐𝑜𝑢𝑛𝑡𝑒𝑑
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑔𝑟𝑖𝑑𝑠 𝑐𝑜𝑢𝑛𝑡𝑒𝑑
× 10,000 
 
𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 = 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 × 𝑇𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 (𝑚𝐿) 
 
2.4 Flow cytometry analysis and in situ 
Flow cytometry analysis 
Cells for flow cytometry analysis were first dissociated into single cells and counted. Following 
centrifugation at 1000rpm for 3 minutes, supernatant was aspirated and cells resuspended in 
FACS buffer (10% FCS/PBS) at a cell density of 1x107 cells/ml.  200µl of sample was transferred 
to a 5mL FACS tube, the relevant primary antibody appropriately diluted and 200 µl was added 
to each sample. Cells and primary antibody were incubated at 4oC for 30 minutes an occasionally 
disturbed to resuspend the cell pellet. Following incubation, cells were washed in 4ml FACS 
buffer, centrifuged and supernatant aspirated three times prior to resuspension in 200µL FACS 
buffer. 200µl of diluted, relevant secondary antibody was added to each sample and incubated 
at 4oC for a further 30 minutes with occasional disturbance to resuspend the cell pellet. After 
incubation in the secondary antibody, the cells were again washed three times in 3ml FACS 
buffer, centrifuging each time at 1000rpm for 3 minutes, and resuspended in 500µL for flow 
cytometry analysis using the CyAn (Beckman Coulter) flow cytometer, or for cell sorting using 
either a MoFlo (DakoCytomation) or FACSJAZZ (BDBiosciences) platforms. 
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Cell flow cytometry analyses were performed with Summit software. Events registered during 
flow cytometry and FACS sorting were gated in order to remove noise from the dataset such as 
debris or cell doublets (example in Figure 2.3). These events were excluded based upon size 
measures from forward scatter/side scatter measurements; where the main cell population was 
inferred to be the most numerous. Therefore, only events within this main size distribution were 
accepted.  Secondly, cell doublets were excluded using the pulse width metric. 
 
 
 
Flow Automated Cell Sorting 
Cells were prepared in the same manner as described above but cells were also filtered using a 
70μm filter (Miltenyi Biotec 130-095-823) to ensure single cells were used, and the FACS buffer 
used for cell sample washes was replaced with the relevant cell media; i.e. DMEM/10% FCS for 
human embryonic carcinoma cells and human embryonic stem cell media for human embryonic 
stem cells. Additionally, cells were sorted into cell line relevant media supplemented with 
50µg/mL gentamycin. To aid survival, sorted human embryonic stem cells were re-plated in 
media additionally supplemented with Y-27632. 
 
 
Figure 2.3 – Cell density plots to provide examples for cell gating measures undertaken during flow 
cytometry for the exclusion of events representative of debris and cell doublets. The FS Lin/ SS Lin  
measures of the population provides information on general cell size; events were gated around this density 
plot in order to exclude outlying events  that may be more representative of debris. The Pulse width against 
FS Lin exclusion is used to exclude cell doublets where flow cytometry data are not acquired on a single 
cell basis. 
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Immunostaining cells in situ 
Following fixation (see above) in PFA, the cells for in situ immunostaining had PBS aspirated and 
were incubated with a blocking solution (10% FCS/PBS 0.3M Glycine and 1% Bovine Serum 
Albumin) at room temperature for one hour. The blocking solution was removed from cells and 
replaced with relevant primary antibody that was diluted in PBS/10% FCS at an appropriate 
concentration. Cells were incubated with primary antibody at 4oC for one hour. Primary antibody 
was then removed and cells washed three times with PBS. The Cells were incubated for one hour 
at 4oC with relevant secondary antibody and Hoechst 33342 also dissolved in PBS/10% FCS at an 
appropriate concentration. Secondary antibody was aspirated away and cells washed three 
times in PBS. Cells could then be stored in PBS at 4oC until examined using the InCell Analyser 
system. 
 
2.5 Cell Fixation 
Paraformaldehyde preparation 
Paraformaldehyde solution used for cell fixation was prepared using powdered 
paraformaldehyde dissolved in PBS heated to 65oC in a dilution of 4% paraformaldehyde in terms 
of weight per volume. 5M NaOH was added dropwise until solution became transparent, then 
filtered to remove any residual particulates and left to cool. Aliquots of PFA were either used 
immediately when or frozen to -20oC for storage and used within 2 weeks. 
 
For in situ immunohistochemistry 
Cells that were subject to immunostaining in situ were fixed using 4% paraformaldehyde. Media 
was aspirated from cell cultures, washed three times with PBS and incubated with 4% PFA for 
12 minutes at 4oC. Following incubation, cells were washed three times with PBS and stored at 
4oC in PBS ready for later staining. 
 
For Raman Spectroscopy 
Cells grown for Raman spectroscopy (see above) were fixed in paraformaldehyde prior to 
interrogation with Raman spectroscopy. Media was aspirated from the culture vessel and cells 
were washed with Dulbecco’s phosphate buffered solution three times. PBS was aspirated off 
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the cells, 4% paraformaldehyde added and incubated at 4oC for 12 minutes. Following 
incubation, PFA was aspirated off and the cells again washed three times with PBS (w/o Ca++ and 
Mg++). PBS was then aspirated off the cells replaced with dH2O and incubated at room 
temperature for one minute prior to being aspirated and left to dry in a lamina flow hood. 
 
Clonogenics 
Clonogenic experiments were carried out on the NTera2 embryonic carcinoma cell line. In this 
context, Clonogenic assays were performed after FACS cell sorting. Sorted cells were centrifuged 
at 1000rpm for 3 minutes and resuspended in DMEM/ 10% FCS supplemented with 50µg/mL 
gentamycin. Cells were passed through a 70μm filter counted and diluted to a cell plating density 
of 1000 cells/cm2. After plating in DMEM/10% FCS supplemented with 50µg/mL gentamycin, 
fractions were cultured for 4 days in DMEM/10%FCS under a humidified atmosphere of 10% CO2 
humidified incubators at 37oCin air. After 4 days, cells were fixed in PFA and stained for 
appropriate markers. 
 
2.6 Raman Spectroscopy Data Collection and Processing 
Two Raman microscope setups were used to generate data presented in this thesis. The data 
discussed in Section 5.2; “Different Cell Types” were acquired using the inVia Reflex confocal 
Raman microscopy system, designed by Renishaw plc, that was fitted with a 532nm laser. The 
collection and analyses of these data were outsourced to the Raman microscopy company 
Renishaw plc (uksalessupport@renishaw.com) and performed by Dr. Katherine Lau.  
All other Raman spectra (Chapter 4 and Section 5.3 onwards) were collected using an in-house 
modified HoribaLabRam HR (Wellsens Biotech. Ltd., China) that employed a 532nm Nd:YAG laser 
(Ventus, Laser Quantum Ltd, UK), a Newton EMCCD (DU970N-BV, Andor, UK) and integrated 
Olympus microscope (model BX41) for sample observation and Raman acquisition. A pinhole of 
300µm and a slit size of 100µm was used enabling a spatial resolution of 1µm2 laser spot size to 
be obtained. The System was calibrated prior to analyses and monitored using a Silicon Raman 
band reference. Raman spectra were collected from cells spatially and temporally defined for 
specific experiments. 
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Spectra collected were pre-processed using Labspec software (Horiba) for spectral zeroing and 
normalisation by area under the curve. In the case of spectral maps, relevant spectra were 
selected from the acquired data by use of a tool developed in MatLab (Biga & Mason, 
unpublished) that was developed to group spectral data according to stored X and Y coordinates 
within mapping files against microscope photographs of the relevant sample. File management 
and spectral database compilation was performed in R Language for statistical computing (R 
Foundation for Statistical Computing).  
 
2.7 Multivariate analysis 
A number of multivariate analytic techniques were employed to analyse the Raman spectra 
collected. Multivariate analyses of spectra were performed using the Simca (version 14, 
UMETRICS) analysis software, unless otherwise stated. Multivariate analytic techniques are 
designed to address data that presents multiple measured variables as outcomes for a particular 
sample(s). Raman spectra contains information from multiple wavenumbers which are all 
measured variables and so suitable for multivariate analysis.  Two multivariate analytical 
techniques were applied to the Raman spectra; Principal component analysis (PCA) and Partial 
Least Squares Regression (PLS). 
 
Principal Component Analysis 
PCA is a technique that is employed to reduce the number of dimensions present within a 
dataset by an orthogonal transformation of the data from a set of possibly correlated variables 
(e.g. wavenumbers) into a set of linearly uncorrelated principal components (PC). The PC are 
calculated in such a manner as to account for as much variation within the dataset as possible 
and are defined that the first PC accounts for the largest possible variance in the dataset with 
each subsequent PC accounting the most variance that is orthogonal (i.e. perpendicular) to the 
preceding component. The number of PC generated by this transformation is less than or equal 
to the number of original variables and each PC is linearly uncorrelated to the other PCs since 
they are orthogonal. PCA therefore transforms the dataset in such a way as to best explain the 
variation seen within the dataset on a hypothetical axis which the first principal component, 
whilst each subsequent PC describes the next largest axis of remaining variation.  
The application of PCA presents an unbiased examination of the variables, which aims to reduce 
the number of dimensions in the dataset by systematically describing those variables most 
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responsible for differences between all samples. This calculation is performed on all samples 
and does not take into account any a. priori knowledge regarding the samples such as 
classification or experimental treatment. Therefore, if samples separate according to PCA in a 
manner that correlates with experimental treatment, then this is a correlation born out of the 
dataset rather than one presupposed by the PCA and so indicates a real difference between the 
experimental treatments. 
The PC themselves do not exist directly from the variables measured in the original dataset but 
instead are hypothetical axes through the multidimensional dataset that best capture the 
remaining variance of the dataset. Each PC does however have a relationship with all the 
variables in the dataset, since the variation of each variable is in part responsible for the 
calculation of the PC. It is possible then to calculate the degree by which all variables contribute 
to the PC of interest (termed PC loadings) and thus enables those variables that are contribute 
the most for samples separating according to that PC to be determined. A sample that has a 
particularly large measurement (compared to the rest of the dataset) for a variable 
(wavenumber) that contributes to a positive separation on a PC will tend to be positive when 
compared against that PC in relation to other samples. However, this trend is true for all 
variables and so the degree to whether a sample is positive or negative on a PC axis is an 
integration of all variables from that sample with respect to the PC. A PC that shows a trend of 
separation between samples may be examined to determine what variables (or wavenumbers) 
contribute most heavily towards that sample separation. It is important to note that all PCs are 
particular to their respective PCA and so the PC data from one PCA/dataset is not directly 
comparable to that of any other PCA/dataset. 
 
Partial Least Squares Regression 
PLS is a multivariate technique that bears some resemblance to PCA analysis, however instead 
of determining the PC of maximal variance between variables in an unbiased manner, the 
technique also factors in a. priori information about the experimental treatment of samples into 
the analysis as predicted variables (e.g. whether sample cells have or have not been treated with 
RA). PLS acts to find a linear regression model that projects the predicted variables with the 
observed variables (wavenumber) in order to find the observed variables that are the strongest 
predictors of the predicted variables. This type of modelling is particularly useful for predicting 
the predicted variable (experimental treatment) of a novel sample, but is not suited for 
understanding the relationship between these variables. 
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2.8 Calcium Fluoride slide cleaning protocol 
Raman grade Calcium Fluoride slides (Crystran; Figure 2.4) used for Raman analysis were washed 
after use for cell culture, prior to sterilisation and reuse for further experiments. CaF2 slides were 
washed by; thorough rinsing in sequence with distilled water, tergazyme (prepared as per the 
manufacturer’s instructions, Sigma-Aldrich), distilled water, coulter cleanser (Beckman Coulter) 
and distilled water. In between cleansing agent exchange, CaF2 slides were polished with lint 
free cloths. After washes, CaF2 were left to air dry until ready for use. In preparation for cell 
culture, CaF2 slides were sterilised by submersion in 70% ethanol and exposed to ultra-violet 
radiation for one hour in a lamina flow hood. CaF2 slides were then rinsed in filter-sterilised 
water and allowed to dry in the lamina-flow hood before use in cell culture. 
 
 
Figure 2.4 – Raman Spectra of CaF2 slides produced by manufacturer Crystran. Raman grade CaF2 slides 
(black) used in experiments here do not present a strong Raman band within the organic fingerprint region 
between wavenumbers 500cm-1 and 1800cm-1 and so are ideal for cell based applications  
 
2.9 SSEA3 Dynamics Modelling 
The approach adopted to model the SSEA3 intensity dynamics is based on methods developed 
by Nie & Coca (2015), with whom we collaborated. Nie and Coca performed the modelling 
using experimental data generated (see chapter 3). For more details regarding the modelling 
algorithms and application to other experiments please contact Professor Daniel Coca 
(d.coca@sheffield.ac.uk).  
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Chapter 3 
 
 
Modelling Pluripotent Cell 
Heterogeneity 
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3.1 Introduction 
Heterogeneity 
 
The behavioural heterogeneity displayed by human ES cells during culture and 
differentiation remains an enigmatic problem, both conceptually and practically. 
Lineage biases may be inferred by observing the differentiated derivatives of a 
pluripotent stem cell long since left the pluripotent state (Tonge and Andrews, 2010). 
Alternatively, investigations into global gene expression patterns of human ES cells while 
maintained in a pluripotent state in culture requires the destruction of the cell of 
interest, so that the future behaviour of cells presenting gene expression patterns 
predicted to represent substates cannot be studied. All of these problems precede the 
conceptual issue that the definition of ES cell substates mandates the property of 
interconvertibility and so the substate identity of any one particular cell would be in flux 
preventing any “snap-shot” profiling approach of cells in culture from accurately 
representing this dynamic system. Currently, no established method exists by which 
particular substates may be prospectively identified and even less is known about the 
interconversion dynamics of substates within what is termed the hypothetical “stem cell 
compartment” (See Figure 1.2). 
 
Although there exists functional evidence for interconvertible stem cell substates 
(Tonge and Andrews, 2010), there are currently no direct methods for the readout of 
substate status of either individual cells or of a population. Currently, different methods 
for the gross categorization of cells based upon marker expression are not the same as 
defining the position of a substate proper. However, examination of the fluctuating 
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expression of pertinent markers should reflect the dynamical changes of cells within the 
stem cell compartment. 
 
It should be noted that the marker modelled should not be taken as a direct readout of 
any given substate since at the moment we have no proper marker for substates. The 
most appropriate marker would sensitively reflect the pluripotency of the cell, as well 
as having a dynamic, heterogeneous expression that has been associated with substate 
behaviours previously. The approach adopted here does not look for absolute marker 
expression, but the rather interrogates the dynamics of that marker expression with 
respect to a population over time. An adapted model of Waddington’s canalization of 
development purports that cells within a specific substate are expected to be more 
stable than cells inter-substate (Figure 3.1, (Andrews, 2002)). Therefore, we look 
specifically for indications for marker expression levels that are more stable over time 
and that less stable marker expression levels tend towards: termed ‘attractors’. 
Attractors represent equilibria in the stem cell substate landscape visualized as wells or 
depressions, where cells are liable to reflect observable behavioural phenotypes. 
 
A dynamical model of the system would allow determining analytically the location of 
these equilibrium points in the state-space defined by the marker variables.  
Subsequently, it should be possible to isolate cells in different putative substates that 
can be tested further for their lineage biases or other differences in biological behaviour. 
If there are putative substates identified, they require investigation to see whether they 
are in fact representative of substates with different behaviours. Cells in a substate 
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should be more uniform in their behaviour than those between substates and cells in 
different substates should behave differently in some manner, for example with regard 
differentiation lineage biases. However, the way in which substates manifest differing 
behaviour could be varied and unexpected. 
 
In order to address the problem of stem cell substates identification, a new method to 
characterize the dynamics of stem cell population was developed. This method involves 
measuring the marker expression patterns of distinct cell fractions within the stem cell 
compartment at regular time intervals over a period of time. The experimental data 
generated takes the form of sequences of probability density functions that reflect at 
population level individual state transitions for cells within the stem cell compartment. 
The behaviour of heterogeneous stem cell populations, as reflected by FACS 
measurements of a sensitive pluripotency marker, was subsequently modelled using a 
technique recently developed by (Nie X, 2013).The model not only predicts the evolution 
of the pluripotent marker distributions over time but also the location and stability of 
equilibrium points that are potential substates.  
  
Figure 3.1 – Waddington’s canalisation of development.
Visual representation of Waddington’s canalisation of
development. The “ball” represents a potent cell and the
valleys in the landscape represent lineage choices and
differentiation along with the progressive loss of potency.
a.) Classic visualisation of Waddington’s canalisation of
development where the cell continues rolling through
valleys until terminally differentiated.
b.) Interpretation by Andrews (2002); Valleys are nuanced
with divots in which the ball (or cell) may reside during the
same process of differentiation as in a.). Here the divots
represent stable attractor points which manifest themselves
phenotypically as cell types that are stable but not yet
terminally differentiated. Regions between divots are
unstable cell states in which the cell may only transiently
reside until it comes to a new, stable attractor state.
Figure from Andrews, 2002
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3.2 Stage Specific Embryonic Antigen 3 
 
The ideal marker for the delineation of substates within the stem cell compartment is 
one that has a strong association with pluripotency, is heterogeneously expressed and 
whose expression is itself dynamic. The cell surface antigen Stage Specific Embryonic 
Antigen 3 (SSEA3) represents an ideal candidate in this case. 
 
The expression of SSEA3 and its association with pluripotency have been studied in 
detail elsewhere and it is clear that with human pluripotent stem cells, SSEA3 is 
expressed and is one of the first known cell surface antigens to be lost from cells during 
differentiation (Draper et al., 2002; Enver et al., 2005a; Kannagi et al., 1983b; Shevinsky 
et al., 1982). Furthermore, it has been proposed that SSEA3 is lost from cells prior to 
differentiation commitment proper, suggesting that SSEA3 expression may be sufficient 
to identify a stem cell as pluripotent, but it is not necessary for pluripotent stem cell 
identity (Brimble et al., 2007). In normal culture, human ES cells present a very 
heterogeneous expression pattern of SSEA3, with cell populations occupying a broad 
range of expression, including cells that do not present SSEA3. 
 
The expression of SSEA3 is also dynamic with cells being able to change their SSEA3 
expression over time. For example, cells that are sorted for SSEA3 positive and negative 
fractions and cultured separately eventually yield an SSEA3 expression pattern just as 
heterogeneous as the original parental population, although the negative population 
reconstitutes the expression of the parent population considerably faster  (Olariu et al., 
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2009). That being said, the relationship between SSEA3 and pluripotency is not causal 
and the biological function of SSEA3 on ES cells, if any, remains enigmatic. As a globo-
series glycolipid, SSEA3 expression is not the direct determinant of any particular gene 
but is instead the product of several glycosyltransferases and so represents the 
integration of several processes that culminate in the production of the SSEA3 antigen. 
Therefore, the extent of SSEA3 expression presents an indirect measure of cellular 
behaviour rather than as a direct determinant of gene expression (See Section 1.5). 
 
Due to the heterogeneous expression of SSEA3 on human ES cells, coupled with its 
strong association with the pluripotent state in humans, SSEA3 represented an ideal 
marker to explore ES cell heterogeneity in culture.  
 
3.3 Introduction to modelling approach 
 
The investigation focussing on SSEA3 expression and its dynamics is predicated on the 
hypothesis that the heterogeneity displayed is the result of deterministic chaotic 
behaviour rather than a random, stochastic manifestation (See glossary table 3.1). 
Chaotic systems generate densities of states and can be studied using probabilistic 
approaches. The main difference is that in the case of chaotic systems the evolution of 
the system is governed by a deterministic rule rather than a stochastic process.  Since 
embryonic stem cells are programmed to follow very precise development programs it 
is reasonable to assume that the deterministic rules that hESCs follow ‘in vivo’ may lead 
to chaotic behaviour under the culture conditions.  
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Table 3.1 – Glossary of Modelling Terms  
Term Meaning 
Probability 
Density 
Function 
With respect to an SSEA3 distribution; A manipulation of the raw count 
histogram of a population’s SSEA3 distribution to reflect the likelihood of 
SSEA3 expression intensity. This normalisation procedure across the 
range of SSEA3 intensity allows for comparison of SSEA3 expression 
distributions taken from different cell populations that may have been 
acquired using different total cell numbers. 
Chaotic When used in the context of chaos theory, a chaotic behaviour refers to 
an apparently random but deterministically driven behaviour (Thietart 
and Forgues, 1993).  
Determinism A deterministic system is one in which no randomness is involved in the 
development of the future states of that system. A knowledge of the 
present allows accurate prediction of the future. 
Deterministic 
Chaos 
A deterministic system is chaotic whenever its evolution is extremely 
sensitive to the initial conditions; where two quite different trajectories 
may emerge and exponentially diverge over time starting from two 
different but close initial conditions (Boccaletti et al., 2000). Although 
Deterministic chaos is predictable since it may be described without the 
introduction of random variables, the quality of the prediction is 
dependent on precise knowledge of the initial conditions. 
 
This feature is often popularised as the butterfly effect, where slight 
changes in initial conditions may have very different latent effects. 
Edward Lorenz summarised as: “When the present determines the 
future, but the approximate present does not approximately determine 
the future.” (Lorenz, 1963) 
Stochastic A Stochastic event is one that is unpredictable because it is reliant on a 
random variable. This differs from that of an event resulting from 
deterministic chaos since there is no need to use random variables in a 
deterministically chaotic system. 
Probabilistic 
approaches 
Considering the outcome states of a system in terms of the probability of 
an individual component exhibiting a particular behaviour. For instance, 
the probability of any given cell displaying any particular SSEA3 intensity 
within a defined population. 
Dynamic 
Systems 
A system whose states change with respect to time based upon its 
current state. 
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Many systems in the real world exhibit chaotic behaviour (Ott, 1993) and indeed some 
of the best known examples of chaotic systems were originally proposed to model 
population dynamics (May, 1976). Other examples of chaotic behaviour include that of 
predicting weather patterns, where although these may be governed by deterministic 
rules, prediction of future weather is confounded by imprecise knowledge of the present 
(Lorenz, 1963; Palmer, 2000). One of the simplest examples of a deterministic system 
that exhibits chaotic behaviour is the motion of a double pendulum (Shinbrot et al., 
1992). The motion of a single pendulum is extremely easy to predict with approximate 
initial conditions, however the motion of a double pendulum is extremely sensitive to 
initial conditions, making its future motion difficult to predict. Two double pendula that 
are set in motion with a miniscule difference in initial conditions may appear in phase 
for some time before their trajectories exponentially deviate from each other  (Shinbrot 
et al., 1992). An alternative simple example is that of a quincunx (or Galton Board) where 
a ball is dropped through a harrow of pins (Judd, 2007). Although the ball’s motion may 
appear random, it is actually determined by a series of individual collisions with the pins, 
determining its velocity for the next collision and so on. Slight changes in the initial 
condition of the ball such as linear velocity or rotational velocity results in different 
trajectories (Judd, 2007) . Deterministic chaos is perhaps best distinguished from a 
stochastic system (i.e. relies upon random elements) by the phrase “When the present 
determines the future, but the approximate present does not approximately determine 
the future” as coined by Edward Lorenz who pioneered Chaos theory (Lorenz, 1963). 
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In many cases in which it is of interest to study chaotic systems, it is not possible, or is 
extremely challenging to observe individual point trajectories over time and instead the 
distributions of the variable of interest are measured at regular intervals. For instance, 
here it is very difficult to know by direct observation how any particular cell’s SSEA3 
expression will change over time, yet its SSEA3 expression remains observable at any 
discrete instant.  
 
Recently Nie & Coca introduced a method to infer the models of discrete time chaotic 
dynamical systems based solely on sequences of density functions measured 
experimentally. Specifically focussing on one-dimensional chaotic maps described by 
𝑥(𝑡𝑘+1) = 𝑆(𝑥(𝑡𝑘)) 
Where x(tk) is the variable of interest at a given moment in time (tk), S is a non-linear 
function, t(k+1)=t(k)+Δt is the future timepoint and Δt is a constant time increment. In the 
particular case here, x denotes the SSEA3 fluorescence level of a cell population as an 
observed probability density function and Δt is 24 hours. Thus the SSEA3 dynamics of a 
cell population may be explored and, given the relationship between SSEA3 expression 
and pluripotency employed to interrogate the stem cell substate hypothesis (Nie X, 
2013). 
 
Although simulated data have been successfully modelled with this approach, we 
provide here real data for the modelling procedure within the SSEA3 heterogeneity 
context. By taking cells from the population of SSEA3 expressing cells and following their 
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change in SSEA3 expression over time, a model of the rate of change between particular 
intensities of SSEA3 from one day to the next is made. With a comparison made with 
enough samples of SSEA3 expressing cells and their transition between time points, a 
comprehensive model explaining these transitions is constructed. Therefore, large 
populations of SSEA3 expressing NTera2 cells were cultured to be stained for SSEA3 and 
separated into different fractions of differing SSEA3 intensity by Fluorescent-Activated 
Cell Sorting (FACS). Following the evolution of the resulting SSEA3 fractions 
subsequently provides temporal information on how the SSEA3 distribution behaves 
depending on its initial distribution. The transition from one day to the next could be 
modelled by considering each SSEA3 distribution to be a probability density function of 
which SSEA3 intensity any cell from that population is likely to display. The probability 
density function redefines the initial histogram of a population’s SSEA3 profile in terms 
of the probability of any cell expressing any particular SSEA3 intensity; essentially 
normalising the raw count data to a proportion that allows for SSEA3 profile 
comparisons having taken into account differences in the number of cells used to 
generate the profiles. This probability density function describes the SSEA3 distribution 
across the whole intensity range and thus generates vectors for each sample that may 
be readily compared irrespective of time point or raw count data. Following the SSEA3 
evolution from any particular sorted set of cells is then described by determining the 
transition matrix (S) that will describe the conversion of a sample’s vector from one day 
(xt(k)) to the next (xt(k+1)). 
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3.4 Generating and Interpreting the Model 
 
Modelling the evolution of SSEA3 intensity within culture populations over time is performed by 
the examination of many independent observations of the SSEA3 intensity within populations 
as it changes with respect to time. The trajectories of SSEA3 intensity evolution are estimated 
by the examination of different populations that have been sorted by their SSEA3 expression 
and the way in which these sorted populations go on to generate their own SSEA3 intensity 
profiles. Examining the way SSEA3 intensity transitions over time (daily in this case) in these 
different populations provides insight of the underlying system that governs these transitions. 
Multiple (~35) SSEA3 intensity transitions from one day to another are used to generate an 
optimised model that is able to predict SSEA3 intensity transitions for any given population.  
 
Observation of the SSEA3 profiles to be used in this modelling procedure is performed by flow 
cytometry that provides SSEA3 intensity information of the population in the form of a 
histogram with a total cell count measured. These distribution data are each transformed into 
that of a probability density function (x); maintaining the shape of the SSEA3 intensity 
distribution for each measured population and so by treating these data in a probabilistic 
approach enables different distributions to be compared against each other in a manner that 
normalises for differences in the total number of cells used to generate these distributions 
(Figure 3.2). 
 
These probability density functions are then partitioned (λ) along the intensity axis (Conceptual 
example figure 3.2). The process of partitioning the probability density functions is described 
elsewhere (Nie and Coca, 2013) The probability of any particular cell occupying one of these 
partitions is related to the proportion of the population that exists within that segmentation. 
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Thus this partition may be used to convert the entire probability density function into that of a 
vector, with each number in the vector relating directly to its corresponding interval along the 
SSEA3 intensity axis. 
 
Converting the probability density functions into their own unique vector format permits the 
calculation of a transition matrix (P) that describes the specific transition of a vector from one 
timepoint (tk) onto the next timepoint (tk+1). Where, 
𝑥(𝑡𝑘+1) = 𝑃(𝑥(𝑡𝑘)) 
P is the matrix that maps this specific transition of the probability density function (x) of a 
temporally consecutive pair of observations of SSEA3 intensities from the population. This 
transition matrix (P) only describes one particular transition, albeit accurately, but it does not 
describe the way a population’s SSEA3 dynamics behave generally. In order to generate a 
generalised model (S) that describes the underlying transitions of SSEA3 intensity 
comprehensively and generates predictions for any probability density function of SSEA3 
intensity, many individual transitions (P) must be calculated. These numerous transition 
matrices (P) undergo together a least-squares optimisation process to culminate in a generalised 
model (S) that describes SSEA3 intensity dynamics (Nie and Coca, 2015). Where 
𝑥(𝑡𝑘+1) = 𝑆(𝑥(𝑡𝑘)) 
The generalised model (S) may be presented graphically in order to visualise the behaviour of a 
given SSEA3 intensity/distribution from one timepoint to the next (conceptual example in figure 
3.3). In such a graphical portrayal, the axes (grey lines) both represent the range of SSEA3 
intensity (from 0 to j) on day tk (x-axis) and day tk+1 (y-axis) and the dotted lines that intercept 
the axes correspond to the partitions (λ) used in the formulation of the model. In figure 3.3, a 
simple 3 partitioned (λ1 – λ3) graphical representation of a hypothetical model (S) is portrayed 
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(the solid black line) with three examples of what the model would predict with given SSEA3 
intensities at time tk. For the sake of simplicity, each example is only given over one partition, 
(λ1, λ2 or λ3) however real life examples would most likely involve multiple partitions 
simultaneously. For a given SSEA3 intensity/distribution at time tk the prediction for the 
following day’s SSEA3 intensity can be found by reading where that intensity crosses the map of 
the model (black line) and reading across to the y-axis value to give the predicted SSEA3 intensity 
on tk+1. The line y=x (red dashed line) is a particularly useful reference line for interpreting the 
graph of the model since if the model intercepts the line y=x, then a given SSEA3 intensity on 
that point is not expected to change, for example, an SSEA3 intensity of ½j at tk is expected to 
remain at ½j at tk+1 (green line). Additionally, if the map of the model lies above or below the line 
y=x, then the predicted SSEA3 intensity on the following day is anticipated to rise or fall 
respectively (demonstrated particularly in Figure 3.3 c’ and d’). 
 
Figure 3.3 (b-d) each show a hypothetical SSEA3 probability density distribution at time tk with 
a range of intensities covering their respective partitions (λ1, λ2 or λ3). In each case, the blue 
arrow underneath represents the application of the model (S) to those hypothetical distributions 
with figure 3.3 b’-d’ representing the predicted probability density distributions at time tk+1. In 
the case of b, the map of the model (S) shows that across partition λ1, the model happens to 
match y=x across its entirety. In this instance, the gradient of the model is equal to 1, which 
means that the general shape of the distribution remains unchanged but in addition, the line 
lies on y=x and so the distribution is not transposed to that of a greater or lesser intensity on the 
following timepoint. As a result, it is predicted that that each intensity maps perfectly back onto 
itself and so the probability density distribution remains unchanged in b’. The lack of change in 
distribution from one day to the next exemplified in b - b’ is interpreted that this is a stable 
region for SSEA3 intensity that does not readily change from one day to the next. 
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 In the case of c, the probability density distribution of SSEA3 intensity lies across the range of 
the λ2 partition. Figure 3.3 a shows that across the λ2 partition, the gradient of the model is 
constant but greater than 1 and therefore the distribution is predicted to stretch across a greater 
range of intensities on tk+1, which is demonstrated in c’ since the predicted distribution can be 
seen also in partitions λ1 and λ3. Furthermore, the depiction of the model (S) shows that across 
partition λ2 the model also intersects the line y=x, meaning that the intensity at that point (½j) 
will also be present on the following day tk+1. Since these graphs are all described in terms of 
probability density functions, the area under the curve for the distributions are all equal to one 
which explains why the maxima in example c’ is lower than the maxima in c as well as b’.  
 
The final hypothetical example in figure 3.3 d and d’ is the most complicated. The initial SSEA3 
distribution at time tk in d lies across the partition λ3 and the predicted distribution for time tk+1 
shown in d’. The model (S) in figure 3.3 a shows that across partition λ3 three gradients are 
depicted; two gradients being greater than one, with one gradient being less than one. The two 
gradients greater than one predict that there will be a spread of SSEA3 distribution (as seen with 
example c and c’), however the gradient that is less than one may be interpreted to predict that 
SSEA3 intensities will condense around that intensity for the following timepoint. The 
condensation around this region of the model (S) with the gradient less than one is reflected by 
the large population of cells in d’ λ3 albeit across the narrow range that they are predicted to 
occupy in λ3 at time tk+1. This is due to the fact that approximately half of the range of SSEA3 
intensity across λ3 maps into a narrow range on λ3 for the following timepoint. Furthermore, the 
model (S) predicts that d’ will have an SSEA3 distribution that covers the entire range of λ2 and 
some of λ1, however it is expected that there will be a greater population in λ1 than λ2 given the 
small range of intensities from λ3 that are predicted to enter λ2 compared to the range of 
intensities predicted to enter λ1. Indeed, this is reflected by the bi-modal distribution in d’ where 
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there is a large area under the curve occupied in λ1 compared to λ2. The final point of note is that 
across partition λ3, no part of the model lies on nor above the line y=x so the entire range of 
SSEA3 intensity is expected to be lower at timepoint tk+1 than at tk if within partition λ3 at tk. 
 
Finally, the predictions generated at time tk+1 may all be iterated against the model again if they 
are used as the next tk. In this way, the distribution in b’ could be used as the input for the model 
in order to generate a prediction for the following timepoint. Since b predicted b’ at time t k+1 
and the distribution of b’ was identical to b, it is further predicted that at time tk+2 that the 
distribution will still remained unchanged from that of both b and b’. A stable, unchanging 
distribution for future timepoints is not predicted for the distributions from c and d since, in 
part, their predicted counterparts c’ and d’ now have intensities in other partitions. If run 
iteratively enough times it is likely that the SSEA3 distribution in this example will always end up 
approximately similar to that of b and b’ since anything in partition λ1 is not predicted to escape 
λ1 and anything that ends up in the first half of the λ3 partition will decrease, with most going 
into λ1. Anything that is of particularly high intensity in λ3 is anticipated to form a compact 
distribution that is in the lower intensity range of partition λ3 which, as already mentioned, will 
mostly enter λ1 from which there is little chance of escape. 
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Figure 3.2 – Conceptual example of the modelling procedure
for one hypothetical distribution transition. The two
distributions shown represent two SSEA3 distributions from
one day (tk) to the next (tk+1). Both distributions are
normalised by means of conversion into a probability density
function and the sum of the area under each curve is equal to 1
(equation (1)) to enable a comparison of the distributions
independent of the total number of cell counts used to
generate the raw data. The distributions are partitioned,
symbolised by the series λ1… λn (dashed blue lines). All
distributions in the dataset are partitioned in the same way.
The partitioning method and calculation is described
elsewhere (Nie & Coca, 2015). The proportion of the
distribution occupying each partition is calculated and
converted into a vector format (Equations (2) and (3)); again
the sum of the elements of these vectors are equal to one and
therefore, each other (hypothetical example in figure; equation
(1)). These distributions can be described as shown in
equation (4), where the distribution on day tk+1 is equal to the
distribution on day tk+1 multiplied by some factor, P that
represents the transition matrix for these distributions between
timepoints. The transition matrix, P, describes very accurately
this one particular transition and is extremely unlikely to
describe all the transitions of a population. To acquire a
generalised model of transition dynamics (S) of the
distribution in question across a population, (in this case
SSEA3), many transition matrices are acquired that describes
multiple types of transition (i.e. different starting distributions)
over consecutive time points. These multiple P undergo an
optimisation process to generate a generalised model (S).
෍
𝜆1
𝜆𝑛
𝑥 𝑡𝑘 =෍
𝜆1
𝜆𝑛
𝑥(𝑡𝑘+1)(1)
(2)
(3)
(4)
Figure 3.3 – Hypothetical map of a generalised model and transition predictions. A generalised model (S) of distribution transitions determined (as described in Figure 3.2) may be
viewed graphically as a map of the model (a). Both axes represent an SSEA3 intensity distribution (from 0 to j) at time tk (x-axis) and tk+1 (y-axis), with the model describing the
relationship between them (black lines). The partitions used for generating the individual distribution transitions are plotted on both axes (blue dashed lines, λ1.. λ3), where each
partition has a direct correspondence on each axis i.e. λ1 on the x-axis covers the same SSEA3 intensity range on the y-axis. The map itself (black lines) describes how a given
SSEA3 intensity at time tk is predicted to transition to for time tk+1. For interpreting the model, the line y=x (red dashed line) is particularly useful since whenever the map
intersects the line y=x, that point is not expected to change and is termed an equilibrium point (e.g. ½j; green line). The relative position of the map of the model to the line y=x is
also useful since where the map is above or below the line y=x, then the predicted SSEA3 distribution is more or less intense respectively. Example hypothetical distributions (b-d)
and their predicted distributions (b’-d’) are explored. For the sake of simplicity, the hypothetical distributions are confined to the range of individual partitions, although in reality
this is rarely ever the case. Distributions are described in terms of probability density and so the area under each curve, whether original or predicted are equal to one. b) The map
of λ1 partition lies exactly on the line y=x, and so the distribution is expected to remain unchanged (b’). c) The map of λ2 is of one gradient, greater than one, that intersects the line
y=x. Therefore, the predicted distribution is covers a greater range of SSEA3 intensities (c’), but the point at ½j remains unchanged. d) The map of λ3 partition is the most
complicated; it is entirely below the line y=x and has multiple gradients. The most intense population in λ3 is predicted to become slightly less intense and condense around the
lower region of λ3, a small proportion of the population is predicted to cover the entirety of λ2 and the remaining, larger, portion of the population expected to occupy λ1 which
altogether results in a bimodal distribution (d’).
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3.5 Cell line used 
 
Modelling the heterogeneity of human pluripotent stem cells with respect to SSEA3 
expression mandates the use of a pluripotent cell line that also displays the SSEA3 
epitope. As a proof of concept approach, the pluripotent EC cell line NTera2.D1 was 
used. NTera2 also has the advantage that it is a robust cell line that is easy to expand, 
which made it an ideal candidate since a large population of cells were required in the 
first instance. Indeed, the culture of EC lines is considerably easier than that of ES cell 
lines since EC cell culture requires less expensive reagents and EC cells display a 
“robustness” that early passage ES cell lines simply do not. The result of such robustness 
is the easy expansion of cell lines to achieve large cell numbers for experimentation that 
experience an extremely low rate of spontaneous differentiation (ISCI, 2007). NTera2 in 
particular is a long-standing pluripotent EC cell line that also displays heterogeneous 
expression of SSEA3 in culture that may be readily induced to differentiate in vitro in 
response to various differentiation cues such as induced by all-trans retinoic acid or 
Hexamathylene Bisacetamide (Andrews et al., 1990). As outlined previously, NTera2 has 
also been shown to present at least two substates within the stem cell compartment 
(Tonge et al., 2010). Therefore, due to its robust nature, easy expansion, pluripotency, 
heterogeneous expression of SSEA3 and demonstrable substates, NTera2 was a prime 
candidate cell line for modelling in this proof of concept approach. 
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3.6 Summary of introduction and main aims 
 
Here we aim to develop a method by which the dynamics of SSEA3 within the stem cell 
compartment may be explored. We anticipate that, by being able to predict these 
dynamics and how readily cells with particular SSEA3 intensities are liable to maintain 
or change that level of expression, clues leading to substate identity and isolation from 
the stem cell compartment will be found. Pursuing these clues should help us to readily 
and repeatedly isolate these substates that should behave in a more uniform manner. 
This proof of concept approach, initially applied to SSEA3 in the NTera2 context, will 
open up other avenues by which heterogeneity may be explored in other cell line 
contexts and with other markers. Adopting a flow cytometric approach in the first 
instance is easier for data generation but it does require a large number of cells to 
complete, which is one of the reasons that the human EC cell line was chosen. Therefore, 
we also aim to develop a strategy that can be applied using substantially fewer cells that 
can be readily applied to cell lines, such as human ES cells, which are more expensive to 
culture and less robust. The method we exploit here is in vitro in situ cell culture 
immunofluorescence on the InCell analyser imaging platform where fewer cells are 
required for population analysis. 
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3.7 Overview of Approach 
 
In order to model the SSEA3 dynamics within the NTera2 population, the approach 
adopted for interrogating this system was based upon dividing a population of NTera2 
cells into sub-populations. The experiment was replicated three times, with each 
replicate referred to as a “Batch.” Each batch underwent workflow outlined in Figure 
3.4, where a number of sister flasks of NTera2 cells are expanded to provide enough 
cells for the experiment and represent the “parental population.” The cells in these 
flasks were then harvested, stained and measured for SSEA3 using the MC631-2C2 
antibody coupled with flow cytometry. Cells were then sorted based upon their SSEA3 
expression profile by Flow Assisted Cell Sorting (FACS). Five separate culture vessels, one 
for each day, were used to culture samples of each sub-population (or “fraction”). In this 
way, samples of cells from each fraction were plated in five separate culture vessels, 
where each day, one of these cultures would be expended for analysis of their SSEA3 
distribution. Once the SSEA3 distribution of each fraction for each day was acquired, 
data was sent to Dr. Xiaokai Nie for modelling the SSEA3 dynamics of the population  
(Materials and methods, Conceptual overview Section 3.4). 
 
Given the replicates available, the SSEA3 distribution data from Batch 3 was used to 
model the SSEA3 dynamics since it was the most complete dataset (Figure 3.7). Data 
collected from Batch 2 was used to test against the model generated from the Batch 3 
data (Figures 3.6, 3.12, 3.13). No viable data was collected from Batch 1 and so is not 
referred to hereafter. 
Harvest Cells and
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-ve low mid high
Measure and sort cells by 
SSEA3 intensity
Plate cells sorted by intensity; using one 
culture plate for each of the Five days
Figure 3.4 – Modelling SSEA3 Dynamics Workflow for cell sorting and modelling SSEA3 dynamics in a cell population. a.) Parental cell population is cultured
and expanded in order to provide enough cells for the experiment. Cells are then harvested, stained for SSEA3 expression and sorted into subpopulations
(“fractions”). One culture plate per day is prepared in which all fractions are represented. b.) The fractions from one plate for each subsequent day are harvested,
stained and analysed for SSEA3 expression separately. Finally, data from all five days of the experiment are sent to model the populations’ SSEA3 dynamics.
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Figure 3.5 – SSEA3 Expression in NTera2 Populations. Examples of flow cytometric analysis against populations of NTera2.D1 cell line examined via indirect
immunohistochemistry for expression of SSEA3 and P3X. a.) Negative control for off-target binding assessed using P3X primary antibody permits the
designation of a baseline level of fluorescence exhibited by the sample. The baseline is set to be apparent at around 101 intensity. b.) A large population of
Ntera.D1 (~6x106 cells) reveals a broad range of SSEA3 expression exhibiting multiple peaks (arrows). This particular population was used in a sorting
experiment to collect Four different fractions of different, non-overlapping SSEA3 expression (“negative”, “low”, “medium” and “high”) which are demarked
accordingly. c.) An example of an SSEA3 stain performed on a more usual sample size of NTera2.D1 (~1x104 cells) cells from regular laboratory experiments;
note that although there is a large distribution (as in a.), the lower cell count does not enable the same degree of the multimodal characteristic seen in a.) to be
resolved.
a) b) c)
P3X negative control SSEA3 NTera2 (~6x106 cells) SSEA3 NTera2 (~1x104 cells)
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Results 
 
3.8 Parental population 
 
Cultures of NTera2 were expanded (described in methods) in order to provide the cell 
number required for the experiment (100,000 cells per fraction per timepoint per rep). 
This equated to approximately eight T-75 flasks of NTera2 cultured per sort; containing 
approximately 1.2x108 cells per sort. Following staining for SSEA3 (See materials and 
methods), samples were subject to a gating regime to exclude events that do not 
represent cells such as debris and cell doublets (See materials and methods). A baseline 
for off-target antibody binding effects was obtained as a negative control by 
simultaneously staining a separate randomly acquired subsample of the cell population 
with P3X as opposed to SSEA3 as the primary antibody. 
 
A typical examination via flow cytometry of a large population of NTera2 cells reveals a 
multimodal distribution of SSEA3 intensity; with several peaks over a large range of 
expression (Figure 3.5b).  This pattern of SSEA3 expression cannot be attributed to non-
specific binding of the secondary antibody used for immunofluorescence since the P3X 
negative control does not also exhibit the same pattern (Figure 3.5a). It is worth noting 
that some of the distinct modal regions (arrows) only become clear when dealing with 
a large sample of Ntera2 cells (~106 cells) (Figure 3.5c). Thus, the heterogeneous 
expression of SSEA3 in the NTera2 was confirmed and a four-way sort was performed to 
include different, non-overlapping levels of SSEA3 intensity representing negative, low, 
medium and high levels of expression and dubbed eponymously (Figure3.5b). Cells from 
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these four fractions were collected and separately plated at a density of 10,000 cells/cm2 
in six-well plates. Five replicate wells were seeded and incubated for each fraction in 
order to perform further flow cytometric analysis on these samples over the subsequent 
five days; harvesting and exhausting one replicate per fraction per day for this purpose 
(Figure 3.4). 
 
It was plausible that cell sorting and/or antibody staining could affect behaviour in the 
resulting cell fractions. Therefore, in order to account for any effects that cell sorting or 
antibody staining may have on cell behaviour, three other conditions were included: 
Unstained Unsorted (UU), Unstained Sorted (US) and Stained Unsorted (SU). These 
subsamples were from the same population of harvested cells used for the sort. The 
fractions UU and US were both exempt from the antibody staining protocol prior to 
seeding, whereas fractions UU and SU did not undergo the stressors associated with cell 
sorting (UU and SU conditions were plated at a lower density in order to account for 
anticipated lower mortality 1,000cells/cm2). If there were any major effects caused by 
these processes, it was anticipated that it would be noticeable by discrepancies between 
the populations resulting from these conditions. 
 
Biological replicate sorts were performed on separate days. To avoid confusion, 
replicates as distinguished by sort day were termed batches and numbered 
chronologically. In an attempt to ensure fair comparison between batches, flasks used 
for sorts were all cultured to have similar confluence of between 90-100% on the day of 
harvest for their sort. Ensuring comparable confluency between batches necessitated 
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staggered culture of flasks in preparation for use. This was achieved by adjusting the 
seeding densities of flasks several generations in advance so that the regular time for 
passage was offset between batches by at least one day. Once cultures for each batch 
were staggered, all cultures were passaged several times using the regular split ratio in 
order to re-establish more usual conditions for several generations prior to their use in 
the sorts. 
 
3.9 Evolution of the sorted fractions 
 
Cell fractions were plated in separate vessels for each fraction and timepoint in order to 
facilitate cell harvest and flow cytometric analysis of cell cultures from each fraction 
daily over the following five days. Cells were once again stained to elucidate SSEA3 
expression via indirect immunohistochemistry. Once collated, the SSEA3 dynamics of 
the various sort fractions were examined using data from Batches 2 and 3 (Figures 3.6, 
3.7 and 3.8).  
 
Examination of the SSEA3 population dynamics between fractions reveals that all 
fractions generate cells from all other fractions by the end of the experiment and indeed 
from the range of the original distribution of the parental population. It is also clear that 
the propensity of a fraction to repopulate the parental distribution differed between 
fractions; for example, the High fraction took considerably longer to reach a distribution 
similar to the parental population than the medium and low fractions. There were no 
cell fractions that did not eventually re-occupy the SSEA3 expression range of the 
parental population, although the low and medium fractions did so at a greater rate 
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than the negative and high fractions. Indeed, the High fraction consistently took longer 
to reconstitute a distribution that looked similar to that of the starting population. 
 
The control fractions of UU, SU, US from Batch3 revealed relatively little difference 
between conditions over time with regard to the SSEA3 dynamics of the population, 
effectively mimicking each other (Figure 3.8). In Batch2 there was some variation 
between the conditions, which is exemplified by the poor resolution in conditions SU 
and UU that was the result of low cell numbers, indicating mediocre cell growth in these 
conditions. Due to the complete nature of the Batch3 dataset as well as its consistent 
and concordant control samples Batch3 was chosen for use in the modelling procedure. 
  
Batch 2:
Fraction: Negative Low Medium High Parental Population
Day 1:
Day 2:
Day 3:
Day 4:
Figure 3.6 – Evolution of SSEA3 Dynamics in Batch 2.
Fractions taken from the parental population (see figure
3.3) that have been subsequently plated and analysed over
the following five days. For all fractions there is a tendency
towards the heterogeneous distribution as seen in figure 3.1,
however some fractions acquire this heterogeneous
phenotype at a greater rate than others (e.g. the “High”
fraction takes longer to re-establish that distribution than
the “Medium” fraction).
Day 5:
Batch 3:
Fraction: Negative Low Medium High Parental Population
Day 1:
Day 2:
Day 3:
Day 4:
Figure 3.7 - Evolution of SSEA3 Dynamics in Batch 3.
Fractions taken from an alternative parental population to
that in figure 3.3 that have been subsequently plated and
analysed over the following five days. For all fractions
there is a tendency towards the heterogeneous distribution
of the parental population, however some fractions acquire
this heterogeneous phenotype at a greater rate than others
(e.g. the “High” fraction takes longer to re-establish that
distribution than the “Medium” fraction).
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Figure 3.8 – Evolution
of SSEA3 Dynamics in
Control Samples.
Control samples that
have also been plated
for examination over
the following five
days. Stained Unsorted
(SU) have been stained
for SSEA3 but not
sorted by FACS.
Unstained Sorted (US)
have not been stained
for SSEA3 but have
been through the cell
sorter. Finally, the
Unstained Unsorted
fraction has been
neither stained for
SSEA3 nor sorted by
FACS. These fractions
display quite similar
SSEA3 dynamics since
being plated;
especially in Batch3.
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3.10 Map of the model 
The dataset from Batch3 (See section 3.7) was used for modelling and a map of the 
model is shown in Figure 3.9. Such maps depict aspects of the rules underlying chaotic 
systems modelled in this manner and are designed to illustrate how systems change 
over time (Conceptual examples in figures 3.2 and 3.3). Here for instance, SSEA3 
intensity is presented on both axes; with SSEA3 intensity (x) at day “tk” on the x-axis and 
at day “tk+1” on the y-axis. The map of the model enables predictions of future SSEA3 
intensities based upon present SSEA3 levels. For instance, cells expressing SSEA3 at 102.2 
intensity on day “tk” are predicted to have an SSEA3 intensity of 102.8 on day “tk+1” 
(Shown in blue in Figure 3.9). 
  
Any part of the slope that lies on the line y=x (superimposed on the graph) represents 
an SSEA3 intensity that will remain unchanged from one day to the next. These 
intersects are equilibrium points. If the gradient about an equilibrium point is between 
1 and -1  (denoted <|1|) then it may be classified as an attractor since the adjacent 
intensities would condense upon that equilibrium point on the subsequent iteration (or, 
day). It may be useful to visualise a ball in a cup that will proceed to reach that basin (or, 
attractor) under gravity. 
 
On the other hand, regions where the gradient is <|1| about an equilibrium point 
actually implies that surrounding intensities of SSEA3 drift away from any particular 
equilibrium point. In line with the previous analogy, this would be akin to a ball resting 
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perfectly balanced on the apex of a hill (having an unstable equilibrium point); anything 
adjacent to, or any perturbation of, that ball would see it accelerate away from that 
nearby equilibrium. 
 
In this case, the map reveals that there no attractors relevant to NTera2 SSEA3 dynamics 
but there are several equilibrium points (Table 3.2). In general, the magnitude of 
gradients present across the map are quite large suggesting that the SSEA3 properties 
of individual regions are subject to change position quite substantially from one day to 
the next. 
 
 
 
Table 3.2 – Calculated equilibrium points for SSEA3 expression in populations of NTera2 cells from the 
model trained using Batch3 data. Equilibrium points represent intensities where SSEA3 expression is 
predicted to remain unchanged from one day to the next 
 
 Calculated Equilibrium Points 
(log10) 
 
 0.4682  
 0.5667  
 0.6593  
 0.9772  
 1.0333  
 1.4815  
 2.9288  
 3.0731  
 3.1403  
 3.2442  
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3.11 Model Predictions and Observed Data 
 
The model generated boasts a predictive capacity for SSEA3 distributions, enabling 
future SSEA3 distributions to be predicted from any given SSEA3 distribution. The 
simplest test of this is against the data used to train the model from Batch3 already 
collected above. A comparison of observed data against predicted data from Batch3 
demonstrates that the model is capable of generating predictions (Figures 3.10 and 
3.11). Predictions were made by computing iteratively the SSEA3 expression trajectories 
for individual cells using the inferred map S 
SSEA3day=tk,cell=i=S(SSEA3day=tk-1,cell=i)  
given the initial (day tk=0) expression level SSEA3day=0,cell=i where i=1,...,N and N is the 
total number of cells analysed. The predicted SSEA3 expression levels for the entire cell 
populations were subsequently used to estimate probability density functions for each 
time point. Figures 3.10-3.13 show the measured and the predicted density functions 
generated by the model. 
 
Generally, there is a lot of overlap of predicted distributions and observed predictions 
for the training dataset from Batch3. Of sorted fractions, the most consistent overlap 
between observed and predicted data appears to be in the negative and low fractions 
with the greatest discrepancy being with the medium and high fractions; particularly on 
days two and three. The control fractions (UU, SU and US) all also exhibit consistency 
between predicted and observed SSEA3 distributions.  
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In a more quantifiable manner, Bhattacharyya distances were calculated as a measure 
for the degree of disparity two distributions lying on the same axes (Hazewinkel, 1994). 
These distances are expressed numerically, where the larger the number, the greater 
the disparity between the distributions. In this case, measuring the distance between 
the observed and predicted distributions of SSEA3 reveals that there is a substantial 
amount of overlap between the distributions (Table 3.3). An examination of the 
Bhattacharyya distances for the predictions demonstrates that the predictions tend not 
to deviate from the observed data. Bhattacharya distances between observed and 
predicted data are generally quite small, with the largest discrepancy on Day 4 for the 
medium fraction at 0.113. On average, Bhattacharya distances for each fraction were all 
less than 0.08 in size; suggesting an accurate model. 
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Figure 3.9 – Map of the model. A hypothetical
model and explanation of interpretation/
generation are provided in figures 3.2 and 3.3.
Axes represent the Log SSEA3 intensity (X) on
day “tk” (x-axis) and one day later “tk+1” (y-axis).
Both axes represent the range of SSEA3
intensities measured during the experiment.
Generating the model requires partitioning of the
SSEA3 intensity range (figures 3.2, 3.3), and the
partitions used are marked by the dotted black
lines. This map represents a generalised model of
SSEA3 dynamics that allows predictions of
future SSEA3 intensities. For example, if a cell
has an SSEA3 intensity of 102.2 it will be
expected to have an SSEA3 intensity of 102.8 on
the following day (Example in blue).
Any case where the map of the model intersects
with the line y=x (solid red) represents an
equilibrium point where SSEA3 intensity of a
cell is predicted not to change the following day.
For example, a cell with an SSEA3 intensity of
101.4815 on day “tk” is anticipated to have
unchanged with respect to SSEA3 intensity on
day “tk+1” (dotted red line).
This map reveals that SSEA3 is generally not
anticipated to remain unchanged between
timepoints, and that SSEA3 intensity will vary
between days. Finally, there are no basins of
attraction. The mode reveals ten equilibrium
points that are noted in Table 3.2.
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Figure 3.10 – Observed and
Predicted data of Training
Dataset. Predictions generated
from the model using observed
data from Batch3 that were
used to train the model. X-axis;
log SSEA3 intensity ranging
from 100 to 104. Y-axis plots
calculated probability density
function transformations of
observed data; a normalisation
that allows cross comparison
between data (arbitrary units).
Observed data is shown here in
red, predictions in blue.
Predictions are generated using
the model and the observed
data from the previous day. The
predictions generally align
closely to the observed data,
with the greatest discrepancy
shown in the Medium fraction
on day 2.
Batch3
Control: Stained Unsorted Unstained Sorted Unstained Unsorted
Day 1:
Day 2:
Day 3:
Day 4:
Day 5:
Figure 3.11 – Observed and predicted
SSEA3 distributions on Training Dataset
control treatments from Batch3. X-axis;
log SSEA3 intensity ranging from 100 to
104. Y-axis plots probability density
function transformations of observed data;
a normalisation that allows cross
comparison between data (arbitrary units).
Observed data is shown here in red,
predictions in blue. Predictions are
generated using the model and the
observed data from the previous day. The
control fraction SSEA3 distribution
changes over time are well predicted by
the model.
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Fraction: Negative Low Medium High
Day 1:
Day 2:
Day 3:
Day 4:
Day 5:
Figure 3.12 – Observed and
predicted data of Test Dataset.
Predictions from the model
using observed data from
Batch2. These data were not
used to train the model and so
represent a test on data
independent from the model’s
generation.
X-axis; log SSEA3 intensity
ranging from 100 to 104. Y-axis
plots probability density
function transformations of
observed data; a normalisation
that allows cross comparison
between data (arbitrary units).
Observed data is shown here in
red, predictions in blue.
Predictions are generated using
the model and the observed data
from the previous day. The
predicted distributions mirror
closely the observed data, with
the greatest discrepancy being
in the High fraction on day4.
Batch2
Control: Stained Unsorted Unstained Sorted Unstained Unsorted
Day 1:
Day 2:
Day 3:
Day 4:
Day 5:
Figure 3.13 – Observed and predicted
SSEA3 distributions on Test Dataset
Control Treatments from Batch2. X-axis;
log SSEA3 intensity ranging from 100 to
104. Y-axis plots probability density
function transformations of observed data;
a normalisation that allows cross
comparison between data (arbitrary units).
Observed data is shown here in red,
predictions in blue. Predictions are
generated using the model and the
observed data from the previous day. As
with the training data, these control
fractions are quite well predicted by the
model.
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Table 3.3 – Bhattacharyya Distances comparing the distribution similarities between predicted and 
observed SSEA3 distributions from the Batch 3 dataset (Figure 3.10) from the model of SSEA3 
dynamics (Figure  3.9). Bhattacharyya distances are expressed on a scale between zero and one, where 
the larger the number, the less similar the distributions under comparison. All distances are relatively  
small (<0.1) with the exceptions of the High and Medium fractions on Day 4. 
  
Bhattacharya Distances 
Day 2 Day 3 Day 4 Day 5 Mean 
Negative 0.058 0.063 0.090 0.084 0.074 
Low 0.045 0.050 0.054 0.065 0.054 
Medium 0.065 0.059 0.106 0.050 0.070 
High 0.076 0.070 0.113 0.054 0.079 
 
 
An application of the model to a non-training dataset, such as the biological replicate 
data that is Batch 2 from the aforementioned experiment was performed to test 
predictions against data that was not used to train the model (Figures 3.12 and 3.13). 
Predictions from the model were tested against data from Batch 2; which was a dataset 
obtained independently from the data used to train the model (Batch3). Again these 
predictions were generally consistent to the observed data. The negative and low 
fractions also show a substantial degree of overlap between observed and predicted 
distributions. The High fraction displays the greatest discrepancy between observed and 
predicted distributions although there is still a fair degree of overlap, with Day 4 and Day 
5 for the high fraction showing the greatest differences. As with the Batch 3 comparison, 
the control samples (UU, SU, US) all display general concordance between the predicted 
and observed data. 
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3.12 Clonogenic Analysis 
 
With equilibrium points predicted (Figure 3.9 and Table 3.2), another sort experiment 
on NTera2 was performed in order to interrogate regions that contained equilibrium 
points for evidence of putative substates by assessment of aspects of behaviour within 
the confines of a clonogenic assay (see materials and methods). The assay used here 
provided information on the rate of colony formation of cells, the growth rate of 
colonies as well as cell size (see discussion). 
 
As with the previous sort, cell culture was staggered so as to provide several batch 
replicates prepared for sorting on different days. Since there were more fractions taken, 
with each fraction representing a lower proportion of the entire population, it was 
necessary to increase the number of cells used in the sort; requiring approximately 24 
T-75 flasks per batch (corresponding to approximately 3.6x108 cells per batch). These 
were harvested and stained as described above and in materials and methods. 
 
The SSEA3 distribution of the various batches were examined and an example is shown 
in Figure 3.14. This distribution, similar to the first experiment, covers a large range of 
intensities and the large number of cells used in the sort permitted sufficient resolution 
to identify several peaks (arrows). In contrast to the example distribution shown in the 
first experiment, this distribution contained a larger proportion of negative cells, yet also 
seems to encompass a slightly larger range of intensities. 
 101 
 
The fractions sorted for are shown on this sample population, with fractions containing 
equilibrium points indicated in red. Equilibrium and non-equilibrium points were 
acquired from across the entire range of the SSEA3 distribution. For instance, Region R9 
was deliberately chosen to represent a region where SSEA3 was of high intensity but 
was not predicted to contain an equilibrium point as opposed to its neighbours, (R13, 
R7 and R8) which either all contained, or were extremely close to, predicted equilibrium 
points. 
 
The fractions described above were plated for subsequent clonogenic analysis (materials 
and methods). This was designed to help assess whether there were pertinent biological 
differences between the fractions collected and whether these had any relevance to 
equilibrium points. Cells were seeded in six-well plates at a density of 1,000 cells per cm2 
in order to account for the poor clonogenicity of these cells (see discussion) and fixed 
after 5 days of culture. Cultures were stained with Hoechst 33342 and analysed using 
the InCell analyser platform. Instances of Hoechst staining with an area greater than 
35µm2 were considered cells. For each nucleus identified, a mask was applied about that 
nucleus’ perimeter of 50 µm, overlapping masks between cells were considered to be 
within the same colony and this combined overlap used to estimate colony area. 
  
Parental population:
SU
US
UU
SU
US
UU
Back-gated populations:
Figure 3.14 – NTera2 cells
stained for and sorted according
to SSEA3 expression. The
parental population chart shows
the original population’s SSEA3
expression level, which is
multimodal (Black arrows
indicating multiple peaks) as well
as the gates used for sorting the
population into multiple fractions
for further analysis. Regions R4,
R5, R3, R13 and R7 are predicted
to contain equilibrium points
predicted by the model. Predicted
equilibrium points are marked in
red along the x-axis and represent
those points shown in table 3.2.
Samples of populations from
sorted fractions were examined
for their SSEA3 expression to
assess sort accuracy. Sort
accuracy was generally very
good, with regions R10 and R3
showing the greatest inaccuracy.
R4
R5
R6 R12R10
R13R3 R11
R7
R8
R9
SU
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All fractions taken from the original sort contained cells that could attach to the plate 
and proliferate (Figure 3.15). With regard only to survival and attachment of cells, 
generally at least 1000 cells from each fraction adhered to the plate regardless of 
whether they went on to proliferate; i.e. colonies of size 1 cell or greater by the end of 
the experiment. There were marked differences between the fractions, with R4 
(negative for SSEA3) having the lowest number of adherent cells (~800), and fractions 
R10 and R9 tending towards the largest number of adhering cells (~3,500). Generally, 
fractions that were low or negative for SSEA3 expression had a low rate of adherence 
for cells, whereas Fractions that were most positive for SSEA3 had a greater degree of 
adherence. The fractions R10 and R11 appear out-of-place; representing regions where 
the number of adherent cells was noticeably larger than surrounding fractions. 
 
Of those cells that attached the proportion that were proliferative are displayed in 
Figure 3.15b. Colonies were considered proliferative if they contained more than 3 cells. 
Fractions displayed similar proportions of cells (out of all adherent cells) that were 
proliferative. Overall, roughly 15-25% of cells that adhered to the well plates were 
capable of proliferating with a few exceptions. Region R4 displayed the lowest 
proliferative capacity with on average 15% of colonies being of a greater size than 3 cells. 
Regions R12 and R13 for their third replicate each showed the greatest proportion of 
proliferative colonies (Figure 3.15b), which also coincided with their lowest number of 
adhered cells (Figure 3.15a). 
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The number of cells per colony from each fraction was generally low, with the median 
number of cells being 6 ±1 across all fractions (data not shown). The frequency 
distributions of the number of cells per colony appear similar and were all heavily 
skewed (Figure 3.16). The least skewed distributions were fractions R12 and R13, which 
were relatively high for SSEA3 at the time of the sort, whereas the most skewed 
distribution was that of fraction R6. Given the timeframe of the experiment (5days/ 120 
hrs) and assuming short cell cycle duration (~20hrs) (personal communication with Prof. 
Andrews), it would only be possible for a single cell to generate a colony of maximum 
size 26 (or 64) cells. Therefore, colonies examined in Figure 3.16 contain between 4 and 
64 cells inclusive. 
 
Colonies that contain more than 64 cells cannot be explained only by one single, 
proliferative cell and must have occurred by some other means which includes: multiple 
cells seeded together, colony merging by proximity, or colony merging caused by 
motility (see discussion). Regardless, colonies greater than 64 cells did occur (Figure 
3.17). The formation of colonies larger than size 64 did appear to differ between 
colonies, with fraction R10 having the greatest spread (Figure 3.17). Fraction R4, on the 
other hand, was the only fraction not to have any colonies with more than 64 cells 
(maximum= 52 cells). Generally, fractions that were negative or low for SSEA3 did not 
tend to produce giant colonies. 
 
The cell sizes within colonies, as calculated based upon colony size divided by colony 
area for each colony, ranged from about 500 µm2 to 3500 µm2 for each fraction (Figure 
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3.18). The control fraction, US, displayed an even distribution in cell sizes across this 
range, similar to region R6. Regions R9, R7, R13, R12, R11 and R10 all had fairly similar 
distributions with a low proportion of smaller cells. Regions R4, R5, R3 and R8 displayed 
an alternative distribution that appears bimodal in nature, with average cell areas of 
approximately 1250 (µm2) and 3000 (µm2) for the two modes displayed (Figure 3.18). 
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Figure 3.15 – Colony survival and
Proliferation. Examination of the
clonogenic data analysed using the
InCell platform. All sorted fractions
(according to sort parameters in fig3.10)
were seeded at 1,000 cells/cm2, and left
to grow for 5 days prior to fixation,
staining and analysis. a.) The total
colony count returned for each rep in
each fraction, Colonies were included of
any size (>0 cells) in this analysis. The
number of colonies, including single
cells in this instance, is used as a metric
relating to the survival rate of cells
within each fraction that were able to
survive long enough to attach from the
initial seeding.
b.) The percentage of attached colonies
(as measured in a.)) that demonstrated
proliferation after attachment (i.e.
colonies with a cell count>3). Overall
approximately 15-25% of cells that
attach display proliferated, displaying
clonogenic potential of all cells
regardless of parent fraction.
a.
b.
Figure 3.16 – Number of Cells per Colony Distribution. Examination of the number of cells per colony distribution from clonogenic cells from clonogenic
analysis of NTera2 cells examining cell fractions initially sorted for differing levels of SSEA3. These data are calculated from cell colonies between 3 and 65
cells in size. All fractions show a similar pattern of a very skewed distribution of number of cells per colony. A measure of skew is included on for each chart.
R4 R5 R6 R3 R10 R11 R12 R13 R7 R8 R9 US
Fraction
Figure 3.17 – Large Colony Formation Rates. Boxplot examining the propensity of fractions to form colonies that are larger than 65 cells in size. These colonies
are too large to be caused only by regular cell division by an individual cell. Explanations for these colonies are; increased motility of cells, cell doublets at the
time of seeding and/or random chance of colony distributions. Different fractions appear to have differing propensity of large colony generation, with fraction
R10 being the most susceptible and fraction R4 not producing any colonies larger than 64 cells in size.
Figure 3.18 – Cell Size in
Clonogenic Assay. Histograms
of the average cell areas (μm2)
within colonies from different
populations sorted based upon
SSEA3 intensity (Figure 3.14).
Cell area calculated by dividing
colony size by colony area as
measured on the InCell analyser
platform. Fractions R10, R11,
R12, R13, R7 and R9 present a
similar distribution of cell areas
with a negative skew; generally
containing cells of a modal area
of approximately 2750μm2.
Regions R4, R5, R6, R3, R8 and
US seem to display a slightly
different distribution where there
is a larger number of smaller
cells compared to the other cell
area distributions.
The red line on each plot
represents the median cell area
for the control group (2193μm2)
and acts as a reference point for
comparison between graphs.
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3.13 Cell Cycle comparison and Sort duration 
 
In addition to the previous experiment where SSEA3 fractions were sorted for (as well 
as the controls of UU, SU and US), these sorts afforded the opportunity to examine two 
other factors capable of influencing cell behaviour that may, by result of artefact, appear 
to be correlated with fractions taken independent of SSEA3 expression.  
 
Firstly, if there were an increase in cell mortality over the course of a sort, then the 
sequential acquisition of fractions would mean that those collected later would conta in 
a greater proportion of dead cells; which may influence the behaviour of surviving cells 
in that fraction. This was a particularly pertinent question considering the unusually long 
time these sorts required of approximately seven or eight hours. To assess this, cell 
samples were taken both at the start and end of the sort to be treated with propidium 
iodide that is normally actively exported out of cells. These samples were then examined 
by flow cytometry to measure the proportion of cells that contained propidium iodide 
at the beginning and end of the sort (Figure 3.19). 
 
Examination of the cell mortality by propidium iodide staining revealed that on average 
0.67±0.37% (n=4) of cell population were compromised prior to sorting whereas by the 
end of sorting, 1.00±0.25% (n=3) of the cell population were stained with propidium 
iodide (Figure 3.19). Overall this does not represent a significant change in mortality 
between the beginning and the end of the sort. 
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The second consideration was whether the difference in SSEA3 expression of cells in the 
population was in fact reflective of that cell’s position in the cell cycle, which would imply 
that differences seen between fractions could be attributed to differences in cell cycle 
rather than SSEA3. This question was addressed by taking sub-samples from the parental 
population that, in addition to SSEA3, were co-stained with Hoechst 33342; a 
fluorescent dye that stains DNA (materials and methods). Dual plots showing cell SSEA3 
intensity and Hoechst 33342 fluorescence reveal that there is very little to no correlation 
between the two factors (Figure 3.20). 
  
Sample
Early PI 
dead cell 
(%)
Late PI 
dead cell 
(%)
Relative 
change
Rep 1 1.20 1.10 0.917
Rep 2 0.54 - -
Rep 3 0.58 0.72 1.241
Rep 4 0.34 1.19 3.500
Average 0.67 ± 0.37 1.00 ± 0.25 -
0
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Rep1 Rep2 Rep3 Rep4
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Proportion of dead cells in NTera2 populations 
at the beginning and end sort duration
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Figure 3.19 – Cell Sort Mortality. Examination of cell
mortality over the duration of a sort assed via PI staining. At
the start of a sort, on average, 0.67±0.37% (n=4) of the
population incorporated propidium iodide, whereas by a
sort’s conclusion, this proportion rose to, on average,
1.00±0.25% (n=3).
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Cell Cycle analysis and SSEA3 Expression
Rep1 Rep2 Rep3 Rep4
G1
S-phase
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SSEA3 vs 
Hoechst
Figure 3.20 – Cell Cycle and
SSEA3. A comparison of
SSEA3 expression from cells
in different stages of the cell
cycle as determined by
Hoechst33342 analysis in four
replicates. There does not
appear to be a marked
difference in SSEA3
expression as a result of being
in a different stage of the cell
cycle. The dual plot of SSEA3
against Hoechst expression
relays little, if any correlation.
Regardless of position in the
cell cycle, the complete range
of SSEA3 expression is
present.
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3.14 Development of Modelling on the InCell Analyser Platform 
 
The application of the modelling process currently requires a large cell number of cells 
seeded in order to facilitate flow cytometry analysis of sorted fractions on subsequent 
days. Cell preparation for flow cytometry mandates sufficient sample material for 
analysis but also inevitably results in cell loss during harvest and wash steps. Ntera2 cells 
are more robust than human ES cell lines, with a greater survival rate from the stressors 
associated with cell sorting. Already the current method used for Ntera2 was only just 
feasible to perform over 8 hours of sorting. To conduct a similar sort to acquire 
comparable surviving cell numbers for fractions from human ES cell lines from fractions 
would quickly become impractical and prohibitive. 
 
In order to reduce cell number required for application of the modelling process, a 
method independent of flow cytometric analysis was proposed that exploited in situ 
methods for staining cells directly within plates. This approach, in principal, circumvents 
the cell loss associated with cell harvest for flow cytometry and allows for a lower 
number of cells required as sufficient starting material. For instance, culture vessels with 
lower well surface areas may be readily employed such as a 96 well plate (surface are 
~0.33cm2 per well) as opposed to a 6 well plate format (10cm2 per well). The reduced 
emphasis on initial cell number could facilitate the use of culture vessels that have a 
reduced absolute surface are, whilst maintaining cell density; dramatically reducing the 
number of cells required for a sort. This reduction in cell number would relieve pressure 
on the cell culture and line expansion in advance of the sort, and enable the examination 
of less robust cell lines such as human ES cell lines. 
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In the first instance, a sort was performed similar to the first experiment; a four-way sort 
for SSEA3, plating cells in a 6-well plate format in order to compare the in situ method 
against the flow cytometry approach. Sorted fractions were plated as described above 
at a density of 10,000 cells/cm2. The distribution of the parental population can be seen 
in Figure 3.21. Instead of harvesting cells for flow cytometric analysis of the sorted 
fractions on subsequent days, plates were fixed using 4% w/v paraformaldehyde (PFA) 
prior to staining against SSEA3 and with Hoechst 33342 (see materials and methods). 
Stained cells were analysed using the InCell analyser platform with measures for both 
SSEA3 and Hoechst 33342 fluorescence; these data were then post processed in order 
to generate values for cell number, SSEA3 intensity per cell and SSEA3 intensity across a 
cell’s area (materials and methods). These data were chosen so as to provide 
information analogous to that generated by flow cytometry; principally enabling 
examination of the SSEA3 distribution across a population ready for use in the modelling 
process. 
 
Once the plated cells were imaged and examined, it became apparent that some 
misclassification occurred as evidenced by the cell size data (Figure 3.22).  Some “cells” 
presented in these data were evidently too small and existed outside of the relatively 
normal distribution of the logged (base 10) cell size data (Figure 3.22a). Closer inspection 
of the cell data on a linear scale, revealed a “jump” in cell size frequency between 50 
µm2 and 60 µm2 (Figure 3.22b). These “cells” were interpreted as debris/noise from the 
collection procedure and were removed from subsequent analysis.  
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The SSEA3 expression patterns of the fractions collected on the InCell platform are non-
identical, but do not display the same classic distribution as cells interrogated by flow 
cytometry (Figure 3.23). Despite this reduced heterogeneity, the cell populations do 
tend towards a norm over time, with a median log intensity vale of around 5.59 (red 
line, Figure 3.23) that is evidence for some SSEA3 dynamics. It is clear that this technique 
is not directly comparable to that of the flow cytometry counterpart, but with further 
development, may provide data that is amenable to similar modelling procedures 
described by (Nie and Coca, 2013). 
 
  
Figure 3.21 – Initial Sort for in situ Model Generation. Parental Population distribution of NTera2 cells stained for SSEA3. Cells from this sort were sorted
according to the listed fractions (Negative, Low, Medium and High) in order to examine their future SSEA3 dynamics’ behaviour within an Incell analyser in situ
format. Sorted cell fractions were plated into 6 well plates and samples fixed daily over the following five days for examination using the Incell analyser
platform.
Figure 3.22 – Cell Size Exclusion. An
examination of the cell size data reveals that some
noise was also collected as data a.). cells which
were clearly too small did not fit the normal
distribution of the logged data, and the bounds of
this distribution were around 101.5. b.) An
examination of the region around 101.5 on a linear
scale reveals that there is a clear change in the
behaviour of the distribution around this region.
These were interpreted as noise and removed from
further consideration.
Figure 3.23 – SSEA3
Heterogeneity Analysed in situ.
Examination of cells examined
using the InCell analyser
platform in a similar manner to
the flow cytometry based assay,
reveals that the distribution of
SSEA3 is not manifest
identically to the flow
cytometry counterpart.
Although the cells do not appear
with identical distributions, the
typical heterogeneous display of
SSEA3 is not present. The red
line on each plot represents the
median intensity of the cells on
Day5 for the control group and
acts as a reference point for
comparison between graphs.
Cells do tend towards this
median regardless of sorted
population with the possible
exception of the ”low” fraction,
which appears to remain more
negative than the other
fractions.
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3.15 Discussion 
Main Conclusions 
 
These experiments demonstrate that SSEA3 dynamics of model pluripotent cell line 
NTera2 can, for the first time, be effectively modelled using this approach. By observing 
the evolution of SSEA3 distributions over time it was possible to infer directly from data 
a chaotic one-dimensional map that predicts well the SSEA3 dynamics. This shows that 
the heterogeneity associated with SSEA3 expression across populations in standard cell 
culture can be the result of deterministic rules exhibiting chaotic behaviour rather than 
purely stochastic. In this context, given that embryo development is in essence a 
deterministic process, this suggests that heterogeneity reflects the transition to chaos 
of a deterministic system as a result of changes in the system parameters induced by 
the culture conditions.  
 
One of the key features of the model is that it is capable of making predictions of future 
SSEA3 distributions that were generally well aligned with observed data from both the 
training and test data sets acquired during the first sort. 
 
The model itself produced a non-uniform map which in itself contained several notable 
features. Examination of this map revealed that there are particular intensities of SSEA3 
that had a higher propensity to vary over time than others. Additionally, equilibrium 
points were present upon this map of the model which, it was postulated, represented 
candidates for substates within the SSEA3 expression axis of variation. These notable 
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regions were sorted for in order to assess, via clonogenic analysis, whether there were 
any obvious biological corollaries associated with these highlighted points. 
 
One of the fundamental findings from the clonogenic data was that there were some 
behavioural differences between fractions sorted by SSEA3 expression. Indeed, this was 
anticipated due to the already documented differences in behaviour particularly 
between SSEA3 positive and negative populations (Enver et al., 2005a). The most 
obvious differences shown were with regard the cell survival/attachment data, but there 
is no obvious corollary between predicted equilibrium points and observed behavioural 
patterns. Although cells were plated as singlet cells at a low seeding density (1,000 
cells/cm2), it is possible for individual cells to associate with each other, especially early 
on which could obfuscate the data. If a cell doublet were seeded at time zero, then all 
else being equal, it could produce a colony twice the size of a colony founded by a single 
cell. This is an issue that is particularly important with regard the differences seen in cell 
adherence to the culture vessel that may also influence/correlate with cell:cell 
adherence. Although efforts were taken to ensure cells remained as singlet cells by 
filtration prior to seeding, this does not guarantee that cells did not adhere to each other 
after filtration. This issue was also in part addressed by removing particularly large 
colonies from analysis, however this could also be erroneously disqualifying cells/ 
colonies that merged later due to differences in cell motility or even simple colony 
proximity. Strictly speaking, a clonogenic assay could be performed by the examination 
of a single cell isolated in culture, but human pluripotent stem cells are notorious for 
their poor clonogenic efficiency as well as evidence of improved survival when near 
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neighbours and this shortcoming usually overcome by seeding multiple cells as 
performed here (Enver et al., 2005a; Harrison et al., 2007; Li et al., 2010).  
 
The final key objective was to develop a method by which data appropriate for modelling 
in this way could be acquired using significantly less material. Fulfilling this objective 
would make amenable the modelling of hESCs and other, less robust, cell lines where 
cell survival from sorts is low and cell line expansion is particularly impractical and 
expensive. The SSEA3 distributions derived from the fractions used in this analysis did 
display some degree of heterogeneity and indeed evidenced changing SSEA3 levels over 
time, although the appearance of these distributions were considerably different to that 
of those acquired by flow cytometry. Altogether this is not surprising since data acquired 
from the two different techniques are not directly analogous and it is encouraging to 
see the differences between fractions from the InCell-measured data. Further 
optimisation of the data collection approach and post-processing is clearly required to 
replicate the SSEA3 distribution appearance that is readily available with flow cytometric 
analysis. The observable SSEA3 expression differences contingent on sorted fraction and 
time support pursuing the development of this approach. 
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3.16 SSEA3 Population Distributions 
 
Despite the fact that the SSEA3 distribution across NTera2 populations consistently 
displayed heterogeneity, it would be incorrect to assert that these distributions were 
identical. Take for example the difference between the distributions of batches 2 and 3 
from the first sort; it is clear that despite some shared characteristics, they are clearly 
not identical. The distribution from Batch2 displays a multimodal distribution, but there 
are two clear larger populations representing an approximately bimodal population 
(Figure 3.5). The Batch3 distribution on the other hand did not present this broadly 
bimodal distribution; although there are multiple peaks and a broad range of intensity. 
There are several factors that could explain this difference; one of the main indirect 
corollaries of SSEA3 expression is culture confluency. From my own experience, SSEA3 
expression generally appears bi-modal but expression rapidly decreases once cultures 
approach and surpass confluency. To counteract this, efforts were made to stagger cell 
culture in an attempt to perform sorts on cultures that were at approximately 90-100% 
confluency as a compromise between cell number and SSEA3 expression integrity. 
Despite this, there was in fact variation in culture confluency between these batches; 
with Batch3 being more confluent than that of Batch2. This difference could account for 
the reduced proportion of cells with high levels of SSEA3 expression. Regardless, cells 
from each fraction were available to sort between the batches and so could be 
examined. One crucial potential flaw would be if the reduction in the proportion of cells 
from these fractions was reflective of a global behaviour that would take time to resolve 
and become manifest in the behaviour of these fractions over subsequent days. In other 
words, if the proportion of cells of a particular fraction affects the behaviour of an 
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individual cell taken from within that fraction in advance of the sort, then subsequent 
SSEA3 dynamics observed would be contingent on the parental population and 
consequently altered by differences in this initial condition. An alternative interpretation 
is that once sorted, all cells exist, roughly, from within a fraction that is 100% reflective 
of itself, and so is no longer influenced by the proportion of cells occupying other 
fractions. A comparison of the observed and predicted data, not only of the training 
dataset (Batch3) but also of the test data-set from Batch2, demonstrates that the 
predictions were generally well reflective of the observed data. This implies that there 
was not a huge impact caused by the difference in the starting population SSEA3 
expression patterns of these batches. 
 
On the other hand, there were also differences between the SSEA3 distributions of the 
first and second major sort that are not the same as those seen between batch2 and 3 
within the first sort. Firstly, the entire range of SSEA3 expression was larger in the second 
sort as compared to the first sort; in the first sort, SSEA3 intensity did not go much above 
1x103 whereas in the second sort, the maximum SSEA3 intensity was approximately 
5x103. There are several non-mutually-exclusive potential explanations for this. Firstly, 
this effect could be an artefact of some difference manifest during antibody staining 
resulting in a change in observed range of expression. This could be due to antibody 
degradation or different batches of secondary antibody resulting in a minor change in 
the range of expression pattern. Secondly, there could be differences in baseline as 
calibrated by the P3X negative control; a change here could alter the range that SSEA3 
appeared to occupy. Thirdly, a change in the voltage sensitivity of the channel used to 
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measure SSEA3 intensity by indirect immunohistochemistry would alter the range upon 
which the intensities were seen. Finally, this could be a real effect, where the expression 
of the two populations really was different as measured. 
 
In consideration of the aforementioned possibilities that could result in the difference 
seen between the SSEA3 distributions observed in the two sorts, the hypothesis with 
greatest power of explanation is probably a difference in the voltages associated with 
the channel. An offset here would change the range that the SSEA3 population appears 
to cover, and a comparison of the p3x medians between the two experiments reveals 
that they were indeed different. 
 
Another issue to consider is that of sort accuracy. If there were significant inaccuracies 
in the sorting procedure, then the possibility that the dynamics we see are due to 
misclassified cells present by contamination during the initial sort. Considering the 
relationship between SSEA3 and pluripotency, where cells negative for SSEA3 are much 
more likely to have left the stem cell compartment whose progeny are unlikely to return 
and resume SSEA3 expression. A difference in classification could be particularly 
cumbersome for the negative/low fractions; where it could be argued that positive cells 
present in later fractions are the result of an inaccurate initial sort. An examination of 
back-gated data from the initial sorts reveals that sorts were generally accurate with 
distinct populations sorted from the main population (Figure 3.14). 
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Another consideration to the modelling approach is that samples examined between 
days are not directly linked, since the cells used to generate the model are discarded 
each day. The connecting factor between cells from the same SSEA3 fraction between 
days is that they were sorted for the same levels of SSEA3 expression prior to plating. 
Following that, the different timepoints for the sorted fractions are maintained in 
different cultures and thus no longer directly linked. This begs the question of whether 
cells examined on different days (that have been separate since the original sort) are 
directly comparable. One way to address this question is via technical replication, in 
which multiple plates are prepared for replicates of the same fraction from the same 
sort/Batch. Generally, due to the large cell number required to get enough cells from 
across the range of SSEA3 expression not enough sorted cells were available to run these 
technical replicates. That said, there were some occasions where multiple technical 
replicates of the same fraction from the same sort could be performed. Good evidence 
that this modelling procedure is fair is that the SSEA3 distributions from technical reps 
are similar for each day examined, implying that the distribution observed is 
representative of their behaviour. Such examples of these data are displayed in Figure 
3.24, where indeed it appears that technical replicates are almost identical to each 
other. 
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Figure 3.24 – Technical
Replicate Comparison.
Technical replicates
performed using excess
cells from sorts of these
listed fractions. The
evolution of the SSEA3
distributions from these
fractions appear extremely
similar, if not identical to
each other for respective
cell fractions. These data
support the notion that
SSEA3 changes over time
are not stochastic and that
the behaviour of sorted cell
fractions over time is
predictable
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Additionally, it is quite unlikely that all negative cells have left the stem cell 
compartment. If that were the case, then there could not be any cells that once negative 
for SSEA3 then go on to express SSEA3 later. The increasing proportion of cells positive 
for SSEA3 within the Negative or Low fractions over time is itself evidence of this. It 
could, however, be argued that this is due to differential growth rates of cells that are 
either negative or positive for SSEA3. Taking this argument to its most extreme 
condition, it could be the case that no cells negative for SSEA3 ever reproduce and that 
all cells positive for SSEA3 reproduce and remain positive. Assuming the normal NTera2 
cell cycle time of approximately one day, an estimate of the maximum proportion of 
expected positive cells based upon the previous day’s proportion of positive cells in a 
population is calculable. In a hypothetical example, a population contains 5% positive 
cells (proportion positive= kn), with the remaining 95% of cells being negative for SSEA3 
expression (proportion negative = 1-kn). Assuming that all positive cells replicate (2kn) 
and none of the negative cells replicate (1-kn), the expected maximum proportion of 
cells positive for SSEA3 on the following day (kn+1) in the new population size (2kn+(1-
kn)) is estimated by: 
𝑘𝑛+1=
2𝑘𝑛
(1 − 𝑘𝑛)+ 2𝑘𝑛
 
In this hypothetical example, the maximum proportion of positive cells possible on the 
following day is estimated to be 9.1% if they can only come from other positive cells. If 
the actual proportion of positive cells observed on the following day exceeds this 
proportion, then these cells must have come from an alternative population ( i.e. 
negative cells). Of course, these are an extreme set of assumptions, which also includes 
the assumption that no cells in the population die. A comparison between the observed 
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proportion of positive cells and the calculated maximum on the following day is outlined 
in Table 3.4. Examples where the observed proportion of positive cells exceeds the 
predicted are highlighted in green. It is worth noting that this does not happen with all 
transitions and indeed for most examples that are highlighted, the predicted maximum 
is not exceeded by a large amount. It is worth emphasising that indeed this is the 
maximum proportion of cells positive for SSEA3 anticipated under a set of extreme 
conditions which are unlikely to all be accurate. If for instance, the criteria that negative 
cells never replicate and that positive cells never become negative are relaxed, then the 
predicted proportion of positive cells will decrease. Indeed, considering the observed 
cell population growth over the five-day period the replication of cells negative for 
SSEA3 is extremely likely (data not shown). Therefore, the fact that there are 
proportions of cells positive for SSEA3 that are equivalent or surpass this predicted 
maximum also evidences that cells negative for SSEA3 are indeed capable of giving rise 
to cells positive for SSEA3 and that cells positive for SSEA3 occurring within negative or 
low fractions cannot be merely attributed to inaccuracies in sorting.  
 
Finally, the effects of SSEA3 staining itself and the bearing this has on the resulting 
behaviour of the cells examined. Cell surface antigens are likely functional to some 
degree and as such, the act of measuring SSEA3 expression via antibody binding is liable 
to elicit some change in behaviour that an untreated population of cells would not 
experience. In this case, it is especially true that, since we are sorting  for cells based 
upon their expression of SSEA3, that different fractions are liable to respond differently 
to each other. For instance, by definition the population that is highly expressing SSEA3 
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will have more antibody for SSEA3 bound to it than the population that is not expressing 
SSEA3. Consequently, the dynamics that are witnessed are, strictly speaking, how cells 
that have had their SSEA3 antigen bound by antibody behave. This is not presently 
avoidable and is very much an inherent part of this modelling. Regardless, this model of 
SSEA3 dynamics can really only be used if the SSEA3 expression levels of the population 
of interest are known, which requires antibody interference anyway and thus remains 
suitable for practical purposes. 
 
 
Table 3.4 – Table displaying the observed (Obs) and maximum predicted (Pred) proportion of cells 
positive for SSEA3 under the assumption that cells negative for SSEA3 do no produce cells positive 
for SSEA3 (other assumptions and calculation in the text). Predictions for any particular day are 
matched alongside the observed proportion and are calculated based upon the previous day’s observed 
proportion of SSEA3 positive cells. Cells highlighted in green represent occurrences where the 
proportion of cells positive for SSEA3 exceeds the maximum predicted; indicating that some of these 
positive cells must have come from the negative cells and cannot be simply explained by positive cell 
reproduction. 
 Percent positive (%) Using fraction: -ves Percentage positive (%) Using Fraction: R5 
Replicate May Batch1 May Batch2 May Batch3 Nov Batch1 Nov Batch2 Nov Batch3 
 Obs Pred Obs Pred Obs Pred Obs Pred Obs Pred Obs Pred 
Day0 - - - - - - - - 1 - 2 - 
Day1 15 - 20 - 17 - 15 - 7 3 7 4 
Day2 35 27 22 33 17 30 - 26 16 13 - 13 
Day3 51 52 36 36 32 29 40 - 21 28 22 - 
Day4 63 67 - 53 53 48 58 57 28 34 41 36 
Day5 63 77 60 - 49 69 51 73 42 44 52 58 
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3.17 Future directions 
 
The modelling approach utilised here presents a completely novel way for investigating 
heterogeneity within the Stem cell compartment. Steps here have been made to 
develop the modelling procedure on the pluripotent EC line NTera2, and although the 
NTera2 system is not completely understood, applying this modelling to the human ES 
context is clearly desirable and more directly relevant in the context of regenerative 
medicine. Attempts to model NTera2 cells imaged in the InCell system have begun to 
make this setup more amenable to lower cell numbers. This work here provides the basis 
from which to develop a comprehensive method that would allow the analysis of 
heterogeneity within human ES cell lines in particular. 
 
This modelling procedure has elucidated possible relationships between equilibrium 
points, which merits further investigation into how this informs our understanding of 
real biological behaviours. An examination of the differentiation potential of different 
equilibrium points will be the most likely method by which lineage bias may be assessed; 
this is one of the most important next steps. Alternatively, an examination of the gene 
regulatory networks by RNA sequencing, or examination of the pluripotency 
transcription network by qPCR may also draw out differences between these 
equilibrium points. 
 
In this investigation, we have modelled one axis of variation (SSEA3 in these examples) 
but it would be exciting, and is plausible in principle, to extend the model to 
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simultaneously include other axes of variation. Such application could be useful in 
studies of cell lines using multiple markers such as the Sheff4.Gata6 cell line which has 
a GFP marker for Gata6 transcription. Studies performed by our group demonstrate that 
Sheff4.Gata6 exhibits multiple populations when its SSEA3 expression is compared 
against Gata6 (Figure 5.15a and personal communication with Dr. Thomas Allison). 
Sorting based upon these markers alone reveals that these different populations have 
different lineage biases. 
 
Furthermore, it is possible to use this modelling procedure to examine how different 
environments affect the behaviour of cells with respect to a modelled marker. For 
example, the role of different culture media in ES culture is a heavily discussed feature 
of ES cell work, with many competing formulations generated and marketed frequently. 
The effect that different formulations on ES cell culture, in terms of ease of culture and 
spontaneous differentiation varies between users and laboratories. The effect that 
these media have on stem cell dynamics or substates within the stem cell compartment 
remains unknown but using this modelling technique provides a method by which to 
examine this problem. In a similar way, modelling of this kind could highlight how 
dynamics within the stem cell compartment differ between normal and culture adapted 
variants of ES cell lines. 
 
This represents a promising new method by which to interrogate cell population 
heterogeneity dynamics that can be applied to the examination of substates within the 
stem cell compartment. Although this is a potentially powerful technique, it requires 
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labelling cells in some way, which may have unexpected consequences on cell 
behaviour, especially when dealing with subtle behaviours. In the next chapter a 
complementary method for analysing stem cell behaviour without the use of markers is 
explored.  
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Chapter 4 
 
 
Raman Spectroscopy Use and 
Optimisation 
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4.1 Introduction 
Techniques that permit the effective tracking and isolation of particular cells from within a much 
larger population such as cell surface antigen binding or the generation of fluorescent marker 
cell lines have been of great assistance for the interrogation of human ES cell biology. However, 
both of these approaches mandate some degree of interference with the cells of interest. 
Furthermore, there are very few approaches that provide a global readout of a cell’s phenotype 
without requiring the destruction of that cell, particularly in the fields of transcriptomic and most 
metabolomic techniques such as mass spectrometry.  
 
A technique that is steadily gaining traction in the biological sciences is Raman spectroscopy. 
Raman spectroscopy is a vibrational light spectroscopic technique that is capable of providing a 
plethora of information on the types of chemical bonds present within a sample. Although this 
technique has been traditionally used in the chemical and material sciences for sample 
identification and verification of sample chemical purity, it is being utilised steadily more 
frequently for biological research. Furthermore, it is also emerging as a technique applied to the 
field of pluripotent stem cell research. In effect, Raman spectroscopy represents a minimally 
invasive method for the examination of the biochemical state of a cell which may be readily 
compared against its neighbours or, indeed, other cell types.  
 
Raman spectroscopy has a twofold advantage when it comes to biological research. It can be 
used for the generation of “spectral signatures” reflective of particular cell types, but it also 
contains biological information that is directly pertinent to the cell’s biochemical composition.  
An example Raman spectrum typical of a cell is presented in Figure 4.1. The x-axis represents 
the Raman shift that is a measure of the inelastic scatter of the photons that interacted with the 
 136 
 
sample. Raman shift is typically presented in wavenumber format (Δω (cm -1)) and is calculated 
by 
∆ω (𝑐𝑚−1) =  (
1
𝜆0
−
1
𝜆1
) × 107 
Where λ0 is the excitation wavelength (i.e. of the incident photon) and λ1 is the Raman spectrum 
wavelength, with both λ0 and λ1 measured in nanometres. The y-axis represents relative 
intensity in arbitrary units. Since the Raman shift any incident photon experiences is as a result 
of its interaction with particular molecular bonds, it is possible to identify particular peaks and 
patterns that are attributable to different classes of molecule or even of specific candidates. For 
instance, phenylalanine typically has an extremely sharp peak at 1000.3 cm -1 that is readily 
identifiable and is evidence that a biological sample is under consideration (Krafft et al., 2006) 
In addition, there are particular regions in the Raman spectra that are attributable to nucleic 
acids, proteins as well as saturated and unsaturated fatty acids (Figure 4.1; (De Gelder, 2007; 
Harz et al., 2009; Kneipp et al., 2006; Maquelin et al., 2002; van Manen et al., 2005) . Organic 
molecules have Raman shifts that are typically in the region of 500-1800cm-1 and is termed the 
“fingerprint” region (De Gelder, 2007). 
 
Raman spectroscopy has been used in a variety of biomedical research and the scope of its use 
has developed in line with the technology around it. The earliest applications of Raman 
spectroscopy were of large volumes of highly concentrated biomolecules, with spectra collected 
over a long time-frame owing to the weak Raman effect (Krafft et al., 2006).   However, the 
advent of several key technologies has significantly reduced the acquisition time of Raman 
spectra. Indeed, the availability of modern commercial benchtop Raman spectroscopy systems 
was only made possible with the development of the air-cooled LASER, Charge coupled device 
(CCD) multi-channel detectors, the desktop computer and holographic notch filters for Rayleigh 
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scattered photon suppression (Adar, 2007). The feature of high powered lasers for maximal 
signal generation and sensitive CCDs for efficient collection have facilitated the use of Raman 
spectroscopy within the single cell context (Excellently reviewed in Smith et al, 2016).  
 
With regard to pluripotent stem cell heterogeneity, the ideal scenario would be the live, real-
time acquisition of Raman spectra where cells are maintained in a healthy environment, i.e. 
aseptic, 37oC in appropriately buffered cell culture media. Raman spectroscopy has been applied 
in a number of ways to interrogate cellular systems and has been used to examine cells in 
suspension (Crow et al., 2005; Krishna et al., 2006; Mourant et al., 2005; Short et al., 2005), live 
cells in a standard culture monolayer format (Notingher, 2002), as well as chemically fixed (Krafft 
et al., 2006; Swain and Stevens, 2007) and dried cells (Crow et al., 2005; Krafft et al., 2006; 
Krishna et al., 2006; Mourant et al., 2005; Notingher, 2002; Schuster et al., 2000; Short et al., 
2005; Swain and Stevens, 2007). These different approaches come with their own sets of 
considerations, of which the most notable is the difference between fixed and live cells (Swain 
and Stevens, 2007). Fixed cells are killed and preserved by chemical means, which translate to 
an altered chemical composition compared to living cells that is certainly reflected in the Raman 
spectra (Meade et al., 2010). However, this does not preclude the examination of biochemical 
information from fixed cells in comparison to each other.  
  
Figure 4.1 – A typical Raman spectrum of a live pluripotent embryonic carcinoma cell, NTera2. Raman spectra are information rich and provide
substantial information about the biochemical state of the cell. Almost all Raman scatter related to organic molecules occur in the region 500-1800cm-1
wavenumbers and is thus termed the fingerprint region. Raman spectra of cells generate a plethora of Raman bands reflecting the degree of complexity
biochemical complexity of the cell. The Raman spectra of many organic molecules have been determined elsewhere which allows the tentative
identification of molecules represented in the biochemical mixture. For instance, there are several bands associated with proteins, lipids and nucleic acids
of both RNA and DNA. The association of particular Raman bands to organic molecules has been studied elsewhere and these examples are compiled
from the literature (De Gelder, 2007; Harz et al., 2009; Kneipp et al., 2006; Maquelin et al., 2002; van Manen et al., 2005)
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The application of Raman spectroscopy to cell culture is still a developing technique and there 
currently exists no standardised method. One of the key differences among existing methods is 
the time required to acquire Raman spectra from cells of interest, which is also affected by the 
format in which the cells are presented; for example, live/fixed or suspension/monolayer. If 
Raman bands of interest are known a priori then the collection time required for suitable 
comparison between particular samples is considerably shorter than holistic approaches to 
examine general cellular “signatures” since only a direct comparison between known bands of 
interest is required. For instance, a technique, using culture media containing metabolites 
labelled with alternative radioisotopes (such as 13C rather than 12C) can be used to readily 
identify microbes that metabolise the labelled metabolite with extremely short acquisition times 
(100ms) since the differences of interest are already known (Huang et al., 2004b; Li et al., 2013) 
; Radioisotope labelling is effective in Raman spectroscopy since the altered mass of the labelled 
nuclei causes a change in the vibrational frequency of that molecule and this difference may be 
calculated a priori (Huang et al., 2004b; Li et al., 2013). 
 
Different Raman techniques also contribute to the manner in which Raman spectra are collected 
in terms of acquisition time and spectral information. Spontaneous Raman imaging, which is 
used here, acquires Raman spectra from individual points from the sample of interest using a 
single laser for the generation of Raman scattered photons. Alternatively, coherent anti-Stokes 
Raman spectroscopy (CARS) utilises a multiple photon approach using tuneable lasers that 
produces a signal where emitted waves are coherent to each other. Coherent radiation emitted 
is greatly enhanced when the difference between the laser pulse frequencies match that of the 
Raman frequency of the molecule of interest. As a result, CARS signals are approximately 105 
times stronger than that of spontaneous Raman spectroscopy and CARS has been used to 
examine the differences between differentiated and undifferentiated mouse ES cells with 
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acquisition times of 0.3s per spectrum (Konorov et al., 2007). CARS remains in its infancy, 
although several successful proof-of-concept approaches have been demonstrated in a 
biomedical context (Keren et al., 2008; Qian and Nie, 2008; Ryder, 2005). Another common 
Raman technique is surface enhanced Raman spectroscopy (SERS) that typically employs the use 
of metal nanoparticles that when adsorbed by sample molecules generate high Raman 
scattering intensities by a plasmonic effect (Nie and Emory, 1997; Qian and Nie, 2008; Schlucker, 
2009). Although SERS can increase the Raman effect 1014 or 1015 fold (Nie and Emory, 1997) it 
necessitates sample interference that can alter cell behaviour which is undesirable in this case 
(Kneipp et al., 2005). 
 
One major prerequisite for the application of Raman spectroscopy to biological samples is that 
the Raman effect reflects the chemical composition of the sample in a quantitative manner. 
However, this quantitative aspect is readily obscured by various experimental factors that 
influence the raw intensity of Raman signal acquired since the emission of Raman scattered light 
depends on multiple factors including the intensity and frequency of the excitation laser, the 
number of molecules (Rea, 1959) and in some instances with sample temperature, although 
usually associated with inorganic compounds (Chattopadhyay et al., 1982; Xie et al., 2001). 
Raman spectroscopy can however be used to infer relative concentrations of particular 
molecules within a sample which, when compared against a calibrated concentration curve for 
that molecule can be used to calculate absolute concentration within solid (Araiza-Reyna et al., 
2013) and liquid samples (Sato-Berru et al., 2016) . 
 
Furthermore, noise is introduced into Raman spectra acquisition from surrounding light and 
cosmic radiation in addition to sensitivity to instrumental parameters that may reduce the 
efficiency of photon flow between sample and instrument. Finally, fluorescence is an especially 
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powerful source of noise in the collection of Raman spectra. Raman scattering is a rare event, 
with only about one in every ten million scattered photons undergoing this process (Ellis and 
Goodacre, 2006). On the other hand, fluorescence is a much stronger effect by several orders of 
magnitude and Raman spectra are easily obfuscated by broad bands of fluorescence. Utilising 
lasers with frequencies in the near infrared or ultraviolet regions. However, the low energy 
infrared laser approach necessitates longer acquisition times, whereas high energy UV lasers risk 
sample heating and destruction (Afseth et al., 2006). Therefore, here, a 532.32nm excitation 
laser was employed which was also found to generate the best single cell Raman spectra in the 
context of bacteria examined with the same system (Huang et al., 2004a). In order to acquire a 
meaningful interpretation of Raman spectra, mathematical correction methods are applied in 
order to remove the unwanted aspects of variation described above.  
 
Raman spectroscopy, like other light vibrational techniques, offers unique insight into the 
biology of the cell, and may be used to identify signatures pertinent to particular cell types (See 
chapter 1). This capacity to distinguish cell phenotype based upon signals generated endemically 
from the cells of interest presents an opportunity to interrogate stem cell substates in a manner 
that is minimally invasive. This is appealing both as a research tool, as the cells can be measured 
and then used experimentally, and later as a tool to identify particular cells pertinent to an e.g. 
medical application by sorting for cell with a particular lineage bias for a differentiation protocol.  
Ultimately, the development of Raman signature-based based method for live cell type 
recognition and sorting for cells of interest, similar to that of flow cytometry, that requires very 
little physical interaction with the cells under consideration. Alternatively, the combination of 
Raman spectroscopy with time-lapse studies on pluripotent cell behaviour could prove 
extremely informative. 
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Raman spectroscopy is not a technique already utilised by the Centre for Stem Cell Biology and 
thus needed to be introduced, developed and optimised for data collection from pluripotent 
stem cells. This chapter deals with the optimisation of Raman spectra collection and data 
processing for use in addressing the biological questions raised in Chapter 5 although this 
optimisation was a lengthy and iterative process meaning that several experiments in Chapter 5 
that were performed in parallel are not addressed using the final methodology.  An outline of 
the Raman spectra collection and spectral treatment process is shown in Figure 4.2. Here, a 
proof of concept approach is adopted for the application of Raman to stem cell substate analysis 
that uses NTera2 as a model cell line in the development of the Raman spectroscopy technique.  
Acquisition Normalisation Clustering Analysis
Fig 4.2 – Typical process of Raman Spectrum acquisition and analysis. Raman spectral data is acquired from cell sample of interest, then normalised in
order to remove undesirable variation in Raman spectrum collection. Normalised data are then compared against each other in a using multivariate
statistical techniques such as principal component analysis (See materials and methods).
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4.2 Results 
Initial studies were conducted using the human EC cell line NTera2. Given the desire to utilise 
Raman as a cell sorting technique, similar to flow cytometry, cells were trypsinised and 
harvested prior to analysis as is usual for flow cytometric analysis (See materials and methods). 
Cells were aliquoted in PBS onto CaF2 slides, a Raman inactive substrate, and analysed by Raman 
spectroscopy. It became immediately apparent that the Raman spectra acquisition time was 
considerably longer than that required for flow cytometry, requiring at least 30 to 60 seconds 
acquisition time per cell. For comparison, flow cytometry systems are capable of examining 
thousands of cell per second. Suspension-based acquisition methods were at this stage 
disqualified from further experiments since this time-scale permits too much cell movement; 
often causing cells to move out of focus during acquisition time. 
 
It quickly became apparent that the substrate on which cells were grown required careful 
consideration when adopting a monolayer approach. The traditional adherent culture plastic on 
which most cell culture is performed in our laboratory transpired to be extremely Raman-active, 
producing a strong background (Figure 4.3a) that appeared significantly different to cells 
analysed on CaF2 (Figure 4.3b in red). The common alternative to culture plastic, glass slides, 
also produced some background (Figure 4.3c), although not to the same extent as culture plastic 
as evidenced by the raw intensity data, especially when compared to the same spectrum of a 
cell analysed on CaF2 (Figure 4.3d). A Raman-inactive substrate as a potential culture substrate 
such as CaF2, was trialled and indeed did not produce any significant background. NTera2 cells 
readily adhered to this substrate and appeared to grow normally (Materials and methods). CaF2 
Is relatively expensive and so we developed a cleaning protocol for the slides so that they could 
be reused (see Materials and Methods). 
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4.3 Media 
Examination of NTera2 cells grown on CaF2 prepared for live single cell Raman spectroscopy 
revealed that the standard culture media for routine NTera2 maintenance was itself Raman-
active, which was attributed to the presence of phenol red (Figure 4.4a). The background 
interference caused by phenol red was significant and saturated the detector. Only by reducing 
the laser power and acquisition time was it possible to acquire spectra that did not saturate the 
detector. Furthermore, attempts at normalising the data in an attempt to remove this 
background interference were not able to produce spectra comparable to that of a cell (Figure 
4.4b). An alternative DMEM formulation that did not use phenol red as a buffer was trialled for 
the maintenance of NTera2 cells (materials and methods). The cells grew readily on CaF2 using 
this media and the high background associated with phenol red was not present in cells 
examined (Figure 4.4a). 
 
When spectra that were previously acquired from cells in suspension in PBS were compared 
against data acquired from cells grown in a monolayer format in phenol free media, a couple of 
things became apparent (Figure 4.5a). Firstly, although spectra presented expected regions of 
biochemical markers (such as protein bands, nucleic acid bands etc…), their pattern differed 
between the two categories. Secondly, the acquisition time required was considerably increased 
in the monolayer format in order to acquire spectra that were comparable in the first place (an 
increase from 10 seconds to 30 seconds). Finally, an examination of the phenol free media itself 
also revealed a similar pattern to that of the cells grown in this media (Figure 4.5b). This 
observation leads to the conclusion that an increased data acquisition time would be required 
in order to obtain Raman spectra from cells of interest that could be distinguished suitably from 
their background media. 
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4.4 Cell Fixation 
The above results so far, in combination, began to indicate that with the present arrangement 
live cell analysis would not be feasible. The data acquisition time for samples far exceeded initial 
expectations that could not be considered comparable to those of a flow cytometry assay. 
Additionally, acquisition time would be compounded further in order to acquire cellular data 
that would overcome noise generated from background media (Figure 4.5). Finally, facilities 
designed to maintain cells within normal homeostatic bounds were not present on the current 
set up, which led to sample infection as well as presumed stress on the sample cells. Although 
30 seconds is not a long period of time for each sample, it still took several hours to collect 
Raman spectra from each treatment. The Raman microscope laboratory did not have any 
available incubator facilities, meaning that all samples were subject to sub-optimal conditions 
during spectral acquisition, being at ambient temperature whilst the treatment being sampled 
was not maintained in aseptic conditions. At this point, it was not financially viable nor practical 
to alter the Raman microscope with an environment chamber therefore the decision was made 
that live cell analysis was not an appropriate avenue to pursue at that time but that a proof of 
concept approach using fixed cells was justifiable (see discussion). The chosen method of cell 
fixation adopted was by paraformaldehyde (PFA) as described in the materials and methods 
section. To prevent the issues associated with infection of fixed samples stored in phosphate 
buffered saline (PBS), after cells were rinsed with PBS after fixation they were washed with 
distilled water for two minutes to remove residual salt that would otherwise crystallise and 
interfere with analysis before the water was removed and fixed cells left to dry.  
 
A comparison between Raman spectra acquired from cells that have been first fixed by 
paraformaldehyde and initial Raman spectra acquired from the cell suspension treatment is 
displayed in Figure 4.6. The spectra share several similarities, with representation from all gross 
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types of organic molecule highlighted in Figure 4.1. There are of course several differences 
between these spectra that is probably attributable to the PFA fixation process. The most 
obvious difference between these spectra is the exaggerated peak at 1003 cm-1 in the PFA fixed 
cells. 
  
Figure 4.3 – Culture Surface and Raman Background. A
comparison of Raman spectra collected from cells grown
on different culture substrates. All spectra were collected
for a 10 second period using the 532nm wavelength laser
at 100% capacity. a) shows the spectral background
typical of adherent culture plastic (green). b) The same
plastic spectrum compared against Raman data collected
from a cell in suspension, aliquoted onto a CaF2 slide
(red). The plastic spectrum is clearly more Raman active
than the cell, producing spectra that are significantly more
intense. c) Shows the spectral background as a result of
glass microscope slides (blue). d) a comparison made
between the same glass spectrum in c and the same
Raman data collected from a cell in suspension, aliquoted
onto a CaF2 slide as in b (red). The glass slides are also
Raman active, but considerably less so than culture
plastic.
a. c.
b. d.
Figure 4.4 – Phenol Red Media Interference. A comparison between Raman
spectra collected from cells in different culture media at the time of acquisition.
a) Raw Raman intensity count data from a cell grown in phenol red free media
(blue); Raman data was acquired over a 30second period using the laser at full
power. In purple, a Raman spectrum acquired from a cell in media containing
phenol-red; Raman data was collected over a 20 second period with 99% of the
excitation laser radiation filtered out. The broad increase in Raman intensity in
the later wavenumbers is reflective of phenol red mediated fluorescence. b) All
spectra are normalised by area under the curve which is not able to generate a
spectrum from cells grown in media containing phenol red that is comparable
to spectra from media that does not contain phenol red. Blue and purple spectra
are the same as in a, except normalised by area under the curve. The green
spectrum is also from a cell grown in media that does not contain phenol red,
however the Raman data was acquired over a 200 second timeframe (laser
unfiltered). The shape of the green and blue spectra are very similar despite the
change in collection time. Spectra are vertically shifted so that a comparison
between spectral shape can be made.
a.
b.
Figure 4.5 – Comparison of Suspension and Monolayer Spectral Acquisition Formats. Comparison of Raman spectra acquired from cells in a suspension
or monolayer format. Spectra are vertically transposed in order to facilitate visual comparison. a) Comparison between normalised data collected from
cells in suspension in PBS (Red, 10 second acquisition time) and Raman spectra collected from cells grown in a monolayer format on CaF2 slides using
phenol free media (Blue, 30 second acquisition time; Green, 200 second acquisition time). There are differences in the spectra between cells cultured in a
monolayer format (Blue and Green) when compared to that of cells suspended in PBS however there are comparable regions, with respect to wavenumbers
associated with fatty acids, amides, and nucleic acids. b) Comparison between the normalised Raman spectra collected from cells suspended in PBS (Red,
10 second acquisition time), cells cultured with phenol free media in a monolayer format on CaF2 slides (Green, 200 second acquisition time) and of the
phenol free media on its own (pink; 60 second acquisition time). The extreme similarity between spectra acquired from cells in the phenol free media and
of the media itself suggests that there is a large contribution to spectra from the organic components of the media alone, making it difficult to determine
whether the spectra acquired from the cell is actually noise from its media.
a. b.
Figure 4.6 - Comparison of Raman spectra from
cells that are live or fixed. Live cell Raman
spectra (red; 10 second acquisition time) were
collected from cells suspended in PBS, whereas
fixed cells (blue; 60 second acquisition time)
were cultured directly onto CaF2 slides prior to
paraformaldehyde mediated cell fixation and
drying. a) Raw intensity data demonstrates that
despite the six-fold increased acquisition time
afforded to PFA treated cells, signal from this
cell is approximately four-fold weaker. b)
Normalised spectra of the data shown in a) for
examination in terms of spectral pattern. Spectra
are vertically transposed to permit comparison of
spectral pattern. There are clear similarities and
differences between the spectra, the most notable
being the exaggerated peak at approximately
1000cm-1 in the fixed cell format. Regardless,
Biochemical information can be acquired from
fixed cells.
a.
b.
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4.5 Intracellular considerations 
Preliminary data obtained from cells were collected using an arbitrary single point to be 
representative of that cell. Although this meant that the sample acquisition time for each cell 
was less than one minute or less (depending on the experiment), it would not be appropriate to 
presume that a fair comparison between cells could be performed with such data.  This is 
principally due to the fact that cells do not exist as a homogeneous collection of their 
biochemical components but instead exist as highly structured and compartmentalised entities. 
Therefore, it is quite plausible that such a comparison may be distinguishing between intra-
cellular components of the cells in question rather than being reflective of those cells’ 
biochemistry in general. For example, the arbitrary sampling of one cell may be acquiring 
biochemical data pertinent to the endoplasmic reticulum whereas the arbitrary sampling of 
another cell may be examining a mitochondrion.  
 
In response to anticipated intra-cell biochemical heterogeneity, two approaches to address this 
issue were developed. The first approach posited that a more appropriate comparison would be 
of specific organelles between each sample cell (Chapter 5). The alternative approach proposed 
that the average spectrum derived from the whole area over the cell would capture the range 
of intra-cellular biochemical variation within that cell. Thus the average Raman spectrum across 
that cell would be a suitable measure by which to compare different cells.  
 
The approach of capturing as much biochemical data from across the cell as possible was 
employed by systematically acquiring data across the cell in the pattern of a square grid, a 
process termed hyperspectral imaging. However, a compromise needed to be made between 
the spatial resolution of data acquired from across the cell and the analysis duration. In the initial 
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preliminary experiments described above, approximately sixty seconds per point were required 
which would be impractical to perform on a large number of points from an individual cell. 
Therefore, a study was conducted whereby the number of data acquisition points from a cell 
was altered in conjunction with the spectral acquisition time per point in order to establish a 
compromise between spatial resolution, signal intensity and time taken per sample (Figure 4.7; 
table 4.1). From this approach, it soon became apparent that the region identified as nuclear 
returned a much stronger signal than the surrounding cytoplasm. For the sake of brevity, the 
scope of these analyses changed to the collection of data from this region only; permitting 
improved spatial resolution from this region. Ultimately, a 2µm by 2µm grid with an acquisition 
time of ten seconds per point represented the compromise by which as much spatial 
information across the cell/nucleus could be acquired whilst maintaining a reasonable collection 
time of about 40 minutes to two hours per cell, which varied according to cell size and whether 
the cytoplasmic component was also included. A typical acquisition across a cell yields 
approximately 100-200 spectra of the cell’s nucleus, and a larger range of spectra for the cell’s 
cytoplasmic compartment. 
 
Table 4.1 - Examination of the spectral acquisition time required to analyse a square grid of 40μm by 
40μm according to differing acquisition times and spatial resolutions. 40μm by 40μm represents a typical 
grid size used for Raman spectral acquisition across a cell area, although of course the actual grid size 
varied according to cell analysed. Times given in the cells are presented in minutes.  The 2μm by 2μm 
spatial resolution was chosen as a practical compromise between spatial resolution and acquisition time. 
 
Acquisition 
Time per Point 
 
Spatial Resolution 
1μm by 1μm 2μm by 2μm 4μm by 4μm 5μm by 5μm 10μm by 10μm 
1s 
27 7 2 1 0.3 
10s 
267 67 16 11 3 
30s 
800 200 50 32 8 
60s 
1600 400 100 64 16 
120s 
3200 800 200 128 32 
 
Figure 4.7 – Compromise between
Acquisition time and Spatial Resoluation. A
study comparing Raman spectrum acquisition
time and spatial resolution, in order to
determine the optimal acquisition time vs grid
density. The top row represents a high spatial
resolution and low acquisition time, the
bottom row represents the lowest spatial
resolution and highest acquisition time per
point. Pixels are pseudocoloured according to
signal intensity relative to other spectra from
that same map. White/yellow is the highest
intensity and black is the lowest.
Spatial 
resolution
Acquisition
time (s)
1µm x 1µm 1
2µm x 2µm 10
4µm x 4µm 30
5µm x 5µm 60
10µm x 10µm 120
Pixel signal intensity
High
Low
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4.6 Antibody staining 
The capacity to couple Raman spectroscopy to other techniques used within the laboratory 
permits an increased scope in the range of questions that Raman could be used to address. 
Indirect immunofluorescence is one such technique that is used frequently to identify and sort 
for, by fluorescence activated cell sorting (FACS), particular cell populations of interest to the 
researcher. The capacity to acquire Raman data on these cells is another measure by which 
particular cell populations, determined by their marker expression, could be compared. It is 
important to consider then, that Raman spectroscopy is dependent on the rare proportion of 
photons that undergo the Raman effect; and that fluorescence is a much more frequent 
phenomenon. Fluorescent molecules that have excitation and emission wavelengths similar to 
the photons produced by the laser can cause significant and overwhelming background 
interference making Raman spectra almost impossible to interpret without significant alteration 
to spectral pre-processing (Figure 4.8). Therefore, it is important to ensure that any secondary 
antibodies used, or other fluorescent markers are appropriate for the laser used in the Raman 
analysis. The 532.32nm laser used in this system precluded the use of FITC, for example, as 
secondary antibody fluorophore but Cy5 (or Alexa 647) proved to present negligible background 
interference. Consequently, these antibodies were used in experiments that included both 
indirect immunofluorescence and Raman analysis. 
 
4.7 Matrigel 
Cultures of NTera2 and 2102EP EC cells grew readily on CaF2 slides. However, these represent 
particularly robust cell lines and readily attached. Cultures of ES cells did not attach with the 
same ease and, considering that some form of matrix is usually required for their growth and 
maintenance even on adherent cell culture plastics, an approach by which CaF2 slides were first 
treated with Matrigel was adopted. An examination of NTera2 cells that were cultured with or 
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without Matrigel revealed that there was no obvious background interference cause by the use 
of Matrigel and did not obscure the data collection, certainly not in the same manner as phenol 
red if at all (Figure 4.9). Therefore, Matrigel is a suitable substrate for use with ES cell lines 
cultured for Raman analysis on CaF2 and was the technique adopted here. In order to 
accommodate for any systematic effect of Matrigel treatment of cells on Raman spectral data, 
one should be careful to ensure that only cells treated with Matrigel are compared against each 
other in analysis. 
  
a.
b.
Figure 4.8 – Examining the effect of
fluorophore interference. a) and b) are of the
same spectra, however a) is the raw intensity
and b) shows the normalised spectra. The
green spectrum is contaminated with
fluorescence, generating a larger tail with
relatively larger intensities for larger
wavenumbers than the uncontaminated blue
spectrum. The effect of this fluorescence is
very clear in the normalised spectra, despite
their visual similarity when considering the
raw spectra.
Figure 4.9 – Matrigel Shows no Obvious Raman Background. A comparison of Raman spectra between NTera2 cells grown directly on CaF2 slides (blue)
or on CaF2 slides that were pre-treated with Matrigel. No obvious background effects were present such as that introduced by media containing phenol red.
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4.8 Data processing 
Once Raman spectra were collected, a number of post-processing steps were required to make 
data comparable for analysis. The “fingerprint” region, as it’s called, from Raman spectra on 
biological samples is present between wavenumbers 500 and 1800 (cm -1). Data from these 
regions specifically were extracted for use in further analysis. 
 
Since Raman is only a semi-quantifiable technique, direct comparison of intensities from one 
sample and another is inappropriate. Therefore, the data are then “zeroed” by which each 
spectrum’s intensities are linearly transposed so that its minimum intensity is equal to zero . 
Spectra are then normalised so that the area under the curve of each spectrum is equal to some 
constant (in this case, 1) so that the relative shape of the spectra may be compared. This 
approach removes problems associated with raw intensity values that may fluctuate according 
to environmental conditions at the time of collection such as temperature. 
 
The Raman microscope requires daily calibration which is achieved by testing against a silicone 
sample (wavenumber should be 520.2 cm-1). However, it is practically impossible to calibrate in 
such a way that the binning strategy for wavenumbers is identical between different days. As a 
result, comparison of data between different days requires further normalisation since the 
differing bin labels between days means that these would be viewed as separate, non-
overlapping variables in the context of multivariate analyses without some standardisation. 
Since the silicone calibration is the standard by which the Raman microscope was attuned each 
day, the main difference between bin labelling on different days was negligible and nominal 
rather than functional. Therefore, data from different days were coerced into the same 
wavenumber bin-labels based around the shared prominent, sharp peak at ~1003cm -1.  
 160 
 
Finally, with regards the spatial resolution data and the generation of other Raman maps, where 
spatial information is present, a method by which spectra from particular regions could be 
extracted from the rest of the dataset was necessary. This was achieved in a collaborative effort 
with the department of Automatic Control and Systems Engineering at the University of 
Sheffield where a tool was developed in MatLab (Mathworks inc.) for the precise extraction of 
spectra within spatial bounds that could be isolated as specified manually by the user (Biga, 
2014, unpublished; Section 1.10). In addition to comparison of intra-cellular regions, this tool 
could be applied to enable the examination of multiple cells from across a monolayer from the 
same Raman sample collection procedure. 
 
4.9 Data analysis 
The most frequently used test to determine whether there was a difference in Raman spectra 
from different cell types or intra-cellular region is by the use of an unsupervised multivariate 
clustering technique such as principal component analysis (PCA; See Materials and Methods). 
PCA is the most commonly used statistical tool for analysing spectral data. Spectra consist of 
many variables (wavenumbers), of which some contain variation that is pertinent to differences 
between samples, whereas variation in other variables reflects information that is not relevant 
to sampled spectra. PCA analysis acts to reduce the multitude of variables into a small number 
of linear combinations or, Principal components (PC). The goal of PCA analysis therefore, is to 
reduce the number of dimensions (variables) to a few PC that describe the main variation across 
the dataset. The application of PCA presents an unbiased examination of the spectra provided 
and aims to reduce the variation of the dataset down to a hypothetical integration of those 
variates that provide the greatest explanatory power for the differences seen between the 
samples. Although the calculation does not account for presupposed differences in the 
categories of the samples provided (e.g. nucleus or cytoplasm), the segregation of samples by 
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such a qualifier indicates a real difference between these categories. Finally, although the 
principal components upon which samples are plotted do not directly relate to any one variate, 
or in this case wavenumber, it is possible to identify the degree of contribution a variate has to 
those components by examination of the variable loadings on these PC. Therefore, the 
wavenumbers that are most responsible for any sample segregation that occurs according to 
principal components are identified and present themselves as probable candidates for the main 
biological differences between samples. 
 
4.10 Discussion 
Raman spectroscopy is a powerful tool for non-invasive cell analysis. Ultimately, we want to 
develop a platform by which to assay heterogeneity of live human ES cells in a way that allows 
further examination of future behaviour as a research or even medical diagnostic tool. Here, this 
work has demonstrated that Raman can be used for the examination of pluripotent stem cell 
profiles, and provides a basis by upon which to further develop this technique.  
 
This work has demonstrated technical considerations, such as the importance of Raman-inactive 
culture media and substrates on which to grow cells, differences in growth formats, fixation, 
acquisition time and appropriate fluorophores for antibody staining.  
 
Although live cell analysis clearly is the ideal, there are a number of factors which led to the use 
of a mainly fixed cell approach in this work. The Raman effect is particularly weak and requires 
long acquisition times that are not comparable to that of flow cytometry. This meant that cells 
were maintained in a monolayer format in order that they were immobile long enough to 
acquire the data. Early attempts to analyse cells in suspension were hampered by cells moving 
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away from the laser spot. However, it was noted that the acquisition time to gain comparable 
intensity counts to the monolayer format cells was much shorter. This is possibly a reflection of 
cell shape (i.e. the cell is spherical in suspension and flat in monolayer) and therefore should be 
considered as a superior format should lower acquisitions times become technically feasible, or 
if immobilisation with optical tweezers/microfluidics are an option. It should be noted that 
spatial resolution, i.e. the distinction between nucleus and cytoplasm is obfuscated in this 
approach, and so would be better suited for whole cell analysis than the spatial mapping of 
cellular processes.   
 
Practically, the Raman microscope used in this analysis did not have an aseptic environmentally 
controlled chamber and that lead to live cells becoming infected and dying during the day-long 
analysis period. Clearly this provided a separate, but related issue to the long acquisition times. 
That is, given the long acquisition times live cell analysis was not feasible with the technical setup 
available. As a result of this, a fixation approach was pursued.  
 
A fixation approach mitigates the chemical changes within dying/stressed cells that could 
present temporal artefactual changes within the data collected. Fixation approaches to Raman 
spectroscopy have been implemented before (Christoph Kraffta, 2005) Our results mirror that 
of other groups in that fixation causes a shift in the spectra collected. However, this change does 
not negate the use of fixed cell spectra, since fixed cells are reflective of heterogeneity at the 
point of fixation. Therefore, it remained rational to continue with fixed cells rather than 
introduce noise associated with cell stress, infection and death.  
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We analysed several different culturing conditions for monolayer-grown cells, including culture 
surface and culture media. It became readily apparent that plastic was highly Raman-active and 
obscured any cell-relevant data. Glass was less Raman active, and could be used, but 
interference was seen in the fingerprint region. This could be mitigated with careful post-
processing, but makes data interpretation more difficult. The best option tested was CaF 2 slides 
that are Raman-inactive. Additionally, NTera2 cells readily attach to this substrate, and appeared 
normal in line with reports from other groups (Notingher, 2002). Therefore, it was used 
throughout much of the data collection. CaF2 slides are expensive, so a cleaning protocol was 
developed so that slides could be reused (see methods). Additionally, cell grown on Matrigel 
were tested for Raman activity and spectra did not contain any obvious artefacts, as reported 
elsewhere (Schulze et al., 2010b). 
 
Standard culture media used in our lab (DMEM, 10% FCS) contains phenol red which proved to 
be highly Raman active, generating a broad band of fluorescence that obscured cell relevant 
data. Therefore, a switch was made to an alternative DMEM formulation that did not contain 
phenol red, and this indeed proved not to generate fluorescence that interfered with data 
collection. However, all media are themselves a combination of proteins and other metabolites 
that of course contribute to the Raman spectra. This effect is further complicated by the use of 
FCS that is not chemically defined and varies between batches. Therefore, Raman comparison 
of cells in media containing different batches of FCS could reflect this difference. Ideally, for live 
cell analysis cells would be immersed in chemically defined media during that does not contain 
phenol red during analysis. The use of chemically defined media would facilitate baseline Raman 
subtraction of this media. Our analysis merited the use of f ixed, rather than live cells that were 
not immersed in media during analysis. However, these cells were grown in phenol red 
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containing media. We demonstrated that the interference caused by phenol red could be 
removed from fixed cells by thorough washing with PBS.  
 
As already mentioned, cells in monolayer format took longer to analyse than cells in suspension, 
and also occupy a greater area in which clear cellular compartments are observed. This provides 
both an opportunity and a problem. This allows us to associate different sub-cellular regions 
with different Raman spectra associated with their biochemical profile. Conversely, the problem 
is that given that the cell is compartmentalised, from where can representative spectra of the 
cell be acquired? For the purposes of examining intercellular heterogeneity, the acquisition of 
spectra representative of individual cells is required. Therefore, a hyperspectral imaging 
approach was used here, in which a grid defined on the microscope over the cell is analysed 
acquiring one spectra per point. After the spectra are acquired an average spectrum 
representative of the cell is calculated. This approach is heavily time consuming and can take 
between 40-180 minutes per cell, which is in line with the work of other groups (Krafft et al., 
2006; Matthaus et al., 2006). One way of overcoming this issue is to utilise equipment where a 
larger laser spot size is generated (Notingher, 2002). This approach reduces the acquisition time 
required for the collection of Raman spectra from a cell of interest, but at the cost of spatial 
resolution. Regardless, this technology was not available for this work (Figure 4.10). The 
hyperspectral imaging approach revealed that the region identified as the nucleus generated 
the largest signal, and was therefore used in later analyses (chapter 5). The reason for this 
increased signal relative to the rest of the cell could be reflective of either extra out-of-plane 
light, or a higher biochemical density resulting in more scattering. One issue that could be 
associated with the low signal intensity is that the excitation laser became gradually misaligned 
over the course of this project; therefore it may be technically possible to have shorter 
acquisition times with this setup.  
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The development of Raman spectroscopy for the examination of cellular behaviour is a non-
trivial task and is still under development in laboratories across the world. With the equipment 
to hand, this fixed cell, hyperspectral imaging approach to Raman spectroscopy provides a 
robust, albeit time-consuming method by which to interrogate the biochemistry of these cells. 
The development of this method does not reveal whether Raman spectroscopy can be used for 
the examination of cells in different, cryptic, substates; which is the substance of Chapter 5. This 
method was developed iteratively over the course of this thesis and so many of the experiments 
performed in Chapter 5 do not in fact employ this final methodology as these questions were 
addressed concurrently. 
  
Figure 4.10 – Sacrificing Spatial Resolution for Improved Acquisition Time. From Stevens and Swain, 2007. A comparison of Raman spectroscopy
carried out with a small spot size, A) or a large spot size, B). In this example, in A) a 1um by 1um laser spot was moved in 1um increments across the
sample, collecting thousands of spectra. The approach with a larger laser spot shown in B) uses a 10um to 20 um spot that requires very few spectra to
map the cell, which much reduces the sampling time.
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Chapter 5 
 
 
Application of Raman Spectroscopy to 
Pluripotent cell heterogeneity 
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5.1 Introduction 
 
Optical microscopy has long proven itself invaluable to biomedical research. White light 
microscopy can be utilised to examine refractive indexes of cells and tissues, but it can only be 
used for thin sample sections or cell monolayers and does not yield information on sample 
biochemistry. Fluorescence imaging has also demonstrated itself as a revolutionary technique 
that enables enquiries into biochemical molecular behaviour that were previously intractable. 
Fluorescence imaging is not without its drawbacks such as sample modification in order to 
introduce the fluorescent molecule, interference of an antibody-bound fluorophore with the 
normal action of the tagged molecule and issues of photo bleaching that limit observation times 
and long term studies. Furthermore, in the case of long term studies, the degradation rates of 
fluorescent molecules, particularly for protein or mRNA tags, results in residual fluorescence 
after the tagged molecule has degraded and no longer relevant. 
 
Raman spectroscopy is a non-invasive, label free technique for the analysis of chemical samples 
by the vibrational excitement of molecular bonds and has had some application already in the 
pluripotent stem cell field. Most studies using Raman on ES cells have been examining 
differences between undifferentiated ES cells and their differentiated progeny, whether 
directed or not. These studies have pulled out differences between undifferentiated and 
differentiated cell types according to Raman spectrum. A study examining CA1 hESCs and their 
undirected differentiated progeny after three weeks demonstrated that Raman spectrum 
differences between these populations predominantly correspond to nucleic acids (both DNA 
and RNA) and protein associated wavenumbers with lipids and carbohydrates also playing a role 
(Schulze et al., 2010a). An alternative study examining differences in Raman spectra between 
the HES2 human ES cell line and their differentiated progeny that had been directed to a 
cardiomyocyte fate also found the two cell types could be distinguished, with the human ES cells 
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displaying Raman spectra that contained peaks associated with DNA/RNA at a higher intensity 
than the cardiomyocytes (Chan et al., 2009a). The association of Raman bands corresponding to 
DNA/RNA molecules and the undifferentiated state of pluripotent cells is a common theme, and 
has been applied to examine the differentiation of mouse ES cell lines in comparison to their 
differentiating progeny as early as four days into differentiation (Notingher et al., 2004a). 
Coherent anti-Stokes Raman spectroscopy has also been used to demonstrate a detectable 
increase in protein:RNA ratio of differentiated cells compared to their undifferentiated parent 
at 3.5 days post directed differentiation (Konorov et al., 2007). These experiments provide 
promising evidence that Raman spectroscopy could have useful application in the identification 
of differentiated cells, but has not been used to examine how early differences between 
differentiating cells and their pluripotent parent can be seen. Indeed, no investigation to date 
has tried to determine the earliest time at which difference can be detected.  
 
All of the above examples demonstrate that there are measurable differences with respect to 
biochemical cellular composition during the process of differentiation, however this is a 
relatively large phenotypic change experienced by cells in comparison to the stem cell substate 
hypothesis. Cells occupying different substates are anticipated to have differing phenotypic 
characteristics that inform lineage bias, however what these are remains unknown. Raman 
spectroscopy offers a unique tool for interrogating this heterogeneity in a non-invasive manner, 
and given that cells occupy substates in a cryptic manner, the sensitivity of Raman to this 
question needed to be addressed. In this thesis therefore, the capacity for Raman to distinguish 
between varying degrees of inter and intra cellular heterogeneity was tested. 
 
The sensitivity of Raman spectroscopy to cellular heterogeneity was tested in four different 
ways. Firstly, the capacity to distinguish between different cell lines was tested using two 
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embryonic carcinoma cell lines and two human ES cell lines, one of which is culture adapted 
subline of the other in which an altered karyotype is associated with enhanced growth 
characteristics (Enver et al., 2005b). As demonstrated in other reports (Harkness et al., 2012), it 
was here anticipated that Raman spectroscopy would be able to distinguish between these cell 
lines and even the culture adapted variant from its “normal” counterpart. Here, an initial study 
was outsourced to the Raman spectroscopy company “Renishaw” (Renishaw plc, See Section 
2.6) for analysis and is the subject of Section 5.2; “Different Cell Types.” All other Raman 
spectroscopy experiments were performed using the setup described in Chapter 2 and a similar 
comparison between mouse Embryonic Fibroblasts (MEFs) and two other human ES cell lines 
was also made. Secondly, the effect of differentiation on pluripotent cell lines has been 
examined using Raman as described above, however all published studies are comparing cells 
that have been differentiating for some time (usually weeks) against the undifferentiated cells 
(Chan et al., 2009b; Notingher et al., 2004b). Consequently, the question of whether Raman 
spectroscopy is sensitive enough to detect early biochemical changes associated with 
differentiation was addressed in this thesis and addressed here by several differentiation studies 
using the pluripotent EC line NTera2. Thirdly, the capacity of Raman to recognise differences 
within cells was explored here with a comparison between spectra obtained from the nucleus 
and cytoplasmic regions of NTera2 cells. Indeed, it was anticipated that Raman would detect 
differences between these regions given that they perform different functions and in particular 
it is expected that the Nucleus region will contain a greater compliment of DNA related Raman 
bands.  
 
Finally, the association of Raman profile with particular pluripotent cell populations was 
addressed in three different ways. The pluripotent cell surface marker SSEA3 was utilised to sort 
NTera2 population, with Raman spectroscopy performed on different fractions of  NTera2 
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according to SSEA3 expression. The human ES cell reporter lines, Shef4 GATA6 and Hes3 MIXL1, 
were also examined (Materials and Methods). Both of these cell lines are currently under 
examination for expressions of lineage biases in other experiments within the laboratory, and 
there is strong indication that lineage biases correlate with fractions defined by the expression 
of their respective reporter and SSEA3 (Mr. Dylan Stavish, personal communication; Dr. Thomas 
Alison, Personal Communication, Thesis). The Gata6 and MIXL1 transcription factors are lineage 
transcription factors for Endoderm and Mesoderm respectively. Therefore, these markers have 
been used in conjunction with markers for pluripotency (such as SSEA3) to examine subtle 
lineage biases within the Stem cell compartment (Mr. Dylan Stavish, Dr. Thomas Alison; Personal 
Communication). Given differences in lineage biases exhibited by cells within these populations 
the question of whether these differences were reflected in the biochemistry of these cells was 
asked by analysis of the Raman profiles. 
 
The development of an optimal methodology for acquiring Raman spectroscopy given available 
equipment is the subject of Chapter 4 however this was a lengthy and iterative process before 
a final approach was adopted. As a consequence, many of the questions asked in this chapter, 
which were addressed in parallel to the development of an optimal method, use slightly 
different data collection procedures to that finally described in Chapter 4 and where relevant 
these differences are stated. 
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5.2 Results 
 
Different cell types 
One of the first differences we tested was whether different cell lines displayed differences in 
their Raman spectra and this experiment was outsourced to Renishaw PLC, a company that 
specialises in Raman spectroscopy. All subsequent experiments (Sections 5.3 onwards) were 
performed using the Raman microscope described in Materials and Methods. The cell lines 
H14.BJ1, H14.s9, 2102EP and NTera2 were used. Cell lines were cultured on CaF2 slides for 5 
days prior to PFA fixation. Fixed cultures were dried (described in materials and methods) before 
transportation to Renishaw for analysis (performed by Dr. Katherine Lau; Section 1.10). A total 
of 5,200 spectra were collected with between 1-2,000 spectra collected over multiple cells per 
cell line.  
 
A PCA analysis of the Raman spectra displays that the different cell types are readily 
distinguishable (Section 2.9; Figure 5.1a). H14BJ1 and NTera2 cell lines are clearly discriminated 
according to principal component one whereas H14S9 and n2102EP are separated according to 
principal component two. The two H14 cell lines do overlap slightly and of the cell groupings, 
they are the most similar. An examination of the average Raman spectra from the analysis 
reveals that the average NTera2 Raman spectrum is very dissimilar from the other spectra and 
this difference is reflected in the first principal component (Figure 5.1b). The second principal 
component is primarily responsible for separating the other three cell lines. Note that principal 
components are specific to each PCA performed and principal components are not relevant to 
other datasets or PCA analyses. 
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Raman spectroscopy distinguishes between embryonic stem and embryonic carcinoma cell 
lines. The H14BJ1 cell line is a culture adapted variant of the H14 cell line whereas the H14S9 
cell line is a karyotypically normal variant. H14BJ1’s adaptation to culture has resulted in a 
reduced rate of spontaneous differentiation and altered differentiation dynamics. NTera2 and 
the 2102 cell lines are both EC cell lines, however the 2102 EP cell line is a nullipotent EC cell 
line, which does not differentiate in xenograft tumours nor in culture unless seeded at 
particularly low densities. Principal component two therefore appears to separate cell lines 
according to their differentiation potential. An examination of the wavenumber loadings 
positive for PC2 indicates that wavenumbers associated with proteins and amino acids, whereas 
wavenumbers negative for PC2 are predominantly associated with glucose and lipids (Table 5.1). 
 
Table 5.1 – Wavenumbers Relating to Differences Between EC and ES Cell lines. Examination of 
wavenumber loadings for Principal Component 2 (PC2) of cell lines sent to Renishaw and molecules  
associated with highlighted wavenumbers  (e.g. Figure 4.1). Cell lines positive according to PC2 tend to 
have spectra associated with proteins and amino acids, whereas cells negative fo r PC2 tend to be associated 
with glucose and lipid molecules. 
PC2 
positive 
Candidate molecule(s)  PC2 
negative 
Candidate molecule(s) 
954 Hydroxyproline  846 Glucose 
1004 Phenylalanine  870 Proline 
1034 Phenylalanine  939 C-C-N stretch (peptide) 
1125 Glucose, C-N protein  1062 Lipid skeletal C-C stretch 
1234 Amide III, beta sheet  1264 Amide Iii and =C-H lipid, 
glucose 
1338 Tryptophan  1295 CH2 lipid 
1574 Amide II, guanine, adenine, 
Tryptophan 
 1437 CH2 lipid 
1667 Amide I beta sheet  1656 Amide I disordered/ 
collagen, C=C unsaturated 
fat 
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Figure 5.1 – Raman Spectroscopy Distinguishes Between Cell Lines. Four different cell lines were cultured on CaF2 slides prior to fixation and analysis by
Raman spectroscopy outsourced to Renishaw. Cell lines include two human embryonic carcinoma cell lines ; pluripotent NTera2 and the nullipotent n2102 EP
cell lines. The other two cell lines were embryonic stem cell lines; H14.S9 and the karyotypically abnormal, culture adapted variant, H14.BJ1. a) PCA analysis
performed on Raman spectra gathered for this analysis demonstrated clear separation between cell lines. b) Average Raman spectra collected from the cell lines;
average spectra are comparable with the exception of the NTera2 spectrum which is markedly different from the others.
a b
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5.3 Retinoic acid differentiation 
From here onwards, all Raman microscopy was performed using the in-house microscope and 
multivariate analyses performed using Simca 14 (Umetrics) as described in the Materials and 
Methods. An initial experiment examining the change of Raman spectrum of cells in response to 
a differentiation protocol was conducted and was performed prior to the final optimised method 
of Raman spectrum collection described in Chapter 4.  Cells that had been grown on culture 
plastic and then treated with all-trans Retinoic acid (RA), or a culture media control were 
cultured for five days in these conditions, including a full media change (including re-dosing with 
RA) after three days. On the day of the Raman Spectroscopy analysis, cells were harvested using 
trypsin, and washed with FACS buffer three times to remove any residual retinoic acid in 
solution. The cells were then transported for Raman Analysis at ambient temperature. 
Immediately before analysis, aliquots of cells were resuspended in PBS then transferred onto 
CaF2 slides. Ten cells from each treatment (exposed to RA or not) were analysed by Raman 
Spectroscopy collecting one spectra from an arbitrary intracellular location within each cell for 
sixty seconds with unfiltered laser power (examples in Figure 5.2a). Additionally, spectra of PBS 
containing trans-retinoic acid was also collected (Figure 5.2a; green Raman spectrum). PCA 
analysis here was performed using Multivariate statistical package (MSVP version 3.1, Kovach 
computing services). PCA analysis on the post-normalised spectra reveals that the treated and 
untreated cell populations segregate by Raman spectra, and that this is not explained purely by 
the chemical signature of Retinoic Acid. The Raman bands primarily responsible for this 
difference were Guanine (669-687 cm-1), Adenine (711-722 cm-1) and unsaturated lipids (1654-
1660 cm-1). This preliminary finding warranted further investigation. It was determined that the 
acquisition time required to analyse cells in suspension was too long for sustained analysis.   
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We determined that cells cultured on a monolayer were more suitable for analysis than cells in 
suspension (as described in chapter 4). Therefore, the second experiment to analyse the effects 
of RA was performed on cells grown on CaF2 slides directly. This time, the experiment was 
replicated three times; with six separate cell cultures where three were treated with RA and 
three were not. For each RA exposed replicate, 10 cells were analysed (30 cells total), whereas 
the three replicate cultures that were not exposed to RA had 15, 10 and 13 cells analysed by 
Raman spectroscopy. Analysis was performed combining data from all three replicates together 
(Figure 5.3) and separately by replicate (Figure 5.4) and again cells separated according to 
treatment as demonstrated by PCA analysis, primarily separating by the third principal 
component. Figures 5.3a and 5.4 display the average Raman spectra of RA treated and control 
cells with each average spectrum flanked by one standard deviation of the relevant sample.  
 
An examination of the wavenumber loadings for PC3 for those wavenumbers primarily 
responsible for the separation of RA treated and control cells shows that wave numbers 
corresponding to proteins and to some extent lipids associate with RA-treated cells, whereas 
control cells tend to be associated with wavenumbers corresponding to nucleic acids primarily 
(Figure 5.3, Table 5.2). This trend is also corroborated by the comparison between RA treated 
and control cells when separated by replicate (Figure 5.4). Each replicate was separately 
analysed by PCA analysis and in each case, the third principal component could act to 
discriminate between the treatments. Further examination of the third principal component 
loadings indicates that the wavenumbers responsible for the separation are similar in each 
separate PCA analysis (Figure 5.4). The relatively low standard deviations, as well as consistency 
in wavenumbers responsible for treatment separation indicate that Raman spectroscopy is able 
to distinguish reproducibly between these treatments. 
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Given the separation shown by PCA analysis a predictive model using a supervised clustering 
method, Partial Least Squares (PLS), was generated using replicates 1 and 2 of the dataset to 
train the model that also showed separation according to treatment (See Materials and 
Methods). This model also successfully categorised the remaining data points that were from 
the third replicate into the correct treatment class (Figure 5.5b).  
 
The fact that Raman Spectroscopy appeared to discriminate between cells that were and were 
not exposed to RA after five days testified to the sensitivity of this technique, and justified a 
more iterative approach to determine the earliest time point at which a difference could be 
distinguished by this technique. 
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Figure 5.2 – Initial Retinoic Acid Differentiation and
Raman Analysis. Raman analysis performed on NTera2
cells in suspension with a comparison of NTera2 cells
that have or have not been exposed to a retinoic acid
differentiation assay. Cells exposed to retinoic acid
produced Raman spectra that were different to their
undifferentiated counterparts and this difference was
demonstrated by PCA analysis.
a
b
Figure 5.3 – Differences in Raman Spectrum
caused by Retinoic Acid Differentiation.
Comparison of NTera2 cells that have (blue) or
have not (green) been exposed to a retinoic acid
differentiation assay for 7 days in culture. a)
Average Raman spectra (dark lines) gathered
across all cells separated by treatment (green, not
exposed to RA; blue, Exposed to RA). Pale lines
show the Standard deviation about the mean. The
x-axis is the wavenumber (cm-1) and the y-axis is
the spectral intensity in arbitrary units. The
graphs have been vertically offset (green+0.1
arbitrary units) from each other to enable visual
comparison. b) PCA analysis of these data
displaying principal components one and three.
Sample separation in PCA analysis primarily
according to principal component (PC) three. c)
An examination of the wavenumber loadings on
PC three reveals candidate organic groups
responsible for the separation along PC three
(see table 5.2). This comparison describes the
relative weighting each wavenumber has with
regard sample separation according to PC three.
A sample that tends to have relatively high
values for wavenumbers with a positive loading
in PC3 will be plotted more positively on the
PC3 axis (b) and vice versa for wavenumbers
with a negative loading on PC3.
Protein
Phenylalanine
Cytosine, Uracil
Amide I
Nucleic Acids
1092-1104 1208-1232
Amide I
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Figure 5.4 – Differences in Raman Spectrum caused by Retinoic Acid differentiation across three replicate experiments. Each experiment examined the Raman spectra from NTera2
cells that had been treated with RA (blue) for five days compared to control cells that were left untreated (green). The average Raman spectrum for each treatment and replicate is
displayed (dark lines), and bounded by ± 1 standard deviation (pale lines). The average spectra are vertically offset from each other in order to facilitate visual comparison (green+0.1
arbitrary units). Principal component analyses of the individual replicates demonstrates that there does tend to be a separation between the treatments, each showing a degree of
separation along principal component (PC) three. An examination of the wavenumber coefficient loadings for PC three in each replicate shows a similar pattern with each other and
Fig5.3c indicating similar biochemical causes for sample separation by PCA.
Average Raman Spectra PCA Principal Component 3 Loadings
Rep 1:
Control 
n=15
RA treated
n=10
Rep 2:
Control 
n=10
RA treated
n=10
Rep 3:
Control 
n=13
RA treated
n=10
Observed Members Correct Control RA
Control 25 100% 25 0
RA 20 100% 0 20
Test 23 13 10
Total 68 100% 38 30
Fishers 
prob.
3.2x10-13
a
b
Figure 5.5 – Predictive Model Classification of cells
into Differentiating or Undifferentiated Phenotype. A
supervised partial least squares model was constructed
to test whether the difference between the RA treated
and undifferentiated samples had predictive capacity
(Figure 5.3). a) 45 spectra of the 68 available were used
to train the model and their separation is clear. b) The
remaining 23 spectra (10 RA treated; 13 control) that
were not used to train the model are plotted according
the model fitted using the other 45 spectra and show
extremely similar separation as to that shown by the
training data in a). The model was then tasked with
classification of the 23 spectra not used for training the
model which it did so with a 100% success rate (table).
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Table 5.2 – Wavenumbers Related to Differences Between Undifferentiated and RA Mediated 
Differentiating Cells. Examination of wavenumber loadings for Principal component 3 (PC3) of PCA 
plot for NTera2 cells that have or have not been exposed to retinoic acid (RA) differentiation. Cells  
positive for PC3 tend to be RA differentiated cells, whereas cells negative for PC3 are generally the 
undifferentiated control. Wavenumbers loadings for PC3 reveal that RA treated cells tend to have 
Raman spectra that have a higher compliment of proteins and amino acids whereas the undifferentiated 
cells tend to have Raman spectra associated with Nucleic acids. “?” Refers to a band that is prominent 
for separation but is not associated with a known molecule/group. 
PC3 positive Candidate Molecule(s)  PC3 negative Candidate Molecule(s) 
1587 Protein  1486 Nucleic Acids 
1156 C-C, C-O ring breathe  1490 Nucleic Acids 
1435 Protein  1488 Nucleic Acids 
1657 Amide I  783 Cytosine, Uracil 
1654 Amide I  1373 Thymine, adenine, guanine 
1742 C=O ester  1346 Thymine, adenine, guanine, 
tryptophan 
676 Guanine  1344 Thymine, adenine, guanine, 
tryptophan 
967 ?  1681 Amide I 
1074 Carbohydrates  1003 Phenylalanine 
1007 Phenylalanine, 
substituted benzene 
derivatives 
 1208 Tyrosine, phenylalanine, 
protein, amide III 
1120 Unsaturated Fatty acids  1232 Amide III random, Lipids 
1268 Lipids/Amide III  1092 ? 
1195 ?  729 Adenine ring stretch 
712 ?  
  
1297 Amide III  
  
870 C-O-C glycosidic link/ CC 
stretch 
 
  
744 O-P-O/ Tyrosine  
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5.4 Retinoic Acid Differentiation Time course 
We then performed a RA time-course differentiation experiment in order to determine the 
earliest time point at which Raman Spectroscopy could distinguish between treated and 
untreated cell populations. Cells were cultured in culture dishes containing a CaF2 slide, with or 
without Retinoic Acid. At the timepoint the cultures were to be analysed, the slides were 
removed from their respective media and placed into a separate petri dish then rinsed and 
stored in FACS buffer for transportation. Remaining cells in the original petri-dish were 
harvested for flow cytometric analysis and did not show any obvious morphological difference 
to cells cultured on CaF2. Cultures on CaF2 slides were rinsed three times with PBS immediately 
before Raman analysis where one spectrum was collected from an arbitrary intracellular 
location per cell with an acquisition time of 60 seconds at 100% laser power. The three-hour 
timepoint was the earliest time in order to permit sufficient time for cells to attach after seeding. 
A total of five timepoints were included in this experiment (3, 24, 48, 72 and 144 hrs post RA 
exposure), with 50 replicate cells analysed per treatment per timepoint (500 cells total). 
 
To determine whether cells were responding to the retinoic acid treatment, antibody profiles of 
pluripotency and differentiation markers were analysed concomitantly by flow cytometry. An 
examination of the antibody profiles of the cell cultures shows that the retinoic acid treated cells 
are noticeably reduced in SSEA3 expression after 48 hours of treatment, and Tra-1-60s 
expression is reduced after 6 days of culture (Figure 5.6). The control cells have reduced SSEA3 
expression by 6 days of culture, but Tra-1-60s was only mildly reduced by the end of the analysis 
period (9 days). SSEA1 expression does not show a great increase in either culture, however the 
RA treated cells seem to show a relatively larger increase than the untreated.  
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PCA analyses of the Raman Spectra between control and RA treated cells at each respective 
timepoint show signs of clustering as early as three hours post-treatment (Figure 5.7). PCA 
analyses were conducted separately between the spectra collected at each time point, thus the 
analysis only examines differences between the cells collected at each timepoint independent 
of the other time points.  Figure 5.7 displays the results of these separate PCA analyses and in 
each case, principal components one and two are shown. Generally, as the time course proceeds 
the more obvious the clustering, with the exception of the 72-hour timepoint, regardless of 
principal component examined. The average Raman spectrum for each treatment is also 
displayed in Figure 5.7 with all spectra offset from each other to allow a visual comparison ( a 
greater offset is displayed to distinguish between timepoints). 
  
A PCA analysis was also carried out to compare RA treated cells at each timepoint against the 3-
hour control timepoint since it could be argued that the earliest control timepoint is most 
representative of the original cell biochemistry (Figure 5.8). To perform this analysis, the control 
treatment cells from the three hour timepoint was compared against the RA treated cells at 
each timepoint, with each comparison analysed separately and independently by PCA. Figure 
5.8 displays the results of these independent analyses, displaying principal components one and 
two in each case. At each timepoint cells tend to cluster along the first principal component. The 
three-hour and seventy two-hour Retinoic acid timepoints also seem to show some 
discrimination along the second principal component. That being said, these two timepoints also 
show the most overlap between control and RA treated cells. 
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Figure 5.6 – Cell surface antigen Expression
Changes During Retinoic Acid (RA)
Differentiation Time-course Assay. Cell surface
antigen expression of sister NTera2 cells from a
Retinoic Acid (RA) mediated differentiation time-
course assay in terms of the percentage of the
population positive for these antigens, baselined
against a P3X negative control . Control cells were
not exposed to RA. The Markers for pluripotency,
SSEA3 and Tra-1-60s downregulate in the RA
treated cells faster than in the control cell line, with
almost no cells being positive for SSEA3 3 days
post RA exposure. The cell surface marker
SSEA1which is associated with human pluripotent
cell differentiation does not show much of an
increase in the retinoic acid treated cells, but does
not increase at all in the control cells.
3 hoursRA vs. 3hoursCtrl
72 hoursRA vs. 72hoursCtrl
24 hoursRA vs. 24hoursCtrl 48 hoursRA vs. 48hoursCtrl
144 hoursRA vs. 144hoursCtrl
Figure 5.7 – PCA analyses performed on Raman spectra collected from NTera2 cells undergoing an RA mediated differentiation time course assay. Five
separate PCA analyses are shown, each comparing 100 cells (50 treated with RA, blue; 50 untreated, green) after different RA exposure times. Samples are
plotted against principal components one and two from each PCA analysis. RA exposed cells (blue) and untreated cells (green) appear to differ in most PCA
analyses, excepting the 72hr timepoint and this sample separation appears as soon as 3hrs post RA induction. In addition, the average spectra of cells at each
timepoint, and by treatment, are also displayed.
3 hrs
24 hrs
48 hrs
72 hrs
144 hrs
Wavenumber (cm-1)
3hoursRA vs. 3hoursCtrl 24hoursRA vs. 3hoursCtrl 48hoursRA vs. 3hoursCtrl
72hoursRA vs. 3hoursCtrl 144hoursRA vs.
3hoursCtrl
Figure 5.8 – PCA analyses performed on Raman
spectra collected from NTera2 cells undergoing an
RA mediated differentiation time course assay. Five
separate PCA analyses are shown, each comparing
100 cells (50 treated with RA, blue; 50 untreated,
green) after different RA exposure times. In this case,
all untreated cells used in the PCA analyses are the
same 50 from the 3hr timepoint since they are
representative of cell population from the start of the
experiment. Samples are plotted against principal
components one and two from each PCA analysis.
RA exposed cells (blue) and untreated cells (green)
appear to differ in most PCA analyses and this
sample separation appears as soon as 3hrs post RA
induction.
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5.5 Intracellular heterogeneity 
As described in Chapter 4, intracellular variation could explain differences seen by PCA analysis 
in previous experiments where data were collected from arbitrary points within analysed cells 
and thus left intracellular variation unaccounted. Therefore, an experiment was conducted to 
examine whether subcellular regions were discriminated by Raman spectroscopy. Visual 
inspection on the Raman microscope revealed three readily identifiable regions within most 
NTera2 cells examined. Each cell exhibited its total perimeter whose area was primarily pale, 
within which a darker but sizable ovate would be present. This distinction was the easiest to 
make and this led to the inference that this dark ovate was the cell’s nucleus and everything 
outside it, but within the cell’s perimeter represented the cell’s cytoplasmic component. Within 
the Nucleus smaller, pale ellipsoids with a “raised” appearance would often be present and were 
in turn inferred to represent nucleoli within the nucleus (Figure 5.9a). Although these regions 
were identified as cytoplasmic, nuclear and nucleolar in nature, this was not formally confirmed. 
 
Following identification, a comparison between these regions was performed by collecting five 
arbitrary points for each region from multiple cells of the same NTera2 population (Figure 5.9b). 
In total, 645 spectra were collected of which 409 were collected from the Nucleus, 129 from 
Nucleoli and 37 from Cytoplasmic regions. Spectra from these regions were normalised and the 
average spectra are displayed in Figure 5.9c&d. It is clear from the averaged spectra that spectra 
collected from cytoplasmic regions were considerably different to that of both the average 
spectra for the Nucleus and Nucleolus regions.  
 
A PCA analysis examining the spectra from these regions reveals that there was not much 
difference in general between the Nucleus and Nucleolus categories, whereas the majority of 
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Cytoplasm spectra were not in that same shared cluster (Figure 5.10a). All Cytoplasm spectra 
were positive for principal component one (Figure 510a), which also seemed to be the main 
discriminant. Most Nuclei spectra were negative for principal component one (Figure 5.10a). 
The Wavenumber loadings for principal component one reveal that known Raman bands 
associated with cytoplasm tend to be associated with protein and phenylalanine although there 
are many unknown bands (Figure 5.10b). Raman bands that cytoplasmic spectra clustered away 
from were generally associated with nucleic acids, although there are also bands associate with 
lipids, Amide I groups and C-H2 (Table 5.3).  
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Table 5.3 – Wavenumbers relating to differences between cell cytoplasm and Nucleus . Cytoplasm 
Spectra were primarily positive for PC1 in the PCA analysis (Figure 5.10) whereas spectra from the 
Nucleus tended to be negative for PC1. “?” Refers to a band that is prominent for separation but is not 
associated with a known molecule/group  
Not Cytoplasm 
(PC1 Negative) 
Candidate Molecule(s) cytoplasm Candidate Molecule(s) 
1241 Thymine, Cytosine, 
adenine ring v 
1722+ Marker 
1269 Lipids 1555 ? 
849 Buried Tyrosine 1598 ? 
1336 Adenine, Guanine, 
tyrosine, Tryptophan 
1601 Protein 
829 Exposed Tyrosine/DNA 1599 Phenylalanine 
928 ? 1506 Protein 
1103 >PO2- Stretch 1497 Adenine? 
956 ? 622 ? 
725 Adenine 1001 Phenylalanine 
780 Cytosine, Uracil 1000 Phenylalanine 
1464 C-H2  1034 Carbohydrates, mainly 
C-C- skeletal, C-O 
1664 Amide I 1185 ? 
1444 C-H2 1154 C-C stretch 
 
  
Figure 5.9 - Intracellular points Raman
acquisition. Examples of examination of
differing Raman spectra from identifiable
intracellular regions. Data were collected
according to a.) Different regions
classified based upon morphology were;
nucleolus (x), Nucleus (y) and cytoplasm
(z). b.) Five Raman spectra were taken
from each cell with an acquisition time of
60 seconds (full power laser). c.)
Average spectra coloured according to
classification. Data were collected from
115 cells; with 5 data points each;
representing nucleolar (n=129), nuclear
(n=409) and cytoplasmic (n=37) regions.
d.) Average Raman spectra graphs are
offset vertically for comparison.
x
y
z
a b
c dCytoplasm
Nucleus
Nucleolus
Cytoplasm
Nucleus
Nucleolus
Nucleolus
Nucleus
Cytoplasm
Figure 5.10 – PCA Analysis on Intracellular Raman Data. PCA analysis performed on the intracellular points
acquisition experiment (figure 5.8). a) Data were collected according to different regions classified based upon
morphology were; nucleolus (green, n=129), Nucleus (blue, n=409) and cytoplasm (red, n=39). The
Cytoplasmic spectra cluster away from the nucleus and nucleolus spectra according to principal component 1.
b) Wavenumber loadings for principal component 1.
a b
Wavenumber (cm-1)
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5.6 Substates 
NTera2 cells were stained for SSEA3 using the MC631-2C2 primary antibody and FITC secondary 
antibody, and then sorted according to intensity by flow cytometry (as described in Materials 
and Methods). The resulting negative, medium and high fractions were then plated onto CaF2 
slides and allowed to attach. An unstained/unsorted control was also plated. Three hours after 
plating the cell cultures were fixed and subsequently analysed by Raman microscopy. Five 
spectra per cell were acquired, all from the nuclear region and analysed by PCA (n=1378 total 
spectra, Figure 5.11b). A total of 276 cells were examined in this manner across all treatments, 
of which 89 cells were sorted from the high fraction (n=444 spectra) , 40 cells from the medium 
fraction (n=200 spectra), 88 cells from the negative fraction (n=440 spectra) and 59 cells from 
the unstained/unsorted treatment (n=294 spectra). All cells were acquired from one FACS 
experiment. 
 
Although high, medium and negative fractions have a degree of overlap, it is clear that the 
groupings are not identical (Figure 5.11b). The high fraction especially separates from the other 
fractions, due to being especially negative for PC1 (Figure 5.11b). The unstained/unsorted 
fraction lies opposite to the high fraction, being positive for PC1 (Figure 5.11b). The negative and 
medium fractions also appear to lie along this gradient, although the negative fraction appears 
slightly more positive for PC1 than the medium fraction (Figure 5.11b).  
 
The loadings for PC1 show that the major difference between samples positive for PC1 is broadly 
due to spectral intensity at wavenumbers within the first two thirds of the fingerprint region, 
from approximately 550 to 1400 cm-1, whereas samples negative from PC1 are due to relatively 
higher intensities at wavenumbers 1400 to 1800cm -1 (Figure 5.11c). Indeed, this pattern is 
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reflected in the average Raman spectra from each fraction, where the fractions that expressed 
more SSEA3 tend to have an increased proportion of intensity in the latter half of the spectra 
(Figure 5.11a). 
 
It was surprising that the unstained/unsorted fraction, that should have represented unsorted 
heterogeneity bias, did not present spectra across the entire range, especially that of the high 
fraction spectra (Figure 5.11b). In conjunction with the sample gradient along PC1 that 
correlates with SSEA3 intensity it appears that the main differences are most likely attributable 
to residual FITC fluorescence.  
 
Given the presumed interference of FITC fluorescence to these spectra a baseline correction 
algorithm was employed to try and mitigate the effects of this fluorophore using the LabSpec 
Raman analysis platform (Horiba). The resulting average Raman spectra for each fraction is 
displayed in Figure 5.12b. The previously described effects of the fluorescence baseline (Figure 
4.8) seemed to have been removed by visual inspection and the spectra appear more similar to 
each other than the spectra that were not baseline corrected (Figure 5.11b). Again these spectra 
show a separation pattern by PCA, although this time according to PC2 and PC3 (Figure 5.12a). 
However, as with the previous analysis the groupings correlate with the SSEA3 gradient from 
unstained/unsorted to high (Figure 5.12a). That said, the loads for PC2 and PC3 responsible for 
the separation (Figure 5.12c and d) do so according to a different pattern to each other and 
respectively to PC1 for the non -baseline corrected spectra (Figure 5.11c).  
  
Figure 5.11 – SSEA3 Heterogeneity Explored Using Raman
Spectroscopy. Raman spectroscopy experiment designed to
examine potential differences in NTera2 cells that have been
sorted according to SSEA3 expression. a) shows the average
Raman spectra for the unstained/unsorted (red), negative
(yellow), medium (blue) and high (green). b) PCA analysis
of all collected spectra from these cell types (n=1378). Cells
appear to separate in a gradient along PC1. The wavenumber
loadings for PC1 are displayed in c) (See materials and
methods).
a b
c
Wavenumber (cm-1)
Wavenumber (cm-1)
ab
c
d
Figure 5.12 – Advanced Pre-
Processing for the Raman Analysis
of SSEA3 based Heterogeneity. This
is the same experiment as in figure
5.10, however spectra have
undergone additional pre-processing
in order to remove baseline effects
associated with fluorescence. a)
shows PCA analysis performed on
transformed data, and this shows a
separation along PC2 and PC3 in
conjunction. b) Average spectra for
the fractions following the additional
pre-processing. c) Wavenumber
loadings for PC2, d) Wavenumber
loadings for PC3.
Wavenumber (cm-1)
Wavenumber (cm-1)
Wavenumber (cm-1)
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5.7 Lineage Reporter Human ES Cell Lines 
Previous work in the lab has shown that the Shef4 GATA6 and Hes3 MIXL1 reporter cell lines 
appear to show lineage bias within the stem cell compartment (personal communication with 
Dr. Thomas Allison and Mr. Dylan Stavish respectively). Further to this, in order to test whether 
the Raman spectroscopy hyperspectral imaging technique developed in chapter 4 was able to 
distinguish between different cell lines, Raman spectra collected from these cells were 
compared against each-other and against mouse embryonic fibroblast cells. All cell lines were 
seeded on Matrigel coated CaF2 slides and allowed to attach overnight before they were fixed 
with PFA as described in the materials and methods. All the Raman data acquired from cells 
sorted by FACS were collected from one culture vessel each of the relevant sorted fraction and 
the mouse embryonic fibroblasts (MEFs) analysed were all from one culture also. 
 
First, both hES cell reporter lines and mouse embryonic fibroblasts were analysed by 
hyperspectral Raman imaging. A 2D PCA plot reveals that there is some degree of clustering 
primarily along PC1 (Figure 5.13). This seems to delineate between MEF and ES cells, whereas 
PC3 seems to separate the ES cell lines. The clustering is very close; however, it appears that 
there are differences between these cell lines that Raman can detect. These PCA analyses, unlike 
others presented previously, were performed in MATLAB (Mathworks inc.). In this analysis, each 
point on the PCA plot is representative of the average spectra from the nucleus of each cell,  
each comprising of around 50 to 350 spectra. More specifically, there are average nuclear 
spectra calculated for; 21 MEF cells (between 29 and 321 spectra collected per nucleus), 38 
Shef4 GATA6 cells (between 36 and 365 spectra collected per nucleus), and 25 Hes3 MIXL1 cells 
(between 43 and 215 spectra collected per nucleus). The comparison of Raman spectra from the 
two reporter cell lines are the data collected from the sorted cell fractions examined in more 
detail below; i.e. all Shef4 GATA6 and Hes3 MIXL1 data regardless of marker expression. 
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We took advantage of the opportunity afforded by the reporter cell lines to sort cell populations 
into different categories based upon dual analysis of their marker and SSEA3 to see if there were 
differences between cells based upon these categories that may indicate state differences. Cells 
were labelled for SSEA3 with the MC631-2C2 and a DyLight 647 secondary antibody and cells 
positive for SSEA3 were sorted into MIXL1 positive or negative fractions by virtue of MIXL1-GFP 
expression before plating onto Matrigel coated CaF2 slides as per materials and methods. Cells 
were allowed to attach overnight prior to PFA fixation and subsequent Raman analysis. Raman 
spectra were collected from both fractions; SSEA3+/MIXL1-negative (12 nuclei; 49 to 175 spectra 
per nucleus) and SSEA3+/MIXL1-postive (13 nuclei; 43 to 215 spectra per nucleus).  PCA analysis 
of the resulting spectra shows that although the two populations do not entirely separate, the 
SSEA3+MIXL1-negative population appears to cluster more tightly, and is generally excluded 
from the PC3 negative domain. 
 
A similar experiment was conducted using a different reporter cell line, Shef4 GATA6. Cells were 
labelled for SSEA3 with the MC631-2C2 and a 647 secondary antibody and cells positive for 
SSEA3 were sorted four ways into SSEA3+/GATA6-High, SSEA3+/GATA6-Low, SSEA3+/GATA6-
negative and SSEA3-negative/GATA6-positive fractions. Again, cells were plated onto Matrigel 
coated CaF2 slides, allowed to attach overnight and PFA fixed as per materials and methods.  
Raman spectra were collected from cells of these fractions; SSEA3+/GATA6-High positive (13 
nuclei; 36 to 189 spectra per nucleus), SSEA3+/GATA6-Low (8 nuclei; 62 to 173 spectra per 
nucleus), SSEA3+/GATA6-negative (10 nuclei; 48 to 365 spectra per nucleus) and SSEA3-
negative/GATA6- (7 nuclei; 67 to 131 spectra per nucleus). PCA analysis on Raman spectra 
collected from these fractions reveal that the SSEA3-negative/GATA6-positive fraction separates 
out from the other spectra most readily according to as negative for PC2. On the other hand, 
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the SSEA3-postive/ GATA6-negative fraction groups in the PC2 positive domain. Most other cells, 
representing the SSEA3+/GATA6-High and SSEA3+/GATA6-Low fractions lie in a band between 
the 0.5 and -0.5 value for PCA2. The SSEA3+/GATA6-High fraction has the greatest degree of 
spread of any of the fractions, with cells lying both very negative and very positive for PC2.  
 
  
Figure 5.13 – A Hyperspectral imaging comparison between Raman spectra collected from multiple different cell lines. Spectra were acquired using a
hyperspectral approach, where each point represents the average of between approximately 50 -350 spectra collected from within an individual cell. Cell lines
examined were mouse embryonic fibroblasts (MEFs, yellow, n=21), and two human embryonic stem cell lines, shef4 Gata6 (green, n=38) and Hes3 MIXL1
(pink, n=25). Two PCA plots are shown showing a comparison between PC1 and PC3 as well as a 3D plot examining PC1, PC2 and PC3. Cell lines begin to
cluster according to species along PC1 and the two different human ES cell lines appear to differ according to PC3.
aFigure 5.14 – Mesoderm Lineage Reporter MIXL1 and Raman spectroscopy. To examine whether Raman Spectroscopy could distinguish between cells based
upon associations with lineage markers in the pluripotent stem cell state, Hes3 MIXL1 cells underwent a dual sort for SSEA3 and MIXL1. a) shows the FACS
plot by which cells were sorted. Cells from regions P5 and P7 were sorted and plated on CaF2 slides, allowed to attach and then fixed for subsequent
hyperspectral Raman imaging. Raman analysis was performed on one culture each of sorted cells, MIXL1+SSEA3+ (green, n=12 nuclei) and MIXL1-SSEA3+
(blue, n=13 nuclei). Each point on the PCA plots b) and c) represents the average of between 43 and 215 spectra obtained from the nucleus of an individual cell.
PCA analysis shows that there are slight differences between the cell classifications with the SSEA3-positive MIXL1-negative fraction being generally positive
for PC3 and vice-versa for the SSEA3-positive MIXL1-positive cells. There is no obvious separation associated with either PC1 or PC2.
b c
Figure 5.15 – Endoderm Lineage Reporter Gata6 and Raman Spectroscopy. To examine whether Raman Spectroscopy could distinguish between cells based
upon associations with lineage markers in the pluripotent stem cell state, Shef4 GATA6 cells underwent a dual sort for SSEA3 and GATA6. a) shows the FACS
plot by which cells were sorted. Cells from regions R3, R4, R5 and R6 were sorted and plated on CaF2 slides, allowed to attach and then fixed for subsequent
hyperspectral Raman imaging. Raman analysis was performed on one culture each of sorted cells, SSEA3+GATA6- (red, n=10 nuclei), SSEA3+GATA6lo (dark
blue, n=8 nuclei), SSEA3+GATA6hi (green, n=13 nuclei) and SSEA3-GATA6+ (light blue, n=7 nuclei). Each point on the PCA plots b) and c) represents the
average of between 36 and 365 spectra obtained from the nucleus of an individual cell. Cell clustering seemed to occur primarily along PC2 for the SSEA3-
negative GATA6-positive, SSEA3-positive GATA6 low and SSEA3-positive GATA6-negative fractions. The SSEA3-positive GATA6-high fraction did not
associate with any one particular region along PC2, and could be found associated with all other fractions.
a b
c
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5.8 Discussion 
Here the sensitivity of Raman Spectroscopy to detect different cell types was explored with four 
different conceptual approaches, representing varying degrees of heterogeneity within and 
between cells. This examination of heterogeneity by Raman spectroscopy occurred in 
concurrence with the development of the final, optimal method described in Chapter 4 and thus 
the methods employed changed over the course of this Chapter.  
 
The first conceptual approach was the examination of differences in cell lines, which was 
addressed in two different experiments. The first experiment, which was outsourced to 
Renishaw, revealed that Raman Spectroscopy spectra could distinguish between different cell 
lines (Figure 5.1). NTera2 grouped furthest away from the other samples according to PC1, 
although this is most likely due to artefacts in its spectra not shared by the spectra of other cell 
lines (Figure 5.1a). Therefore, it appears that PC1 explains most of the variation caused by these 
artefacts. This spectrum also looks notably different from other NTera2 spectra collected from 
other experiments. The remaining cell lines all separated by PC2, irrespective of PC1, so an 
examination of wavenumber loadings responsible for PC2 was carried out. The differences in 
PC2 therefore likely reflects biochemical differences between these cell populations. Although 
it is impossible to rule out the contribution of artefacts from NTera2 spectra, NTera2 is relatively 
neutral for PC2 so it is likely not to be primarily responsible for the separation of cell lines along 
this component. Wavenumbers that had the greatest weighting in PC2 tended to associate with 
proteins/amino acids when positive and glucose and lipids when negative. This association 
implies that the culture-adapted nullipotent embryonic carcinoma cell line N2102 EP is relatively 
more protein rich and lipid-poor than the normal human ES cell line H14.S9.  
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The two human ES cell lines H14.BJ1 and H14.S9 represent culture adapted and karyotypically 
normal variants of the H14 cell line respectively. These cell lines were grouped closer together 
than the other cells lines, however, they could still be distinguished. The main difference again 
lies along PC2 where the H14.S9 Raman spectra have a greater complement of lipid and glucose-
associated peaks. This is not the first study to have examined human ES cells and their 
karyotypically abnormal variants. For example, Raman analysis of the normal cell line Hues9 and 
a karyotypically abnormal variant of Hues9 (47,XX,+20) show that the abnormal variant had 
greater peak intensities for wavenumbers corresponding to cytochrome C, and to a lesser extent 
increased nucleotide, protein and lipid associated wavenumbers (Harkness et al., 2012). The 
results here do not exactly mirror that found by Harkness, et al., and this could be for a few 
reasons. Differences in culture technique, for instance, could be responsible such as batch 
variation in the sera used between our experiments and Harkness et al. In addition, other factors 
such as cellular confluency and differentiation status of the cultures examined remain 
uncontrolled variables between these experiments. However, these results could reflect real 
biochemical differences between unrelated culture adapted cell lines, whereby the biochemical 
phenotypic manifestation of culture adaptation in these systems are metabolically different. 
This interpretation presents the idea that culture adapted cell lines may achieve adaptation 
entering different, stable biochemical states. Furthermore, the addition of N2102EP in this 
analysis may obscure specific differences between H14.S9 and H14.BJ1 that would be otherwise 
elucidated along PC2. Although it is the case that these Human ES cell lines differ along PC2, this 
is really a function of greater difference between N2102EP and H14.S9. Thus, the difference 
between the EC cell line and the ES cell line H14.S9 in PC2 explains a greater proportion of 
variation in the dataset than between the two human ES cell lines, where the difference 
between these two ES cell lines specifically could be more powerfully explained by the same 
biochemical markers highlighted by Harkness et al.  
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In our experiment, thousands of spectra were collected from each cell line, across multiple cells  
and collectively these replicate spectra led to the conclusions discussed above. That said, these 
data were collected from one sample of cultured, and then fixed, cells for each cell line without 
further experimental replication. It is therefore formally possible that the differences observed 
could be the result of differences reflective of these particular samples rather than as a complete 
biological representation of these cell lines. One of the major limitations with this approach is 
that although many spectra are generated, this is across a comparatively small number of cells 
(~10) per cell line. Therefore, these handful of cells are extremely well characterised by Raman 
spectroscopy, however it begs the question as to whether this small number of cells is a fair 
representation of the rest of their cell line, or even their respective sister cells in culture (See 
Section 5.9).  Further sampling with this methodology, across multiple cultures would be 
required to make the claim certain that Raman spectroscopy was discriminating between 
inherent differences in the cell line rather than some aspect of sampling error.  
 
Raman spectra collected using the hyperspectral imaging technique developed in chapter 4 was 
also capable of distinguishing between different cell lines (Figure 5.13). In this case the cell lines 
used were mouse embryonic fibroblasts (MEFs) and two human ES cell lines Shef4 GATA6 and 
Hes3 MIXL1. The technique developed here could indeed demonstrate differences between 
these cell lines with PC1 primarily responsible for separation of cell line by species, and PC2 
began to separate the two human ES cells from each other. These results are encouraging 
however, the separation is not as clear cut as other papers have reported for differences 
between somatic and pluripotent cell phenotypes. 
 
The sensitivity of Raman was also tested in the context of Retinoic Acid (RA) mediated 
differentiation of the pluripotent human EC cell line NTera2. Indeed, preliminary data on live 
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Ntera2 cells examined in suspension presented differences after 5 days of exposure to RA (n=10 
for both treated and control cell types) (Figure 5.2). These differences were associated with 
differences in nucleic acids, protein and unsaturated lipids. These encouraging results warranted 
further investigation, however, the suspension format of the initial experiment presented its 
own problems (see chapter 4). Therefore, a modified version of the experiment was performed 
using cells grown in a monolayer format on CaF2 slides and PFA fixed prior to Raman analysis 
(Figure 5.3, 5.4). Three experimental replicates were conducted for these data, where six sister 
culture vessels of NTera2 cells were analysed (three exposed to RA and three acting as control 
samples) (Figure 5.4). When these replicates were independently analysed by PCA, they 
demonstrated similar separation each coincidentally by PC3, and indeed the wavenumbers 
associated with PC3 separation were similar for all replicates (Figure 5.4) . This experiment also 
demonstrated that differences in Raman spectra between differentiated and undifferentiated 
could be detected using Raman microscopy and that the main differences were primarily due to 
increased protein levels in the differentiating cells, and increased nucleic acid levels in the 
undifferentiated cells (Figure 5.3), which is concordant with other studies examining 
differentiation with Raman spectroscopy over similar timescales (Notingher et al., 2004a). A 
predictive model from our data using a supervised clustering analysis was generated that could 
accurately predict whether cells that were not used for training the model had been treated or 
not with RA (Figure 5.5).  
 
A time-course RA differentiation assay was performed in order to assess how early during the 
process of differentiation Raman spectroscopy could distinguish between treated and untreated 
cells. Concomitant FACS analyses of sister cells confirmed that cultures treated with retinoic acid 
lost SSEA3 and Tra-1-60s faster than untreated cultures, and thus interpreted to be losing 
pluripotency and undergoing differentiation (Figure 5.6). Raman analyses of these cultures 
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generated spectra that showed signs of separation as early as three hours into the time-course 
assay according to PCA analysis, representing a method that is more sensitive to the induction 
of differentiation than traditional FACS analyses of markers sensitive to pluripotency such as 
SSEA3. PCA analyses of treated cells against their untreated counterparts at each timepoint 
show the greatest separation at the 2day and 6 day timepoints, whereas there appears little 
separation after three days (Figure 5.7).  
 
Since it is the case that the untreated cells will also be changing over the time course, it is 
debatable as to how representative these cells are of the undifferentiated state as time 
progresses. This is evidenced by a change, albeit much more slowly, in the untreated cultures. 
Therefore, it could be argued that the earliest untreated timepoint is the most representative 
of the undifferentiated state. Indeed, PCA analyses of differentiating cells against this initial 
untreated timepoint show greater separation than even at the treated 3 day timepoint samples, 
which did not show great separation when compared against the 3 day untreated timepoint  
(Figure 5.8). However, a comparison of the mean spectra even at 6 days (144 hours) RA treated 
cells do not show the same differences in their spectra as in the previous retinoic acid 
differentiation experiment. 
 
The reason for the difference between experiments was unclear and the similar mean spectra 
of the time course experiment was a puzzle. This experiment took considerably longer to collect 
data from live cells, in the order of about 4 hours per timepoint, during which time cells were 
not maintained in normal culture conditions. At the time of examination, cells were maintained 
in PBS only in order to exclude artefacts from contaminates such as foetal calf serum. This is a 
considerable period of time, over which cells will become progressively more stressed. The 
similar mean spectra could be a function of biochemistry associated with stress that may 
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supersede differences resulting from differentiation. However, that in itself does not explain 
why the populations separate according to PCA analysis and this separation could be due to tiny 
differences associated with the differentiation of the cell as a real biological phenomenon. 
Alternatively, an artefact of spectra pre-processing could be responsible. Both of these 
explanations could adequately account for PCA separation from populations whose main 
spectra appear very similar. Further investigation into this effect is warranted, especially if this 
effect is due to problems with pre-processing which would need addressed. There is no reason 
to presume that there are problems with the pre-processing approach adopted, and that has 
been used elsewhere, therefore its appears that Raman spectroscopy can distinguish between 
cells as early as three hours into a differentiation protocol, although repeats of this experiment 
would be required before this could be stated with utmost confidence.  
 
Independent of the issues discussed above, only one single spectrum was acquired from each 
cell examined. The cells were grown in a monolayer format that means the point acquisition 
represents only a small area of the total cell size. Cells are not homogenous and so it would be 
premature to assume that only one spectrum is truly representative of the biochemical state of 
that entire cell. Therefore, anew experiment was designed in order to examine different regions 
within the cell, identified as the nucleus, nucleolus and cytoplasm was performed, in part to 
address whether this Raman system could detect differences between these regions as 
demonstrated in other studies.  Additionally, cells used for these comparisons were fixed in 
order to reduce artefacts associated with cell stress. PCA analysis revealed Raman could 
distinguish between cytoplasmic regions from the nucleus and nucleolus along PC1, whereas the 
difference between nucleus and nucleolus was not clear. The spectra of the nucleolus grouped 
within the broader grouping of nucleus, suggesting that these regions are less varied. The reason 
for this difference along PC1 seemed primarily associated with phenylalanine and protein as 
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positive for PC1 and associated with the cytoplasm whereas DNA/RNA nucleotides were the 
most prominent group negative for PC1. Spectra from the nucleus and nucleolar regions were 
mostly negative for PC1 and this association with nucleotides was anticipated. Also responsible 
for separation along PC1 were several highly weighted bands with unknown association. Not 
every biomolecule, nor their combinatorial effects, have been analysed for their Raman profile, 
and so these regions could be reflective of this. Alternatively, this could reflect a noisy dataset, 
which considering the low number of cytoplasm samples analysed, cannot be excluded as a 
possibility. These data were acquired from monolayer cultures of NTera2 cells which were 
generally dense in appearance, with a high nucleus:cytoplasm ratio. This made accurate 
selection of cytoplasmic regions difficult to achieve. Repeating this experiment using cells in a 
lower density may help to address this issue.  
 
Given that heterogeneity between cytoplasm and nuclear regions was established here and 
elsewhere (Notingher et al, 2002) point spectra analyses of cell nuclei were adopted in an initial 
study looking at SSEA3-based heterogeneity in NTera2. Although the PCA analyses of cells sorted 
for SSEA3 did reveal a difference between fractions, in the main it appeared that the separation 
appeared to correlate with SSEA3 intensity with the unstained/unsorted population lying 
directly opposed to the high fraction. Since the unstained/unsorted fraction should contain cells 
from all other fractions, this difference appears to be due to the effect of the staining itself. 
Indeed, this difference was most likely caused by fluorescence of the fluorophore where there 
was still residual fluorophore despite multiple washes as part of PFA fixation prior to analysis. 
That said, not all high fraction cells exhibited obvious fluorescent background, indicating that 
fluorescence could be from an alternative source not associated with the staining or the cell 
wash steps successfully removed residual fluorophore unevenly from the populations. The final 
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explanation is of inaccurate sort; however this is unlikely given experience with back-gating (see 
Chapter 3; Figure3.14).  
 
Regardless of the source of the background interference, a polynomial baseline correction 
method was utilised prior to regular spectral normalisation. This correction method applies a 
polynomial baseline correction that is calculated for each individual spectrum.  The resulting 
average spectra no longer exhibited the increasing baseline tail associated with fluorescence, 
however, the PCA analysis again seemed to show correlation with SSEA3 intensity with the high 
and unstained/unsorted fractions lying opposite each other. In this case it appears that the 
baseline correction method employed was not able to eradicate the artefactual effect of the 
SSEA3 stain and associated fluorophore. Therefore, further antibody studies will require the 
selection of a fluorophore whose excitation and emission spectra do not interfere. 
Consequently, further antibody studies used Dylight 647 fluorophores that were predicted not 
to interfere with the Raman spectroscopy.  
 
An alternative approach to addressing the problems associated with intracellular heterogeneity 
was adopted by using hyperspectral imaging. This technique collects many spectra per cell that 
can also be coupled to spatial information across the sample/cell (see chapter 4). A method by 
which spectra specific to spatial regions of interest could be extracted from datafiiles was 
developed in Matlab in collaboration with Dr. Veronica Biga. This tool was used to compare 
many average spectra from across the nucleus from multiple cells with regard to the MEF, Shef4-
GATA6 and Hes3-MIXL1 cell lines.  
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Analyses using hyperspectral profiling are incredibly time consuming, taking up to several hours 
to analyse individual cells. As a result, analysis on a cell by cell basis is performed using many 
spectra that are descriptive of few cells. This approach probably provides the most 
comprehensive description of the biochemistry within the nucleus and therefore is arguably the 
most representative of that cells’ nuclear state. For the examination of stem cell heterogeneity 
this approach was adopted and a comparison of different states of the Sef4-GATA6 and Hes3-
MIXl1 cell lines was made according to marker expression. In the case of Shef4-GATA6 there 
appeared definite grouping effects according to marker expression with the SSEA3-positive 
GATA6-high fraction capable of association with any of the other fractions including the 
differentiated SSEA3-negative GATA6-positive cells as a well as the ‘pristine’ SSEA3-postive 
GATA6-negative population. Similarly, there appear to be differences in the SSEA3 positive Hes3-
MIXL1 populations according to MIXL1 expression. These results indicate that Raman 
spectroscopy seems capable of detecting differences in nucleus biochemistry of cells, depending 
upon the expression of particular lineage markers.  
 
5.9 Replication and Sampling 
 
Several experiments have been described over the course of this chapter, including the 
collection of thousands of spectra. A common theme through all of the experiments is a 
comparatively low number of cells analysed by Raman spectroscopy. The largest number of cells 
analysed from any of these experiments was the NTera2 retinoic acid differentiation assay that 
analysed 500 cells across all timepoints and treatments (Table 5.4). In this case, 50 cells were 
analysed by Raman spectroscopy per timepoint for each treatment, meaning that these ten total 
cell cultures are each represented in this data by 50 cells each. Each Cell culture may easily 
contain many millions of cells and it is unlikely that the Raman spectra of tens or even a few 
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hundred cells accurately represents this sample. This is an alternative form of the question 
regarding the best way of gathering Raman spectra that represents the cell of interest except 
extended to ask about the number of cells needed to represent its culture. 
 
As part of developing the Raman spectroscopy technique, it was decided that it would be better 
to capture more information from across the cell in the form of hyperspectral mapping of the 
nucleus since it would provide a better means of comparison between different cells as opposed 
to arbitrary point location (discussed further in Chapters 4 and 6). Hyperspectral mapping by 
Raman spectroscopy is the more time consuming process since it requires the acquisition of 
more spectra per cell. The consequence of this was a reduction in the number of cells analysed 
per experiment. This is also reflected in the low number of experimental replicates; acquisition 
of hyperspectral Raman data could take weeks per condition. Given the problem that 
hyperspectral imaging is time intensive and that a tiny proportion of cells in the culture can be 
analysed for any experiment, the approach adopted to provide better sampling across the whole 
population was to collect more data from an individual replicate that could provide better 
sampling across the whole population rather than a reduced sampling proportion across more 
samples.  
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Table 5.4 – Replication Details for experiments in Chapter 5. The number of cells  and spectra used for 
each experiment, coupled with information on the pertinent figures and experimental replication. 
Abbreviations: G6, GATA6; Hi, High; lo, low; M, MIXL1; MEF, Mouse Embryonic Fibroblasts; Md, 
Medium; RA, Retinoic acid; S3, SSEA3; -ve, negative. “?” symbolises that these data were not collected 
by cell number, but over an area of the dish. 
Experiment Results Figures No of cells 
No of spectra 
collected 
Experimental 
replicates 
Cell Line 
differences 
5.1 ? 
1,000-2,000 /cell line 
Total: 5,200 
1 
Retinoic Acid 
differentiation I 
5.2 
10 per treatment 
Total: 20 
1 per cell 
Total: 20 
1 
Retinoic Acid 
differentiation II 
5.3, 5.4, 5.5 
RA treated: 
(10,10,10) by rep 
Control: 
(15,10,13) by rep 
Total: 68 
1 per cell 
Total: 68 
3 
Retinoic Acid 
differentiation 
time course 
5.6, 5.7, 5.8 
50 cells per 
condition per 
timepoint 
Total: 500 cells 
1 per cell 
500 total 
1 
Intracellular 
heterogeneity 
5.9, 5.10 
Nucleus: 115  
Nucleolus: 100 
Cytoplasm: 12 
Total: 115 
Nucleus: 409 
Nucleolus: 129 
Cytoplasm: 39 
Total: 645 
1 
Substates I 
NTera2/SSEA3 
5.11, 5.12 
Hi: 89 
Md: 40 
-ve: 88 
UU: 59 
Total: 276 
Hi: 444 
Md: 200 
-ve: 440 
UU: 294 
Total: 1378 
1 
Substates II 
Reporter 
line/MEF 
5.13 
MEF: 21 
Hes3 MIXL1: 25 
Shef4 GATA6: 38 
Total: 84 
Approx. per nucleus: 
MEF: 29-321 
(~3,000 Total) 
Hes3 MIXL1: 43-215 
(~3,750 Total) 
Shef4 GATA6: 36-365 
(~5,500) 
Total: ~12,250 
1 
Substates III Hes3 
MIXL1 
5.14 
S3+M-: 13 
S3+M+: 12 
Total: 25 
Approx. per nucleus: 
S3+M-: 49-175 
(~2,000 Total) 
S3+M+: 43-215 
(~1,750 Total) 
Total: ~3,750 
1 
Substates IV 
Shef4 GATA6 
5.15 
S3+G6-: 10 
S3+G6lo: 8 
S3+G6hi: 13 
S3-G6+: 7 
Total: 38 
Approx. per nucleus: 
S3+G6-: 48-365 
(~1,500) 
S3+G6lo: 62-173 
(~1,200) 
S3+G6hi: 36-189 
(~1,800) 
S3-G6+: 67-131 
(~1,000) 
Total: ~5,500 
1 
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Where experimental replication did occur, during one of the earlier Retinoic acid differentiation 
experiments (Table 5.4, Figures 5.3, 5.4), the replicate experiments all produced quite similar 
results. The average spectra shared similar patterns and the graphed standard deviation across 
normalised data indicates that the standard deviation rarely exceeds 10% of the mean. Although 
it is expected that different cells may be performing different biochemical functions that would 
be reflected in differences in Raman spectra, the fact that the variance is low supports the idea 
that Raman spectroscopy is collecting accurate data from the cells. Retinoic acid treated cells 
did tend to separate by PCA from their control counterparts, and the wavenumbers associated 
with this separation appeared quite similar by examination of the third principal component 
loadings. Furthermore, the spectra from the first two replicates, when modelled by Partial least 
squares (PLS) regression were then able to accurately predict which treatment novel spectra 
(those from the third replicate) belonged to. Finally, it is worth describing that although these 
replicates were cultured separately, they were all daughter cells of a shared ancestral flask. In 
this sense they represent a pseudoreplication of the experiment, although this is an unavoidable 
consequence of working with a clonal cell line. 
 
Finally, the nature of replication is one often confounded by the use of cell line-based 
experiments. It is clear for one thing that omniscience with regard to any particular cell line still 
provides no form of biological replication, which necessitates the examination of behaviours 
from independent biological entities. For example, absolute knowledge about the behaviour of 
one single person is not a reliable basis for knowledge on the behaviour of people since the 
subject could easily be an outlier. In order to understand the behaviour of people with regard a 
particular behaviour, study of multiple independent people would be required to accurately 
identify a trend. 
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Cell lines present themselves as a problem in this regard. Although there may be much to learn 
about the behaviour of an individual cell line, no amount of experimentation could confirm that 
the behaviour of that cell line is representative of all cell lines derived in the same manner. Such 
a confirmation requires experimentation on independently derived cell lines. That said, a robust 
knowledge of a cell line’s behaviour has its own merit, such as understanding that of substate 
heterogeneity as a paradigm already identified in NTera2 with respect to SSEA3 expression.  
Indeed, this work was conducted in order to develop Raman spectroscopy as a viable tool for 
interrogating cell behaviour and in order to practically facilitate this task, the behaviours of 
select few cell lines were examined by this system. Raman spectroscopy could be used as a 
holistic interrogator of cell behaviour between cell lines in order to draw more general biological 
trends. Here, the question was over whether Raman spectroscopy was sensitive enough to 
examine substate heterogeneities and so was developed to examine the paradigm as seen in 
the context of NTera2 and the reporter cell lines Shef4 GATA6 and Hes3 MIXL1. This approach 
could indeed be applied to other contexts; however, this would not have been practical within 
the scope of this Thesis. 
 
Altogether this work demonstrates that Raman spectroscopy is a viable tool for examining 
cellular behaviour that is particularly sensitive to experimental design. Nevertheless, these 
proof-of-concept experiments highlight the potential of Raman spectroscopy. These experiment 
have perhaps demonstrated the earliest known timepoints at which changes associated with 
cellular differentiation can be detected, and also possibly demonstrated detectable biochemical 
associations of lineage bias within the stem cell compartment. Excitingly, this provides a non-
invasive platform that can be further developed to elucidate more clearly the role of subtle 
biochemical variation in addressing questions of stem cell fate.  
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Chapter 6 
 
 
Discussion 
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6.1 Summary of aims 
The aim of this project was to develop new approaches for understanding the cryptic 
heterogeneity of cells within the pluripotent stem cell compartment that belies stem cell fate 
decisions. Understanding of the rules governing stem cell heterogeneity opens up opportunities 
to manipulate these features for the improved application of differentiation protocols or even 
regular cell culture maintenance. 
 
To address this, two approaches were developed in the scope of this thesis. One approach 
examined the population dynamics of pluripotent stem cells whilst within the stem cell 
compartment (chapter3). Delineating the rules by which cells change their behaviours over time 
provides a unique insight into cellular behaviour and the location of potential substate positions 
that can be determined by examination of a particular marker’s expression within an axis of 
variation.  
 
The alternative approach adopted was the exploitation of Raman spectroscopy in order to 
examine cryptic stem cell heterogeneity in terms of their biochemical phenotype or 
“fingerprint.” Given that a cell’s function and phenotype is ultimately governed by biochemical 
reactions that occur within the cell, along with all associated variations, it is not unreasonable 
to anticipate that a cell’s behaviour is intrinsically linked to its metabolic state. The advantage 
of Raman spectroscopy is that it is a non-invasive technique that exploits the physical properties 
of photon/molecule interactions which means that in principal no sample preparation is 
required to acquire this information. Indeed, it is possible to collect data from live cells in real 
time that can then be examined to ascertain future behaviour. The capacity to simultaneously 
acquire metabolomic data non-invasively as well as examine a cell’s future behaviour is a novel 
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prospect in the field of stem cell biology since cell destruction is not necessitated. Therefore, 
this approach if implemented to its full potential, should be a revolutionary technique in the 
analysis of single cell behaviour, where metabolomic similarity no longer need be inferred by 
proxy between living and destroyed cells used for metabolomic analysis. 
 
6.2 Summary of Results 
Two novel methods for the interrogation of cryptic aspects of pluripotent stem cell 
heterogeneity have been described, developed and implemented in this thesis. In Chapter 3,  the 
first method adopted successfully managed to model SSEA3 dynamics within the model 
pluripotent Embryonic Carcinoma (EC) cell line, NTera2. The model generated described the 
heterogeneity dynamics of SSEA3 expression in NTera2 pluripotent stem cells and in a predictive 
manner. The resulting model also provided candidate identifiers of substate locations according 
to the SSEA3 axis of variation. 
 
The second approach developed was the application of Raman spectroscopy for the assessment 
of varying degrees of heterogeneity within the stem cell context. Chapter 4 is a description of 
the ongoing iterative optimisation of the Raman Spectroscopy technique. These studies showed 
that a hyperspectral approach proved sensitive for information-rich holistic examination of cell 
biochemistry. Additionally, this study identified that the signal intensity from the nucleus was 
stronger than that of the cytoplasm, narrowing the target for further studies. Chapter 5 utilised 
the Raman Spectroscopy techniques to attempt to answer biological questions. Raman 
Spectroscopy proved sensitive enough to notice differences between the cell lines Ntera2, 
N2102EP, the human ES cell line H14.S9 and the karyotypically abnormal variant of that line, 
H14.BJ1. Separately, mouse embryonic fibroblasts (MEFs) and the human embryonic reporter 
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lines Shef GATA6 and Hes3 MIXL1 were able to be primarily separated by species and secondarily 
by cell line. The differentiation of Ntera2 cells by exposure to Retinoic Acid (RA) was analysed. 
Clear differences were seen between cultures that were and were not treated with RA in both 
suspension and monolayer formats. Additionally, differences appeared to be detectable as early 
as three hours post RA exposure. Raman Spectroscopy appears to be able to differentiate 
between nucleus/nucleolus and cytoplasm. Additionally, spectra from the nucleolus appear to 
vary less than spectra from the whole nucleus, identifying a potential less noisy target for further 
studies.  
 
These studies with both of these techniques represent the cornerstone for further development, 
the full realisation of which could prove revolutionary for stem cell research and future medical 
applications.  
 
6.3 Further experiments 
 
This thesis describes an ongoing and iterative body of work that has been continuously tested 
and refined as it progressed. Thus, the results presented here are still undergoing analysis and 
refinement, and are subject to further studies presented below. Technical considerations are 
also discussed, as a tailored and refined Raman microscope built to facilitate biological samples 
would extend the range of questions that could be addressed.  
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6.4 Heterogeneity modelling 
The modelling of cryptic aspects of pluripotent stem cell heterogeneity though SSEA3 dynamics 
has been successful. However, the major limitation of this approach is the large number of cells 
required for this flow cytometry based approach, and this makes it impractical for use with 
human ES cells. Currently an in situ method using the InCell analyser platform is in development, 
and this has the potential to drastically reduce cell number required and this could make this 
technique applicable for stem cell applications. Presently, analysis of SSEA3 staining does not 
reveal the same heterogeneous expression of SSEA3 in cultured cells as revealed by flow 
cytometry. However, more rigorous image post-processing could be developed to reveal 
analogous SSEA3 distributions. It is not anticipated that models generated using different 
instrumentation will be directly comparable, however, development on the Incell not only 
enables the use of the technique with less robust cell lines, but it is also easier to examine 
multiple markers simultaneously, including for example, intracellular staining of transcription 
factors. The mathematical model could also be extended to include description of the dynamics 
of multiple markers for heterogeneity simultaneously. This extension of the modelling process 
to additional dimensions of heterogeneity is possible in principle but is yet to have ever been 
attempted (Coca, personal communication). Analysis on the Incell analyser platform also opens 
up opportunities to examine spatial arrangement of cell heterogeneity; information that is lost 
with a flow cytometry approach.  
 
Examination of biological behaviours associated with equilibrium points was preformed using a 
clonogenic assay. This assay showed that there were differences between different sorted 
fractions. However, it provides no information on differentiation lineage biases. Additional 
experiments that examined directed differentiation efficiencies would be key to elucidating the 
relationship of equilibrium points to lineage biased substates, if at all. Alternatively, 
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transcriptomic analysis in particular of pluripotency factors and lineage transcription factors 
provides an additional approach whereby any association of equilibrium points to lineage biased 
substate could be addressed. 
 
6.5 Raman spectroscopy  
Given the groundwork already laid out, and the iterative optimisation that occurred throughout 
this body of work, repeating the earliest experiments with the refined technique would be 
informative. For instance, the Retinoic Acid differentiation time course experiment, which 
appeared to show differences between differentiating and undifferentiated cells as soon as 
three hours post induction. This potentially important result was obscured in the original 
experiment by problems associated with cell stress and point acquisition. Repeating this 
experiment using the hyperspectral imaging approach on fixed cells would be a more accurate 
experiment and provide a more definitive result. 
 
The NTera2 SSEA3-based heterogeneity similarly would benefit from reanalysis in the light of 
more sophisticated spectral collection techniques. In particular, the use of a fluorophore that is 
not excited by the laser is paramount to an effective interpretation of biochemical heterogeneity 
associated with SSEA3 expression.  
  
The experiments described about could be extended to include an examination of SSEA3 
heterogeneity with predicted equilibrium points. If for instance, a particular equilibrium point 
was primed to differentiate it may present Raman spectra with the increased protein to 
nucleotide ratio that is the common difference between differentiating and undifferentiated 
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cells. Alternatively, other spectral fingerprints could become apparent that are reflective of 
particular substates or equilibrium points.  
 
One aspect of the hyperspectral Raman imaging approach adopted is that of special 
considerations with regard to biochemistry within the cell. In a crude manner, an examination 
was made between nuclear and non-nuclear regions. However, a converse approach could be 
useful for identifying particular organelles or processes within the cell. For instance, the location 
of mitochondria could be identified by the presence of cytochrome c-specific wavenumbers at 
751cm-1, 1128cm-1, 1314cm-1 and 1583cm-1. Alternatively, spatial association of wound and 
unwound chromatin to different regions of the nucleus could be tracked with minimal 
interference.  
 
6.6 Raman spectra normalisation 
Although we have gone some way towards optimising our approach for data collection, the 
analysis of spectra collected remains challenging. Currently, there exists several approaches for 
normalising and subsequent analysis of spectra. The approach we use here was that suggested 
by the owner of the Raman microscope used in this study, although it has become apparent, 
however that this manipulation of the data is heavily distorted by baseline effects. This could 
itself be the cause of separation in PCA analysis. It is therefore worth exploring other 
normalisation techniques in order to acquire comparable spectra that are representative of real 
biochemical differences, rather than influenced by the baseline. This issue has been explored 
somewhat in in an excellent review by (Afseth et al., 2006) who provided in-depth analysis of 
techniques used in the pre-processing of Raman spectra.  
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6.7 Raman microscope instrumentation for stem cell applications  
The system used in these experiments was ill-equipped for analysis of sensitive live human 
embryonic stem cells. However, with a few modifications suitable system for the analysis of live 
embryonic stem cells in a monolayer format could be easily achieved. First and foremost, the 
capacity to maintain healthy cells is paramount, and the installation of an aseptic, heated 
environment chamber would allow the acquisition of Raman spectra of cells maintained in a 
healthy state. This capacity would simultaneously bypass problems associated with chemical 
alteration caused by chemical fixation as well utilising Raman to its fullest potential as a non-
invasive metabolomic profiling technique. Although this will also be associated with its own 
problems, such as media interference that could be overcome with effective protocols such as 
standardised chemically defined media and effective pre-processing to remove media baseline. 
However, it is likely that an increase in acquisition time will be necessary to ensure a good signal 
to noise ratio. This leads to the prime limitation of this technique, the long acquisition time 
needed to acquire spectra from individual cells. With regards acquiring informative spectra 
representative of individual cells, and increased laser spot size could be utilised that would cover 
a larger area of the cell and consequently reduce acquisition time at the expense of special 
resolution. This technique of increased laser spot size has been used by several groups 
effectively to reduce Raman spectra acquisition time. In addition, examining cells in a monolayer 
format could easily be coupled with time lapse experiments tracking the behaviour of cells over 
time as well as in comparison to its neighbours.  
 
An alternative approach altogether is the use of Raman spectroscopy in conjunction with 
microfluidics for the examination of cells in suspension and can be coupled readily with cell 
sorting based upon Raman spectroscopy. This technique has been recently developed and 
termed Raman Activated Cell Sorting (RACS) (Zhang et al., 2015). This approach collects the 
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Raman spectrum of cells in suspension, which based upon the data collected in this thesis, 
generates a signal that is approximately six times stronger than the cells in monolayer. This 
effect in itself would act to drastically reduce acquisition time per cell. RACS could also be 
coupled with other single cell analyses on sorted cells of interest that could provide a link 
between metabolomic profiles and transcriptomic, genetic or epigenetic profiles.  
 
Alternative ways of boosting Raman signal includes employing techniques such as coherent anti-
stokes Raman spectroscopy (CARS) and surface-enhanced Raman spectroscopy (SERS) 
(described in chapter 1). The former technique is preferable because SERS requires that the 
sample be treated with metallic nanoparticles, that may introduce additional and unexpected 
behavioural effects of the living cells. Although CARS does produce an increased signal 
generation the spectral range that can be acquired is generally reduced to a couple of hundred 
wavenumbers, and requires a tuneable laser. However, this technique is extremely high 
throughput and capable of obtaining spectra from whole cells with collection times of 300ms 
(Konorov et al., 2007). 
 
Within the context of pluripotent stem cell heterogeneity, it would be important to know 
whether heterogeneity observed is due to actual behavioural differences or whether it more 
closely reflects other known cell dynamics. For instance, the difference between heterogeneous 
cell populations may be better explained by their position in the cell cycle rather than an 
independent source of heterogeneity, although it is plausible that cell behaviour and other 
macrodynamics such as cell cycle may be related to some extent. Other groups have already 
examined changes in Raman spectra with changes in cell cycle position and so this may provide 
an angle by which sub state heterogeneity and cell cycle heterogeneity may be untangled. 
Finally, Raman spectroscopy does not have direct explanatory power of the differences between 
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samples of different spectra. The association of particular wavenumbers with biomolecules 
inferred here were collated from various databases in the literature. However, these 
associations are inferred, although probable. Candidate molecules inferred to be responsible for 
differences in Raman spectra would need to be measured by other means in order to 
categorically demonstrate that the concentration of these molecules different between 
samples. 
 
This body of work has developed both novel exploratory techniques and provided a basis for 
understanding heterogeneity within the stem cell compartment. This thesis has laid the 
groundwork necessary for expanding both the dynamical modelling and Raman spectroscopy 
application to pluripotent stem cell biology.   
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